Maheshwari v. Governing Bd. of Sharp Mem’l Hosp.

Maheshwari v. Governing Bd. of Sharp Mem’l Hosp.

Filed 4/10/03 Maheshwari v. Governing Bd. of Sharp Mem. Hosp. CA4/1

NOT TO BE PUBLISHED IN OFFICIAL REPORTS

California Rules of Court, rule 977(a), prohibits courts and parties from citing or relying on opinions not certified for
publication or ordered published, except as specified by rule 977(b). This opinion has not been certified for publication or
ordered published for purposes of rule 977.

COURT OF APPEAL, FOURTH APPELLATE DISTRICT

DIVISION ONE

STATE OF CALIFORNIA

D039509

(Super. Ct. No. GIC771148)

v.

Plaintiff and Appellant,

B. D. MAHESHWARI,

GOVERNING BOARD OF SHARP
MEMORIAL HOSPITAL,

Defendant and Respondent.

APPEAL from a judgment of the Superior Court of San Diego County, John S.

Meyer, Judge. Affirmed.

By this appeal, the plaintiff B. D. Maheshwari, M.D., a cardiologist, seeks to

overturn the court’s decision upholding Sharp Memorial Hospital’s (Sharp’s) decision to

deny his application for staff privileges. When Dr. Maheshwari applied for staff

privileges, the medical executive committee (MEC) for Sharp denied his application on

the basis that (1) it had concerns about the quality of Dr. Maheshwari’s care at another

hospital, Riverside Community Hospital (RCH), where he had previously worked; and

(2) he allegedly did not provide sufficient information to Sharp with his application for

Sharp to perform a complete evaluation of his application. Dr. Maheshwari appealed that

decision to Sharp’s judicial review committee (JRC), and when it denied his appeal, he

appealed to the defendant Governing Board of Sharp Memorial Hospital (the Board).

The Board denied Dr. Maheshwari’s appeal.

Dr. Maheshwari thereafter filed a petition for writ of administrative mandamus

(petition) under Code of Civil Procedure section 1094.5,1 asserting that Sharp’s

application process violated his due process rights, was unfair, and that Sharp’s actions

were arbitrary and capricious. He also contended that there was no substantial evidence

to support Sharp’s decision, and that Sharp erred by excluding certain evidence Dr.

Maheshwari sought to submit at the hearing before the JRC (JRC Hearing).

The court ruled in favor of Sharp on Dr. Maheshwari’s petition. First, the court

found that substantial evidence supported Sharp’s decision. The court also found that

Sharp provided Dr. Maheshwari with a fair procedure in conjunction with his application.

The court found that there was no substantial evidence to support Dr. Maheshwari’s

assertion that Sharp acted arbitrarily and capriciously during the process. The court also

found that Sharp’s decision to exclude certain evidence was supported by the record.

1
All further statutory references are to the Code of Civil Procedure unless otherwise
specified.

2

Finally, the court found that there was no merit to Dr. Maheshwari’s claim of a violation

of his due process rights.

On this appeal, Dr. Maheshwari first asserts his fair procedure rights were violated

because Sharp’s actions were “arbitrary and capricious.” Specifically, Dr. Maheshwari

asserts that Sharp (1) decided to “get rid of” his application before it received any records

concerning the RCH cases; (2) refused to allow him to meet with Sharp committees; (3)

required Dr. Maheshwari to submit patient names and other confidential information in

connection with his application; (4) conducted an investigation searching for medical

malpractice actions filed against him and his wife; and (5) breached its promise to obtain

patient information from other hospitals before making a decision on his application. Dr.

Maheshwari also contends that the process was unfair because Sharp allowed its chief of

medical staff, who was biased against Dr. Maheshwari’s application, to be involved in the

decision-making process.

Dr. Maheshwari asserts that his equal protection rights were violated because

Sharp’s bylaws do not afford applicants for staff privileges the same right to meet with

committee members as members of the medical staff. Dr. Maheshwari asserts that the

JRC hearing officer erred by excluding from consideration on his appeal certain medical

records, follow-up information and declarations from former patients. Finally, Dr.

Maheshwari contends that Sharp’s expert witness who testified before the JRC applied

the wrong standard of care in evaluating Dr. Maheshwari’s care of patients.

We conclude that (1) Sharp did not violate Dr. Maheshwari’s fair hearing rights;

(2) there was no error in the exclusion of evidence he presented for the first time at the

3

JRC Hearing; and (3) Sharp’s expert’s testimony does not require a reversal in this

matter.2 Accordingly, we affirm the judgment.

FACTUAL AND PROCEDURAL BACKGROUND

I. Factual Background

A. Dr. Maheshwari’s Qualifications

Dr. Maheshwari earned his medical degree at a medical school in India and then

worked as a doctor in Great Britain for five years. He came to the United States in 1971.

Dr. Maheshwari completed a fellowship in cardiology, including cardiac catherization, at

Wayne State University in Detroit, Michigan. He has been board certified in internal

medicine since approximately 1973 and board certified in cardiology since 1975. Dr.

Maheshwari is also an attorney.

Dr. Maheshwari has practiced medicine in Corona, California, since

approximately 1975. He had full invasive cardiology privileges, including balloon

angioplasty and coronary stenting, at RCH, Anaheim Memorial Hospital (AMH), and

Western Medical Center, Anaheim (WMC). He also had provisional invasive cardiology

privileges at Scripps Memorial Hospital in San Diego.

B. Dr. Maheshwari’s Application for Staff Privileges at Sharp

In November 1998, Dr. Maheshwari submitted an application for staff privileges

to Sharp. In that application Dr. Maheshwari sought privileges to perform general

2
As we shall discuss, post, based upon the reasons for our holding that there was no
violation of Dr. Maheshwari’s fair hearing rights, we need not address his claim that his
equal protection rights were violated.

4

cardiology, diagnostic catherization and interventional cardiology services. As part of

the application, Dr. Maheshwari agreed that he, as an applicant, had the burden of

producing to Sharp adequate information for it to evaluate his competence and

qualifications. The bylaws of the attending medical staff for Sharp (Staff Bylaws),

paragraph 5.2 provides in part:

“[T]he Applicant shall have the burden of producing information for
an adequate evaluation of the applicant’s qualifications and
suitability for the clinical privileges and staff category requested, of
resolving any reasonable doubts about these matters, and of
satisfying requests for information. The applicant’s failure to sustain
this burden shall be grounds for denial of the application.”

Dr. Maheshwari also agreed to provide patient records for use in the evaluation

process if Sharp deemed them relevant. Dr. Maheshwari was granted temporary

privileges pending a decision on his application.

Shortly after the review process began, Sharp discovered that Dr. Maheshwari was

under review by RCH because of quality-of-care concerns in seven cases Dr. Maheshwari

worked on there. In a memorandum Barbara Grondona, Sharp’s medical staff office

manager, told Sharp’s chief of staff, Dr. David Ostrander, of the review by RCH. The

memorandum also spoke of the status of Dr. Maheshwari’s temporary privileges pending

investigation of the RCH review:

“The issue is that, if we terminate these privileges, it’s reportable to
both the Medical Board and Data Bank and this doctor would be
entitled to his hearing rights, under the Bylaws. I’ve confirmed this
with legal counsel. They had a good alternative: [¶] They suggest
that you speak with Dr. Maheshwari and be candid with him. Tell
him that, in conjunction with the credentialing process, we have
learned that he is currently under quality review at another hospital.
Let him know that, in light of this, it is incumbent upon the Medical

5

Staff to investigate and that, pending conclusion of the investigation,
it is our recommendation that he withdraw his temporary privileges.
Let him know that we will proceed with processing his application
and that any information that he can provide, regarding the quality
review, will be helpful to our medical staff in assessing his
application. Let him know that if he does not agree to this, we will
have to terminate his temporary privileges, we will have to report
him.” (Italics added.)

Dr. Ostrander followed this up with a telephone conversation with the chief of

staff at RCH, Dr. C. Bevan Stuart. Dr. Stuart outlined some of the concerns RCH had

with Dr. Maheshwari’s treatment of patients. Based upon this conversation, Dr.

Ostrander decided that Sharp should investigate the RCH review.

Dr. Ostrander thereafter informed Dr. Maheshwari that Sharp was investigating

the RCH review and advised him that they needed further information that they could not

obtain from RCH:

“We were not able to learn any details regarding the specific reasons
for this review, and our routine query of your status with that
hospital has not been answered, despite several requests. [¶] . . .
[¶] In light of the absence of specific details involving this matter
and our inability to get the required written response from [RCH],
your application is considered incomplete. If there is any further
information you can provide, as to your current situation at that
hospital, please do so.” (Italics added.)

Dr. Maheshwari was also advised that as he had not requested renewal of his

temporary privileges after 90 days, they had expired and would not be renewed.

C. Decision by Hoagland Committee

Dr. Ostrander advised Dr. Maheshwari that a panel of cardiologists would be

appointed to review the quality of care issue. This committee was known as the

“Hoagland Committee” because Dr. Paul Hoagland chaired it.

6

Dr. Maheshwari replied to Dr. Ostrander’s letter as follows:

“I understand that there has been an understanding between you and
Maurice Buchbinder that I will supply you with details of these
cases, and that you will appoint a panel of cardiologists from [Sharp]
to review that cases with respect to the quality. I am sending you
copies of the medical records obtained from [RCH] on these
patients, the observations of the members of the Cardiology Section
of [RCH] on the individual cases, and my responses. . . .

“. . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .

“If you or your committee have any questions with respect to the
[RCH] cases, I will be very happy to visit and answer the questions.”
(Italics added.)

However, only portions of the medical records were submitted at that time. Dr.

Ostrander acknowledged receipt of the documents Dr. Maheshwari provided and

informed him that Sharp would “proceed with the review of these cases and the

processing of your application. Additionally, if you are able to provide any additional

information regarding the status of the peer review proceedings at [RCH], it will be most

helpful. Should additional information be needed, we will contact you.” (Italics added.)

Dr. Maheshwari then sent a letter with information concerning the review at RCH.

Dr. Maheshwari also stated in that letter that he was “very willing to come and talk to you

and/or any other cardiologist(s) who have an interest in exploring further these matters.”

Dr. Ostrander informed Dr. Maheshwari that the Hoagland Committee would need

the radiological studies or “cine films,” which were films taken of the actual procedures

performed by Dr. Maheshwari, for each patient in the suspect cases. Dr. Ostrander

informed Dr. Maheshwari that his application would “be considered incomplete until we

receive this information and any other information which might be deemed necessary.”

7

Although the chief of staff at RCH initially refused to release the cine films, after threat

of a lawsuit by Dr. Maheshwari, RCH sent the cine films to Sharp.

After the cine films were received by Sharp, Dr. Ostrander informed Dr.

Maheshwari that “[t]he information will now be reviewed and you will be informed of

the outcome of this review process.” The Hoagland Committee met and reviewed the

cine films and concluded that Dr. Maheshwari’s treatment was below the standard of care

in six of the seven cases.

Following receipt of the Hoagland Committee’s report, Dr. Ostrander notified Dr.

Maheshwari that Sharp would seek an independent review of the medical records and the

cine films through the California Medical Association (CMA). This was proposed,

according to Dr. Ostrander, as it was “most fair” that the issue be reviewed by someone

not known to any of the parties involved. Dr. Maheshwari responded that he did not “see

any need for independent CMA review of the medical records and cine films since the

cardiologists at [RCH], as well as[] at [Sharp,] have already reviewed them. Any further

review would be redundant.”

D. Denial of Application by MEC

Thereafter, Dr. Maheshwari’s application went to the MEC for a decision. The

MEC, through Dr. Ostrander, advised Dr. Maheshwari that it had reviewed his request for

privileges, had concerns about the quality of care rendered in the RCH cases, and wanted

him to provide patient information for his cardiology cases for the past six months at all

facilities where he currently held privileges. Dr. Maheshwari responded that he would

not provide the information due to privacy concerns as to his patients and that, based

8

upon the information he had already provided, he had established his qualifications for

privileges.

Dr. Ostrander responded to Dr. Maheshwari by clarifying that Sharp was only

seeking a sampling of these cases, that the privacy concerns could be addressed, and by

citing state law that allows physicians to disclose medical information to committees at

hospitals that are reviewing the competence or qualifications of doctors. Dr. Ostrander

reminded Dr. Maheshwari that it was his burden to provide information to establish his

competence and qualifications and stated that if he refused to provide the requested

information his application would be deemed denied. Dr. Maheshwari wrote back,

stating that if Sharp needed the patient information, it should request it from the hospitals

itself. Dr. Maheshwari also stated that Sharp’s delay in rendering a decision on his

application had “damaged” him.

Because of Dr. Maheshwari’s refusal to obtain the requested patient records

requested by the MEC, the MEC itself contacted RCH and other hospitals to attempt to

obtain a sampling of six months of Dr. Maheshwari’s cases. After receiving authorization

from Maheshwari, Sharp requested samplings from RCH and the Corona Regional

Medical Center (CRMC). Dr. Stuart of RCH wrote a letter to Sharp’s then-chief of staff,

Dr. Kenneth J. Roth, expressing concerns about patient confidentiality and stating that he

believed this was information that Dr. Maheshwari himself should provide to Sharp. Dr.

Roth also spoke to Dr. Stuart by telephone around this time. Dr. Stuart told Dr. Roth

about problems RCH had had with Dr. Maheshwari. Dr. Roth’s notes of the conversation

with Dr. Stuart reflect that Dr. Stuart stated as to Dr. Maheshwari that “he’s the worst

9

physician on our staff” and that “I regret the day we ever granted him privileges here.”

Dr. Roth did not relay this information to Dr. Maheshwari. CRMC never responded to

the MEC’s request for records.

Based upon Dr. Maheshwari’s refusal to provide any further information to the

MEC, his expressed concern over the time that had passed since his application was

submitted, and the lack of cooperation from RCH and CRMC, the MEC decided to

proceed with a vote upon Dr. Maheshwari’s application without the six-month sampling.

In February 2000, Dr. Roth, then-chief of staff for Sharp, informed Dr. Maheshwari that

the MEC had voted to recommend denial of the application. The denial was based upon

the MEC’s concerns about the quality of care in Dr. Maheshwari’s coronary interventions

and its doubts concerning his overall clinical judgment in cardiology. Dr. Maheshwari

was also notified that the denial was based in part upon his failure to meet his burden of

producing information that would have allowed the MEC to more fully evaluate his

qualifications and suitability for general cardiology privileges.

E. JRC Hearing

In February 2000 Dr. Maheshwari advised Sharp that he was requesting a JRC

Hearing, as provided in Sharp’s Staff Bylaws, to contest the decision by the MEC. The

JRC Hearing was conducted before the JRC, which consisted of physicians from the

medical staff at Sharp. The hearing was also presided over by a hearing officer, Steven

Landuyt, Esq.

The JRC Hearing took place over five days in April and May 2000. The JRC

received and reviewed medical records, the cine films and other supporting documents

10

from the RCH cases. Dr. Maheshwari testified concerning his management of the RCH

cases. He also established that he was never disciplined by RCH concerning those cases

and that RCH not only renewed his privileges after he treated those patients, but also

granted him additional privileges in interventional cardiology.

The JRC heard testimony from experts retained by both Dr. Maheshwari and

Sharp. Dr. Paul Phillips, Sharp’s expert, testified that Dr. Maheshwari’s treatment in the

RCH cases “fell below the standard of care.” When asked to define the standard of care,

Dr. Phillips stated that it was what a “quorum of physicians” would feel that a “majority

of cardiologists” would have done. Dr. Phillips further explained that in Dr.

Maheshwari’s case “the standard of therapy being administered was below that which I

would accept in my laboratories.”

Dr. Maheshwari called Dr. Maurice Buchbinder as his expert. Dr. Buchbinder was

Sharp’s director of interventional cardiology from 1995 to 1999. Dr. Buchbinder had

known Dr. Maheshwari professionally for 10 to 12 years and had worked on

approximately 20 to 25 interventions with Dr. Maheshwari. Dr. Buchbinder opined that

Dr. Maheshwari’s “judgment was right on in the median and mean of every individual

that I have come across. His synthesis of the cases have [sic] been, generally speaking,

what I would have thought of . . . I have not been struck by anything unusual more than

standard practice.”

Dr. Buchbinder stated that in most cases Dr. Maheshwari’s decisions were the

same as he would have made. Although in some instances he would have acted

differently, Dr. Buchbinder testified that in his opinion Dr. Maheshwari’s actions were

11

reasonable and within the standard of care. Dr. Buchbinder stated that the standard of

care was what a reasonable interventional cardiologist would do in the circumstances of a

particular case.

At the JRC Hearing Dr. Maheshwari also sought to admit the complete medical

records of the six RCH patients, as well as declarations from some of those patients. The

hearing officer requested letter briefs on the issue and concluded that the evidence should

be excluded as Sharp had requested all information concerning the RCH patients from the

beginning. The hearing officer concluded that Dr. Maheshwari understood the

importance of those records and could have submitted the entire chart for each of the

patients initially, but did not do so. Instead, Dr. Maheshwari requested that his

application be reviewed based upon the information he had already provided.

F. The JRC’s Decision

The JRC upheld the decision to deny Dr. Maheshwari’s application for privileges.

In reaching this decision the JRC relied upon the testimony of Dr. Phillips, cine films and

the medical records provided by Dr. Maheshwari. Based upon this evidence, the JRC

concluded that serious quality-of-care issues existed in the six RCH cases. The JRC also

concluded that Dr. Buchbinder’s testimony, rather than supporting Dr. Maheshwari,

“damned” him “with faint praise.” The JRC also was not persuaded by Dr. Maheshwari’s

own testimony concerning his care in the six RCH cases.

The JRC found that Dr. Maheshwari had the burden of producing information for

an adequate evaluation of his qualifications for staff membership and privileges,

including the burden of producing satisfactory information to resolve reasonable doubts

12

concerning his qualifications and suitability for the clinical privileges that he was

seeking. The JRC concluded that Sharp received information that raised reasonable

doubts concerning Dr. Maheshwari’s qualifications for general cardiology and

interventional cardiology privileges. The JRC found that Sharp took reasonable steps to

resolve the questions raised about Dr. Maheshwari’s qualifications. The JRC then

concluded that the evidence demonstrated that in six of the seven cases under review by

RCH Dr. Maheshwari’s treatment fell beneath the standard of care for cardiologists.

The JRC also found that Dr. Maheshwari refused to provide information requested

by Sharp that was needed to establish his qualifications and to resolve reasonable doubts

that had arisen regarding his qualifications. Finally, the JRC found that Dr. Maheshwari

failed at the JRC Hearing to meet his burden of persuading the JRC, by a preponderance

of the evidence, of his qualifications of membership and privileges in general cardiology

and interventional cardiology.

G. Appeal to Sharp’s Board

In September 2000, Dr. Maheshwari appealed the JRC’s decision to Sharp’s Board.

In that appeal Dr. Maheshwari first asserted that Sharp’s evaluation of his application was

a “sham” and that Sharp had decided to deny his application before it had the necessary

information. In the appeal Dr. Maheshwari also contended that he had proved by a

preponderance of the evidence that he was qualified to have privileges at Sharp.

Dr. Maheshwari asserted that the evidence demonstrated that his handling of the

six RCH cases did not violate the standard of care. Dr. Maheshwari also asserted that the

13

hearing officer erred in excluding the new evidence he sought to admit at the JRC

Hearing.

Dr. Maheshwari contended that Sharp’s standards for evaluating applicants for

staff privileges were “arbitrary and capricious” and that it acted in an arbitrary and

capricious manner in denying his application. Finally, Dr. Maheshwari asserted that the

JRC violated Staff Bylaws and his due process rights when it considered different

allegations of improper care in the RCH patients from that considered by the Hoagland

Committee.

In June 2001, the Board issued its decision affirming the decision of the JRC. In

doing so, the Board concluded that the JRC’s decision was not arbitrary or capricious and

was supported by substantial evidence. The Board also rejected Dr. Maheshwari’s claim

that the hearing officer improperly excluded evidence and that certain procedural errors

resulted in a miscarriage of justice. Specifically, the Board found:

“1. The [JRC’s] decision is not arbitrary or capricious and is
supported by subtantial evidence. The record supports the [JRC’s]
conclusion that cases reviewed by an ad hoc committee (the
Hoagland committee) demonstrated problems with Dr. Maheshwari’s
care of patients at another facility and it was reasonable to request
Dr. Maheshwari to produce additional information (i.e., information
sufficient to allow (Sharp) to conduct a review of a random sample
of Dr. Maheshwari’s cardiology cases over a six month period) to
resolve reasonable doubts about his qualifications and suitability for
medical staff membership.

“2. The record supports the [JRC] Hearing Officer’s decision to
exclude certain evidence proffered by Dr. Maheshwari on the ground
that it was inadmissible under Medical Staff Bylaws section 83-7(2).

“3. While it appears that the Medical Staff failed to comply with the
requirement in the [Sharp] Bylaws, Article X, section 1(d), it also

14

appears that such provision is not mirrored by any [Sharp] Medical
Staff Bylaws provision. It is clear from the record that the Medical
Staff sought throughout the proceedings to comply fully with the
procedural requirements of the Medical Staff Bylaws. The standard
for determining the effect of an error in procedure is set forth in the
Medical Staff Bylaws section 8.4-2: ‘In no event shall the decision
of the [JRC] be set aside or reversed on the grounds of improper
admission or rejection of evidence, or for any error in matters of
notice or procedure, unless, after an examination of the entire cause,
including the evidence, the governing body shall be of the opinion
that the error complained of has resulted in a miscarriage of justice.’

“After an examination of the entire cause, the Appellate Panel
believes that the error complained of (i.e., the failure of Dr.
Maheshwari to appear before an ad hoc investigating committee of
his section/clinical department) did not result in a miscarriage of
justice. Dr. Maheshwari was afforded the opportunity to present any
evidence he wished to the Hoagland committee, and he was afforded
and took advantage of the opportunity to appear in person and testify
before the [JRC] and to present evidence. In addition, the Appellate
Panel notes that the [Sharp] Bylaws section in question is vague
and/or confusing about the timing of the right to appear before an ‘ad
hoc investigating committee.’ The [Sharp] Bylaws section appears
to require that the opportunity to apear before the ‘ad hoc
investigating committee’ be afforded AFTER the final decision is
reached by the [MEC] to not confer an appointment, etc.

“4. In all other aspects other than the apparent discrepancy between
the [Sharp] Medical Staff Bylaws and the [Sharp] Bylaws, the
reporter’s transcript of the [JRC] Hearing reflects that Dr.
Maheshwari was afforded a fair procedure in substantial compliance
with the Medical Staff Bylaws. . . .”

H. Petition to Superior Court

Following the Board’s denial of his appeal, Dr. Maheshwari filed his petition with

the San Diego County Superior Court. In that petition, Dr. Maheshwari asserted that the

Board’s decision constituted a prejudicial abuse of discretion because substantial

evidence established that Dr. Maheshwari was qualified to receive privileges at Sharp.

15

Dr. Maheshwari also asserted that his fair procedure and due process rights were violated

based upon Sharp’s handling of his application. Specifically, Dr. Maheshwari asserted

that Sharp (1) decided to get rid of his application before reviewing the RCH cases; (2)

failed to give him the opportunity to meet with Sharp’s committees; (3) refused to inform

him concerning specific concerns about the RCH cases until after it denied his

application; (4) demanded that he provide private patient information; (5) hired a law

firm to conduct a search for lawsuits involving he and his wife; (6) broke its promise not

to decide his application until additional patient information was forthcoming; and (7)

failed to inform him of his right to seek reconsideration of the MEC’s decision. Dr.

Maheshwari also contended that the hearing officer at the JRC Hearing erred by

excluding the evidence he attempted to submit at that hearing. Finally, Dr. Maheshwari

asserted that the JRC erred by relying on the testimony of Sharp’s expert because he did

not use the proper standard of care in rendering his opinion.

After reviewing the record of Dr. Maheshwari’s application process and hearing

arguments of counsel, the court rejected Dr. Maheshwari’s claim. The court detailed the

evidence in the record and the chronology of the application proceeding and concluded

that the decisions of both the JRC and Board were supported by substantial evidence.

The court also found that Dr. Maheshwari was “afforded a fair procedure in substantial

compliance with the Medical Staff Bylaws in that [he] was afforded the opportunity to

question and challenge committee members at the [JRC] Hearing, he was represented by

counsel at the hearing, a record of the proceedings was made, he was afforded the ability

16

to present evidence and cross-examine witnesses, and he was provided with a decision

based on a majority vote by the [JRC].”

The court found that Sharp did not use “arbitrary or capricious tactics.”

Specifically, the court found that the evidence did not support Dr. Maheshwari’s claim

that Sharp decided to reject his application before it reviewed any medical records. The

court found that there was no evidence that Sharp refused to meet with Dr. Maheshwari

as there was no request by Dr. Maheshwari to meet with any committees. The court also

found that there was no evidence an appearance before the committees would have made

a difference or that Sharp’s alleged refusal to meet with him resulted in a miscarriage of

justice.

The court rejected Dr. Maheshwari’s claim that he was treated differently than

other applicants because Sharp requested confidential information concerning his

patients. The court found that substantial evidence demonstrated that Sharp was only

interested in medical records, not personal confidential information concerning his

patients. The court also found that it was not unusual that Sharp performed a lawsuit

search on Dr. Maheshwari. The court rejected Dr. Maheshwari’s claim that Sharp

allegedly broke “promises” that they would advise him when they had completed review

of certain evidence.

The court also found that the hearing officer at the JRC Hearing properly excluded

the evidence submitted by Dr. Maheshwari for the first time at that hearing. The court

found that the evidence was requested by Sharp during the application process and there

was no showing by Dr. Maheshwari that he could not have produced the records earlier.

17

The court rejected Dr. Maheshwari’s due process and fair procedure claims. Based

upon its previous findings, the court concluded there was no merit to Dr. Maheshwari’s

claims that any “tactics” by Sharp denied him his due process or fair procedure rights.

The court found that Dr. Maheshwari was given notice of Sharp’s decision, he “was

provided with the opportunity to question and challenge committee members at the [JRC]

Hearing, he was represented by counsel at the hearing, a record of the proceedings was

made, he was afforded the ability to present evidence and cross-examine witnesses, and

he was provided with the decision based on a majority vote by the [JRC].”

The court entered judgment in favor of Sharp. This timely appeal follows.

DISCUSSION

On this appeal Dr. Maheshwari, although setting forth facts he contends show

there was substantial evidence that he was qualified for staff privileges at Sharp, does not

directly challenge the finding by the court that substantial evidence supported Sharp’s

rejection of his application. Rather, Dr. Maheshwari asserts that the actions by Sharp

violated his fair procedure and equal protections rights, the JRC erred in excluding

evidence he presented for the first time at the JRC Hearing, and Sharp’s expert failed to

apply the proper standard of care in evaluating his performance. We reject these

assertions.

I. Fair Procedure Claims

Dr. Maheshwari asserts that his right to a fair procedure in the application process

was violated because (1) Sharp acted arbitrarily and capriciously in denying his

application; (2) Sharp violated its own bylaws in the process; and (3) Dr. Ostrander

18

should not have been allowed to participate in the process. We address these contentions

in order.

A. Standard of Review

Section 1094.5, governing petitions for writ of administrative mandamus,

provides in part:

“(a) Where the writ is issued for the purpose of inquiring into the
validity of any final administrative order or decision made as the
result of the proceeding in which by law a hearing is required to be
given, evidence is to be taken, and discretion in the determination of
facts is vested in the inferior tribunal, corporation, board or officer,
the case shall be heard by the court sitting without a jury. . . .

“(b) The inquiry in such a case shall extend to the questions whether
the respondent has proceeded without, or in excess of jurisdiction;
whether there was a fair trial; and whether there was any prejudicial
abuse of discretion. Abuse of discretion is established if the
respondent has not proceeded in the manner required by law, the
order or decision is not supported by the findings, or the finding are
not supported by the evidence.

“(c) Where it is claimed that the findings are not supported by the
evidence, in cases in which the court is authorized by law to exercise
its independent judgment on the evidence, abuse of discretion is
established if the court determines that the findings are not
determined by the weight of the evidence. In all other cases, abuse
of discretion is established if the court determines that the findings
are not supported by substantial evidence in light of the whole
record.

“(d) Notwithstanding subdivision (c), in cases arising from private
hospital boards abuse of discretion is established if the court
determines that the findings are not supported by substantial
evidence in light of the whole record.” (Italics added.)

Thus, ordinarily, the superior court reviews an adjudicatory decision by a private

hospital board (such as here) under the substantial evidence standard. (Huang v. Board of

19

Director (1990) 220 Cal.App.3d 1286, 1293.) However, the question of whether a

physician received a fair hearing in an application for hospital privileges is subject to

independent review by trial courts. (Rosenblit v. Superior Court (1991) 231 Cal.App.3d

1434, 1442.) Our review of a claim of violation of the right to a fair hearing is similarly

de novo. (Ibid.; Duncan v. Department of Personnel Administration (2000) 77

Cal.App.4th 1166, 1174.)

B. Fair Hearing Rights

Private hospitals must observe “fair procedures” in rejecting, revoking or

terminating staff privileges of a physician. (Ezekial v. Winkley (1977) 20 Cal.3d 267,

269-270; Westlake Community Hosp. v. Superior Court (1976) 17 Cal.3d 465, 468.)

However, hospitals do not have to accord all of the same due process rights guaranteed to

litigants in civil or criminal trials. (Anton v. San Antonio Community Hosp. (1977) 19

Cal.3d 802, 829-830.) A hospital complies with its fair hearing obligation if it gives the

affected physician adequate notice of the charges and a fair opportunity to present his

position. (Id. at p. 830.)

Nevertheless, under its duty to provide a fair procedure, a hospital may not act in

an arbitrary or capricious manner in rejecting a physician’s application for staff

privileges. (Pinsker v. Pacific Coast Society of Orthodontists (1974) 12 Cal.3d 541, 550,

553.) The right of a physician to a fair hearing must be balanced against the interests of

the hospital in protecting members of the public who receive care at its facility. (Rhee v.

El Camino Hospital Dist. (1988) 201 Cal.App.3d 477, 489 (Rhee).) Because of this,

“courts must not interfere to set aside decisions regarding hospital staff privileges unless

20

it can be shown that a procedure is ‘substantively irrational or otherwise unreasonably

susceptible of arbitrary or discriminatory application.’ [Citations.]” (Ibid.)

C. Analysis

1. Alleged premature decision to “get rid of” Dr. Maheshwari’s application

Dr. Maheshwari first asserts that Sharp decided to “get rid of” his application

before receipt of any medical records regarding the RCH review. We reject this

contention.

In support of this contention Dr. Maheshwari first cites the memo from Grondona

to Dr. Ostrander regarding the review of his cases at RCH and his temporary privileges.

Dr. Maheshwari asserts this document shows that Grondona was advising Dr. Ostrander

how to get rid of Dr. Maheshwari’s application. According to Dr. Maheshwari, the

decision to get rid of him was made at that time and all of Sharp’s actions thereafter were

“designed to justify a decision that it had already made.”

However, the record does not support this contention. First, the memorandum was

concerned about the status of Dr. Maheshwari’s temporary privileges while the

investigation was ongoing. The memo was only advising that to avoid having to report

Dr. Maheshwari he should be given the option to withdraw his application for temporary

privileges pending Sharp’s investigation. The memo says nothing about getting rid of Dr.

Maheshwari’s application and, instead, actually reflects the fact that Sharp was going to

investigate the issue of the RCH cases before making a decision on his application. The

conversation between Dr. Ostrander and Dr. Stuart also reflects that it motivated Sharp to

investigate the RCH cases further, not to summarily deny Dr. Maheshwari’s application.

21

The record reflects that Sharp did investigate the allegations regarding RCH,

requested documents from Dr. Maheshwari, attempted to obtain them on its own when

they were not forthcoming from Dr. Maheshwari, and that Dr. Maheshwari objected to

Sharp reviewing records of additional patients to assist in its review. After the Hoagland

Committee concluded that there were quality-of-care problems with six RCH cases,

Sharp offered to have the matter reviewed by an independent group, the CMA. Dr.

Maheshwari refused this offer. Far from demonstrating that Sharp decided to get rid of

Dr. Maheshwari’s application early on in the application process, the record actually

establishes that Sharp attempted to obtain all relevant information before it made a

decision on his application and that Dr. Maheshwari hindered those efforts.

2. Sharp’s alleged refusal to meet with Dr. Maheshwari

Dr. Maheshwari asserts that Sharp violated his right to a fair hearing by refusing to

meet with him, relying on article X, section 1, subdivision (d) of the Bylaws of Sharp

Memorial Hospital (Sharp Bylaws), which provide in part:

“The Bylaws of the Medical Staff of [Sharp] . . . shall provide
appropriate procedures to insure that all applicants and members of
the staff are afforded a fair and impartial hearing and due process in
any case where an appointment is not to be conferred, is not to be
renewed, or when privileges have been (or are proposed to be)
reduced, suspended or terminated. These procedures shall allow the
affected practitioner the opportunity to make an appearance before
an ad hoc investigating committee of the staff member’s
section/clinical department (in all cases except where summary
corrective action is required). Such hearings shall be conducted
under such procedures adopted by each Medical Staff in its bylaws
and approved by the Board of Trustees, which approval shall not be
unreasonably withheld. In addition, the affected staff member shall
be given the rights to a hearing before a judicial review committee.”
(Italics added.)

22

Sharp in turn argues that this provision only allowed staff members, not applicants

for privileges, to meet with committee members in an evaluation process. However,

although somewhat confusingly worded, it appears that this section of the Sharp Bylaws

was intended to apply to non-staff member applicants for staff privileges at Sharp. The

section does repeatedly refer to the rights of the “staff member,” not those of an applicant.

However, the first sentence states that the rights to be accorded are to apply to both

“applicants and members of the staff.” The term “where an appointment is not to be

conferred, [or] is not to be renewed,” therefore can only be construed as including an

application for staff privileges.3

However, even though this bylaw accords a right to demand a meeting with a

committee evaluating an application for privileges, Dr. Maheshwari still has not shown a

violation of his fair hearing rights. First, the evidence does not show that Dr.

Maheshwari, who was represented by counsel and is himself an attorney, ever made a

demand that this right be honored and that Sharp refused. Dr. Maheshwari relies on two

letters that he sent to Dr. Ostrander after Dr. Ostrander informed Dr. Maheshwari that

Sharp was investigating the RCH cases. Those letters merely stated that Dr. Maheshwari

was willing to meet with any committee or cardiologist at Sharp, if Sharp wanted him to

3
Based upon this conclusion, we need not address Dr. Maheshwari’s assertion that
denying applicants the right to meet with committee members while affording such a
right to staff members violated his equal protection rights.

23

appear and answer questions. There was no request or demand that he be allowed to

meet with committee members made on his own initiative.

Further, even if Sharp should have offered to meet with Dr. Maheshwari in

response to these two letters, the error did not result in any prejudice sufficient to set

aside Sharp’s decision to deny staff privileges. Sharp’s Staff Bylaws, section 8.4-2,

provides that in any appeal from the decision of the JRC, “[i]n no event shall the decision

of the [JRC] be set aside or reversed on the grounds of improper admission or rejection of

evidence, or for any errors in the matter of notice or procedure, unless, after an

examination of the entire cause, including the evidence, the governing body shall be of

the opinion that the error complained of has resulted in a miscarriage of justice.” (Italics

added.)

Here, at the JRC Hearing, Dr. Maheshwari was allowed to testify, explain his

treatment in the RCH cases, and address any other issues he felt important. There is no

suggestion that there was anything further that he would have presented to the MEC or

the Hoagland Committee that was not presented to the JRC. After Dr. Maheshwari’s side

of the story was fully presented, the JRC concluded that there were problems with the

quality of care he rendered in the six RCH cases. Thus, Dr. Maheshwari cannot

demonstrate that the result would have been different had he met with the MEC and/or

the Hoagland Committee.

Indeed, it would have been of a greater benefit if Dr. Maheshwari had provided

complete records of his treatment of those patients and more fully complied with Sharp’s

requests for information. Additionally, following the initial conclusions of the Hoagland

24

Committee, it was Dr. Maheshwari’s position that further information was not necessary

to the decision and that Sharp should make its decision based upon the information it

already had. Based upon all of these facts, Dr. Maheshwari cannot demonstrate that any

miscarriage of justice resulted from any error in procedure in not allowing him to meet

with committee members.

3. The MEC’s request for patient information

Dr. Maheshwari asserts that his fair hearing rights were violated when Dr.

Ostrander requested that he provide a detailed list of all of his cardiology patients for the

prior six months, including the patient’s name, medical records number, diagnosis and the

age of the patient. Dr. Maheshwari objected to this request as a “fishing expedition” that

would “violate the privacy of my patients who have no relationship whatsoever to

[Sharp]. . . .”

In response, Dr. Ostrander wrote to Dr. Maheshwari, stating that the information

was appropriate and necessary to review his application and that if he failed to provide

the requested information, Sharp would deny his application. Dr. Ostrander also clarified

that Sharp was only seeking a “sample” of Dr. Maheshwari’s patients. Dr. Ostrander told

Dr. Maheshwari that such records were appropriately requested under California law to

be used in his review and that Sharp would take precautions to insure the secrecy of the

patient’s information. Dr. Maheshwari continued to refuse to provide the requested

information and told Sharp that if it wanted the information, it would have to obtain it on

its own.

25

Civil Code section 56.10, subdivision (c)(4) provides in part:

“(c) A provider of health care, or a health care service plan may
disclose medical information as follows:

“. . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .

“(4) The information may be disclosed to organized committees and
agents of professional societies or of medical staffs of licensed
hospitals . . . if the committees . . . are engaged in reviewing the
competence or qualifications of health care professionals . . . .”

As part of the application process, Dr. Maheshwari consented to an inspection of

records and documents material to the evaluations and authorized all individuals and

organizations in custody of such records and documents to permit such inspection and

copying.

As these provisions make clear, the disclosure of patient information is permitted

in conjunction with a review of a doctor’s qualifications and competence to receive staff

privileges. The Staff Bylaws contain no proscription on the type of patient information

that may be requested. Dr. Maheshwari cites no law or anything in the Staff Bylaws that

makes Sharp’s request for patient information improper. Indeed, Dr. Maheshwari had

agreed, as part of his application process, to allow hospitals where he treated patients to

release patient information in connection with the review process. In addition, in

response to Dr. Ostrander’s request, Dr. Maheshwari never sought to provide a redacted

version of the patient information, omitting patient names or other information he felt

should not be disclosed. Rather, he simply refused to provide the information. Thus, Dr.

Maheshwari’s refusal to provide the requested patient information was not justified and

26

Sharp was within its rights to consider this lack of cooperation in refusing to grant Dr.

Maheshwari staff privileges at Sharp.

Dr. Maheshwari asserts that Sharp’s request for this patient information was

“unusual.” In support of this contention Dr. Maheshwari cites to testimony from Dr.

Ostrander that in reviewing patient records the patients are usually not identified by name

and that he could not recall another case where Sharp “went through a process like

this . . . .” However, Dr. Ostrander also explained that Dr. Maheshwari’s application was

different than the ordinary situation. He also stated that while in written communications

and recorded proceedings the name of a patient would not be used, in the review process

there was no way the patient’s name could be entirely eliminated. Further, even if Sharp’s

request was “unusual,” that does not mean it was “arbitrary and capricious.” There was

nothing unfair about Sharp’s request for a six-month sampling of Dr. Maheshwari’s

patient care.

4. Lawsuit investigation of Dr. Maheshwari

Dr. Maheshwari asserts that his fair proceeding rights were violated by Sharp’s

hiring of a law firm to search the civil filings index to determine if he had any

malpractice lawsuits filed against him. We reject this contention.

Sharp conducted a review of the civil index of filings to determine the extent of

any medical malpractice lawsuits filed against Dr. Maheshwari after it received

information from his malpractice carrier that he had three malpractice cases that were

repetitious in nature. Patricia Lawson, from Sharp’s medical staff office, testified that

27

this was the normal procedure where Sharp received information that there were a high

number of or repetitious claims of malpractice against an applicant for privileges.

However, although Dr. Maheshwari established that the three cases of malpractice

were dismissed and many of the lawsuits discovered by Sharp had nothing to do with

medical malpractice, he does not indicate why such a search was unfair, arbitrary or

capricious. Further, Dr. Maheshwari does not offer any evidence that this information

had any impact on his application. Indeed, based upon the lack of any detrimental

information found as to Dr. Maheshwari, this information could have only helped his

application for privileges.4

It is reasonable for a hospital reviewing the qualifications and competency of an

applicant for staff privileges to conduct a search of public records to determine if any

medical malpractice actions had been filed against that individual. As discussed, ante, in

reviewing a candidate for privileges, hospitals have a duty to protect members of the

public who receive care at its facility. (Rhee, supra, 201 Cal.App.3d at p. 489.)

5. Sharp’s asserted promise to obtain medical records

Dr. Maheshwari also asserts that Sharp broke a promise to him that it would obtain

medical records concerning his patient care from other hospitals and would not decide his

application until it received those records. We reject this contention

4
Dr. Maheshwari asserts the search for lawsuits also included his wife. However,
the record reveals that Sharp was only searching for lawsuits involving Dr. Maheshwari.
The search merely revealed a lawsuit in which both he and his wife were parties.

28

In support of this contention, Dr. Maheshwari cites Dr. Ostrander’s letter to him

after he refused to obtain patient records from other hospitals. Dr. Maheshwari cites to

Dr. Ostrander’s statement that “[w]e will advise you, should we have any problems with

the hospitals’ provision of this information and would expect that you would help to

facilitate this, if needed.” Dr. Maheshwari also points to the statement that “[w]hen this

information has been received, we will advise you when we have had an opportunity to

review and consider this additional information.” As discussed, ante, the requested

patient information was not forthcoming before the MEC decided that Dr. Maheshwari’s

application for privileges should be denied. The MEC cited Dr. Maheshwari’s failure to

provide requested information as a reason, in addition to the quality of care as to the RCH

patients, as a reason for denying his application.

Sharp’s decision on denying staff privileges without the requested patient

information did not result in an unfair procedure. First, the burden was on Dr.

Maheshwari to provide the requested information. However, Dr. Maheshwari refused.

Indeed, Dr. Maheshwari admitted at the JRC hearing that if Sharp had requested his

assistance in obtaining records from RCH, he would have refused:

“Q. Is it your testimony if after all this process Dr. Ostrander had
come back to you and said, ‘Okay, you know, Dr. Maheshwari, we
tried to get the[] information directly from the hospital up in
Riverside but were unable to,’ is it your testimony to this committee
that you the would then have said, ‘Okay, I’ll get it for you myself?’

“A. No.

“Q. You wouldn’t have, would you?

“A. No.”

29

Dr. Maheshwari cannot persuasively assert that after he refused to obtain the

requested information, Sharp is to blame for deciding his application without obtaining it

themselves. There is nothing unfair, arbitrary or capricious about this decision. Further,

the record demonstrates that after the Hoagland Committee’s report expressing concern

about quality care in the six RCH cases under review, Dr. Maheshwari asserted that no

further review or information was necessary and that Sharp should decide his application

with the information it already had before it. Dr. Maheshwari cannot then fault Sharp for

deciding his application without the patient information from CRMC and RCH.

6. Involvement of Dr. Ostrander in application evaluation

Dr. Maheshwari also asserts that Dr. Ostrander’s involvement in the evaluation of

his application for staff privileges violated his right to a fair procedure because Dr.

Ostrander had decided from the beginning to deny his application and was biased against

Dr. Maheshwari. We reject this contention.

Citing Applebaum v. Board of Directors (1980) 104 Cal.App.3d 648 (Applebaum),

Dr. Maheshwari contends that he was denied a fair hearing because Dr. Ostrander was an

“instigator” of the charges against him and also participated in the process of assessing

his application. In Applebaum, an obstetrician’s privileges were suspended at a hospital

based upon charges initiated by a doctor who received complaints from nurses

concerning his delivery techniques. (Id. at p. 651.) That same doctor later served on an

ad hoc committee investigating the charges against the obstetrician. (Id. at pp. 651-652.)

30

That committee recommended that his privileges be suspended. (Id. at pp. 652-653.) An

appeal committee of the hospital upheld this decision. (Id. at pp. 653-654.)

The superior court granted the obstetrician’s writ of mandate, finding, among other

things, that the presence of the doctor who initiated the charges on the ad hoc committee

that recommended suspension of his privileges violated his due process rights.

(Applebaum, supra, 104 Cal.App.3d at pp. 655-656.) The Court of Appeal upheld this

ruling finding that the process was unfair because (1) the instigator of the charges against

the obstetrician also was on the ad hoc committee; and (2) the ad hoc committee and the

committee that reviewed the decision to suspend his privileges had overlapping

membership. (Id. at pp. 659-660.) However, the court also stated that the fact that some

investigatory, prosecutorial and adjudicatory functions are combined would not constitute

a denial of due process “unless the facts of a case show foreclosure of fairness as a

practical or legal matter.” (Id. at p. 658; Rhee, supra, 201 Cal.App.3d at p. 490.)

The facts of this case are very different from those in Applebaum. Dr. Ostrander

did not “instigate” the charges against Dr. Maheshwari. They were initiated at RCH. Dr.

Ostrander was at most a conduit for that information and an investigator of the

circumstances of the RCH review. He did not sit on any of the committees reviewing Dr.

Maheshwari’s application. Dr. Maheshwari does not allege any overlapping of members

of the Hoagland Committee, MEC and JRC. Dr. Ostrander merely coordinated the

review process in his role as chief of staff and communicated with Dr. Maheshwari

regarding the status of the review and the need for additional information. The facts here

31

do not show a “foreclosure of fairness as a practical or legal matter.” (Applebaum, supra,

104 Cal.App.3d at p. 658.)

In sum, we conclude, upon independent review of the record, that Sharp’s review

of Dr. Maheshwari’s application for staff privileges did not violate his right to a fair

hearing and procedure.

II. Decision To Exclude Evidence at JRC Hearing

Dr. Maheshwari asserts that the hearing officer erred in excluding evidence he

sought to introduce at the JRC Hearing. We reject this contention.

Section 1094.5, subdivision (e) provides in part:

“Where the court finds that there is relevant evidence that, in the
exercise of reasonable diligence, could not have been produced or
that was improperly excluded at the hearing before respondent, it
may enter judgment . . . remanding the case to be reconsidered in the
light of that evidence . . . .”

The hearing officer at the JRC Hearing excluded the new evidence submitted by

Dr. Maheshwari based upon Staff Bylaw, paragraph 8.3-7(2), which provides in part:

“An applicant . . . shall bear the burden of persuading the [JRC], by a
preponderance of the evidence, of his qualifications by producing
information which allows for adequate evaluation and resolution of
reasonable doubts concerning his current qualifications for
membership and privileges. An applicant shall not be permitted to
introduce information requested by the medical staff but not
produced during the application process unless the applicant
establishes that the information could not have been produced
previously in the exercise of reasonable diligence.” (Italics added.)

Dr. Maheshwari does not contend that he had previously provided the disputed

evidence during the application process. Rather, Dr. Maheshwari contends that the

information was not requested or, at least as to the declarations, that he could not have

32

with reasonable diligence submitted the information earlier. The record does not support

this assertion.

In his March 1999 letter, Dr. Ostrander informed Dr. Maheshwari that Sharp had

learned of his review at RCH for quality-of-care concerns, of Sharp’s inability to obtain

information concerning the review, and requested that Dr. Maheshwari provide any

information concerning the situation to Sharp. Thus, there was no limitation on the type

of information requested by Sharp and any information supportive of Dr. Maheshwari’s

position should have been submitted at that time.

Dr. Maheshwari responded by acknowledging that he understood that he was

responsible for supplying Sharp “with details of these cases.” Thus, there is no evidence

that Dr. Maheshwari was confused in any way concerning the scope of what Sharp

wanted to review on his application for privileges.

Dr. Ostrander then communicated to Dr. Maheshwari that he had “received the

documentation you have provided (i.e., copies of medical records and other information

related to the review of these cases at [RCH]).” (Italics added.) Dr. Ostrander further

stated in that letter that Sharp “will proceed with the review of these cases and the

processing of your application. Additionally, if you are able to provide any additional

information regarding the status of the peer review proceedings at [RCH], it will be most

helpful. Should additional information be needed, we will contact you.” (Italics added.)

Dr. Maheshwari asserts that the statement from Sharp that it would contact him if

it needed further information meant that it was satisfied with the information it had and

was not requesting the information he later sought to admit at the JRC Hearing.

33

However, the letter actually indicated Sharp’s belief that Dr. Maheshwari had already

provided all information relevant to the review at RCH, pursuant to its previous request.

The records provided by Dr. Maheshwari to that date were in actuality incomplete and

Dr. Maheshwari did not attempt to submit complete records until the JRC Hearing. The

letter also requested, as did Dr. Ostrander’s previous letter, that if there were any further

information that Dr. Maheshwari felt was relevant, he should provide it. This put the

burden upon Dr. Maheshwari, pursuant to Sharp’s Bylaws, to produce to Sharp any

information he felt relevant. If he wanted Sharp to consider the complete patient files

from the RCH cases and the patient declarations, it was incumbent upon him to do so at

that time.

Dr. Maheshwari asserts the declarations of RCH patients were improperly

excluded as they did not exist during the application process and therefore could not in

the exercise of reasonable diligence have been produced earlier. However, the mere fact

that Dr. Maheshwari did not request declarations from patients until after he was denied

privileges does not mean that they were admissible. Dr. Maheshwari does not provide

any reason why he could not have produced them during the application process. Again,

if Dr. Maheshwari believed that the declarations were supportive of his application it was

incumbent upon him to submit them to Sharp during the application process. The hearing

officer properly excluded the evidence Dr. Maheshwari offered for the first time at the

JRC Hearing.

34

III. Testimony by Sharp’s Expert

Dr. Maheshwari’s last contention is that Sharp’s medical expert, Dr. Phillips,

applied an improper standard of care in opining at the JRC Hearing that Dr. Maheshwari’s

treatment in the six RCH cases fell below the standard of care. We reject this assertion.

Dr. Maheshwari faults Dr. Phillip’s testimony because he did not state specifically

that the proper standard of care is what “reasonable interventional cardiologists would do

in the circumstances of a particular case.” Dr. Maheshwari asserts that Dr. Phillips’s

reference to what a “quorum of physicians” would do, what a “majority of cardiologists”

would do or what he would accept in his laboratories was insufficient to establish the

proper standard of care and therefore his testimony should have been rejected.

However, a review of Dr. Phillips’s testimony demonstrates that although his

testimony was not precise in describing the standard of care for interventional

cardiologists, his testimony did state that the proper standard was what other cardiologists

would do in the same or similar circumstances. Moreover, Dr. Phillips was testifying not

to any new opinion he had as to the propriety of Dr. Maheshwari’s treatment, but rather to

the conclusions reached by the Hoagland Committee that determined that his standard of

care was deficient in six of the seven RCH cases. Whatever he testified was the

appropriate standard of care, the relevant inquiry was whether the Hoagland Committee,

in concluding Dr. Maheshwari’s treatment in the six RCH cases was deficient, actually

employed the appropriate standard of care. There is no assertion that they did not do so.

Finally, the JRC, in upholding the MEC’s denial of Dr. Maheshwari’s application,

relied not only upon Dr. Phillips’s testimony, but also upon the report of the Hoagland

35

Committee and the documentary evidence presented at the JRC Hearing. The JRC then

rendered its own conclusion that Dr. Maheshwari’s treatment fell below the standard of

care. Thus, even if Dr. Phillips’s testimony were disregarded, ample evidence supported

the JRC’s decision to uphold the decision to deny staff privileges to Dr. Maheshwari.

NARES, J.

DISPOSITION

The judgment is affirmed.

WE CONCUR:

HUFFMAN, Acting P. J.

McDONALD, J.

36

Lum v. Vision Service Plan

Lum v. Vision Service Plan

Lum v. Vision Service Plan, No. CIV.97-00226SOM/BMK (D. Haw. June 26, 2000)

An individual brought a qui tam action against a vision plan provider, alleging that the provider violated the False Claims Act (FCA) by charging co-payments to participants in a medical services plan run by the state, but not including the co-payments on the bills it sent to the government. The United States district court, granting summary judgment to the plan provider, held that the provider did not violate the FCA because there was no evidence that the co-payments caused the government to pay out funds.

Luettke v. St. Vincent Mercy Med. Ctr.

Luettke v. St. Vincent Mercy Med. Ctr.

MALPRACTICE – EVIDENCE

Luettke v. St. Vincent Mercy Med. Ctr., No. L-05-1190 (Ohio Ct. App. July
28, 2006)

An Ohio appeals court held that a hospital’s policies and medical
staff rules and regulations could be entered into evidence in a malpractice
case for the purpose of establishing the standard of care. In this case, a
patient sued her anesthesiologist, nurse anesthetist, and student nurse anesthetist
after her esophagus was punctured by the student, who was performing unsupervised
anesthesiology services for over an hour of the patient’s surgery. The patient
alleged medical malpractice and lack of informed consent. Among other things,
the patient complained that she was never told that a student would be participating
in her anesthesia. At trial, the lower court excluded evidence related to the
hospital’s internal policies regarding informed consent, patient rights, and
the supervision of anesthesia procedures performed by student nurses. Notably,
those policies required all anesthesia procedures to be performed in the presence
of an anesthesiologist and that all patients be informed of the name and professional
status of their health care providers, including whether the provider is engaged
in a clinical training program. In excluding those policies from evidence,
the court reasoned that expert testimony – not hospital documents – establishes
the standard of care in a medical setting. The patient appealed after losing
at the trial level. She argued that the hospital’s policies were crucial in
determining the proper standard of care. The Court of Appeals of Ohio agreed,
holding that expert testimony is not the exclusive basis for establishing the
standard of care. The court noted that the hospital’s rules and regulations
were promulgated to ensure that employees and contracting physicians followed
a consistent standard of quality care. The court also ruled that the consent
form used in this particular operation was clearly invalid since it referred
to the administration of anesthesia under the supervision of an anesthesiologist.

 

 

Lyons v. Lutheran Hosp. of Ind.

Lyons v. Lutheran Hosp. of Ind.

GENERAL NEGLIGENCE

Lyons v. Lutheran Hosp. of Ind., No. 104CV0728DFHVSS (S.D.
Ind. Sept. 15, 2004)

The
family of a patient who slipped in the hospital, hit her head, and died from
her injuries sued the hospital alleging premises liability. There was a dispute
amongst the parties over whether the slip-and-fall claim was truly a premises
liability claim or a claim for medical malpractice. The U.S. District Court
for the Southern District of Indiana reviewed Indiana law that draws the distinction
between malpractice and other negligence claims. The court noted one case where
an anesthetized patient fell out of bed because the nurses had failed to raise
the guard rails. That case was found to be one for malpractice. By contrast,
a patient in another case was found to have a claim for premises liability
when the patient fell out of bed after a bedrail gave way. The district court
in this case concluded that the complaint’s statement that the patient "slipped,
fell, and struck her head as a result of the negligence of the Hospital" was
not sufficiently detailed for the court to determine whether or not the claim
was one for malpractice or premises liability.

 

Lynn G. v. Hugo

Lynn G. v. Hugo

Lynn G. v. Hugo,
No. 135 (N.Y.A.D. 1 Dept. June 27, 2000)

Patient sued her plastic surgeon after an abdominal procedure resulted in
“unsightly scarring.” The patient alleged a lack of informed consent
based on the physician failing to advise her of the availability of less
invasive procedures and her inability to give informed consent because she
suffered from Body Dysmorphic Disorder. (The patient had seen the plastic
surgeon 51 times in six years for various procedures.) The Supreme Court,
Appellate Division of New York refused to dismiss the claims. The court
determined that there was sufficient evidence that the physician had not
properly disclosed the appropriate surgical alternatives, indicating that
plastic surgery is subject to the same disclosure standards as any other medical
procedure. Additionally, the court found sufficient evidence of the patient’s
mental disorder to support her contention that the physician should have sought
mental health advice before continuing to perform increasingly invasive
procedures.

Lufti v. Brighton Community Hosp. Assoc.

Lufti v. Brighton Community Hosp. Assoc.


COLORADO COURT OF APPEALS

Court of Appeals No. 00CA0245


Adams County District Court No. 98CV3447


Honorable C. Vincent Phelps, Judge


Bashar Lufti, M.D.,

Plaintiff-Appellant,

v.

Brighton Community Hospital Association, d/b/a Platte Valley Medical Center, Inc.; and John Hicks, individually, as Chief Executive Officer of Platte Valley Medical Center, and as a member of the Board of Platte Valley Medical Center,

Defendants-Appellees.


JUDGMENT AFFIRMED



Division III


Opinion by JUDGE MARQUEZ


Ney and Nieto, JJ., concur



May 10, 2001


Leavenworth & Tester P.C., Sander N. Karp, Julie C. Berquist, Glenwood Springs, Colorado; Antonio Bates Bernard, P.C., Brian E. Bates, Denver, Colorado, for Plaintiff-Appellant

Grund & Breslau, P.C., John W. Grund, Denver, Colorado; Kutak Rock, LLP, Melvin B. Sabey, Denver, Colorado, for Defendants-Appellees

 


In this dispute involving his removal from a schedule of physicians providing services in a hospital emergency medical service department (ER), plaintiff, Bashar Lufti, M.D., appeals the summary judgment in favor of defendants, Platte Valley Medical Center, Inc. (the hospital), and John Hicks, the hospital?s chief executive officer. We affirm.


The hospital contracted with Platte Valley Emergency Physicians, Inc. (PVEP), to provide physicians to cover the hospital?s ER. That contract contained a provision stating that the hospital could require PVEP to remove a physician from the ER. Plaintiff entered into an arrangement as an independent contractor with PVEP under which PVEP scheduled plaintiff to work in the ER.


While plaintiff was working in the ER, a patient with lacerated fingers came in. Although plaintiff denies it occurred, the patient claimed that plaintiff made him wait an inordinate amount of time for treatment, was rude to him, and finally refused him treatment. Subsequently, Hicks contacted PVEP and required, pursuant to the contract between the hospital and PVEP, that plaintiff be removed from the ER rotation.


Asserting racial and national origin discrimination, plaintiff brought this action alleging claims under Title VII of the Civil Rights Act of 1964, 42 U.S.C. ?2000e (1994 & 1998 Supp.), and also under ?42 U.S.C. ?1981 (1994 & 1998 Supp.). He also asserted claims for tortious interference with his employment agreement with PVEP, breach of agreement contained in the hospital?s bylaws, breach of duty of good faith and fair dealing, breach of employment contract, and promissory estoppel. Only the tortious interference and bylaws claims were asserted against Hicks. The trial court granted defendants? motion for summary judgment as to all of plaintiff?s claims for relief. This appeal followed.


Summary judgment is appropriate only when the pleadings and supporting documents demonstrate that no genuine issue exists as to any material fact and that the moving party is entitled to judgment as a matter of law. Our review of an order granting or denying a motion for summary judgment is de novo. Aspen Wilderness Workshop, Inc. v. Colorado Water Conservation Board, 901 P.2d 1251 (Colo. 1995). We conclude that the summary judgment was appropriate here.


I. Title VII


Plaintiff first contends that the trial court erred in dismissing his national origin discrimination claim under Title VII on grounds that he was an independent contractor. He asserts that he need not establish a direct employer-employee relationship with the hospital to establish liability under Title VII, and that he is an employee for Title VII purposes. We are not persuaded.


A. Title VII Does Not Apply to Independent Contractors


Title VII provides, in pertinent part, that "[i]t shall be an unlawful employment practice for an employer ? (1) to fail or refuse to hire or to discharge any individual . . . because of such individual?s race, color, religion, sex, or national origin." 42 U.S.C. ?2000e-2(a).


There must, however, be some connection with an employment relationship for Title VII protections to apply. Thus, Title VII protects employees, but does not protect independent contractors. Adcock v. Chrysler Corp., 166 F.3d 1290 (9th Cir. 1999). Under Title VII, "employee" is defined as "an individual employed by an employer." 42 U.S.C. ?2000e(f).


Plaintiff relies upon Sibley Memorial Hospital v. Wilson, 488 F.2d 1338 (D.C. Cir. 1973), and other cases for the proposition that a nonemployee independent contractor may bring a claim under Title VII.


In recent years, however, federal courts have almost uniformly ruled that a person who is an independent contractor cannot bring a Title VII claim. We find the reasoning of those decisions persuasive. See Schwieger v. Farm Bureau Insurance Co., 207 F.3d 480 (8th Cir. 2000); Adcock v. Chrysler Corp., supra; Zinn v. McKune, 143 F.3d 1353 (10th Cir. 1998); Cilecek v. Inova Health System Services, 115 F.3d 256 (4th Cir. 1997)(physician under contract to provide emergency medical services was an independent contractor rather than an employee and thus could not sustain a Title VII action); Alexander v. Rush N. Shore Medical Center, 101 F.3d 487 (7th Cir. 1996)(physician could not bring a Title VII claim alleging the hospital?s revocation of his staff privileges constituted unlawful discrimination absent proof of an employment relationship, which did not exist because physician was independent contractor); Diggs v. Harris Hospital-Methodist, Inc., 847 F.2d 270 (5th Cir. 1988)(no Title VII claim was proper because independent contractor physician failed to prove existence of an employment relationship with which hospital allegedly interfered); Cobb v. Sun Papers, Inc., 673 F.2d 337 (11th Cir. 1982); Spirides v. Reinhardt, 613 F.2d 826 (D.C. Cir. 1979); Peck v. Democrat & Chronicle/Gannett Newspapers, 113 F. Supp. 2d 434 (W.D.N.Y. 2000); Hannon v. Avis Rent A Car System, Inc., 107 F. Supp. 2d 1256 (D. Mont. 2000). See also 1 A. Larson & L. Larson, Employment Discrimination ?5.22 (1991).


Some state courts also have recognized that Title VII applies to employees and not to independent contractors. See, e.g., Ostrander v. Farm Bureau Mutual Insurance Co., 851 P.2d 946 (Idaho 1993); Marquis v. City of Spokane, 922 P.2d 43 (Wash. 1996).


Further, the cases relied upon by plaintiff are distinguishable. In Sibley Memorial Hospital v. Wilson, supra, the court recognized that in a sex discrimination claim, even in the absence of an employment relationship, a hospital had brought itself within the strictures of Title VII by determining that a female patient should not have a male nurse and thus blocking access of a male private duty nurse to work for a female patient. In Christopher v. Stouder Memorial Hospital, 936 F.2d 870 (6th Cir. 1991), a hospital refused to grant a nurse privileges to work in its facility as a private scrub nurse. Because the hospital had allegedly interfered with her access to employment, the nurse stated a claim under Title VII, even though she was not an employee. The court noted she was not an independent contractor with respect to the hospital. In Zaklama v. Mt. Sinai Medical Center, 842 F.2d 291 (11th Cir. 1988), an anesthesiologist from Egypt was dismissed from a residency program based on adverse evaluations from a director of a training program and the hospital?s decision to bar him from the hospital. The hospital?s actions affected the plaintiff?s employment with an employer other than the defendant, and the plaintiff stated a claim under Title VII. In Pardazi v. Cullman Medical Center, 838 F.2d 1155 (11th Cir. 1988), an Iran-educated medical practitioner was employed by a professional corporation, conditioned upon his becoming a member, with staff privileges, of the hospital. Although he was appointed to the hospital staff, his observation period was extended from four months to one year. Accepting that the plaintiff was not an employee, the court nonetheless concluded that the hospital could be held liable under Title VII if it interfered with the plaintiff?s employment opportunities with the professional corporation.


However, there is no indication in those cases of an agreement of the type between the hospital and PVEP requiring removal upon the hospital?s request. Here, the hospital acted in accordance with its contract with PVEP. Further, as discussed more fully below, the hospital?s action did not affect plaintiff?s employment status with PVEP, because plaintiff here was an independent contractor with respect to PVEP, not a PVEP employee. Additionally, those cases do not contradict the proposition that Title VII does not protect independent contractors. See, e.g., Spirides v. Reinhardt, supra (decision from the same circuit as Sibley Memorial Hospital v. Wilson, supra). Each of those cases is also distinguishable in that they involved defendants who were in a position to influence significantly the plaintiffs? respective employment opportunities. Here, by contrast, there is no evidence that the hospital interfered with plaintiff?s employment opportunities with other parties.


We thus conclude that to prevail under Title VII, plaintiff must establish that he was not an independent contractor.


B. Plaintiff Was an Independent Contractor


To determine whether a person is an employee, the Tenth Circuit Court of Appeals has concluded that the skeletal definitions of "employer" and "employee" provided in 42 U.S.C. ??2000e(b) and 2000e(f) should be fleshed out by applying common law agency principles to the facts and circumstances surrounding the working relationship of the parties. Although the main focus of this inquiry is whether and to what extent a putative employer has the right to control the means and manner of the worker?s performance, other factors inform the analysis, including:

          (1) the kind of occupation at issue, with reference to whether the work usually is done under the direction of a supervisor or is done by a specialist without supervision; (2) the skill required in the particular occupation; (3) whether the employer or the employee furnishes the equipment used and the place of work; (4) the length of time the individual has worked; (5) the method of payment, whether by time or by job; (6) the manner in which the work relationship is terminated; (7) whether annual leave is afforded; (8) whether the work is an integral part of the business of the employer; (9) whether the worker accumulates retirement benefits; (10) whether the employer pays social security taxes; and (11) the intention of the parties.

Zinn v. McKune, supra, 143 F.3d at 1357 (quoting Lambertsen v. Utah Department of Corrections, 79 F.3d 1024, 1028 (10th Cir. 1996)).


The inquiry requires us to look to the totality of circumstances surrounding the working relationship between the parties; no single factor is determinative. Zinn v. McKune, supra.


Here, the contract between the hospital and PVEP expressly provides that "nothing in this Agreement is intended nor shall be construed to create between Hospital and Contractor an employer/employee relationship . . . or to allow Hospital to exercise control or direction over the manner or method by which the Physicians provide professional medical services at Hospital." This leaves no question as to the intent of the parties that no employee-employer relationship would be formed and that the hospital would have no control over the "means and manner" of plaintiff?s ER work.


Plaintiff was also an independent contractor in relation to PVEP. This is shown in an agreement with PVEP, which plaintiff signed, that stated that all "physicians are independent contractors."


In addition, plaintiff had signed an agreement regarding his medical staff privileges with the hospital in which he "expressly acknowledged . . . that [he] is an ?independent contractor? with respect to Hospital and nothing in this Agreement . . . shall be construed to create . . . an employer/employee relationship."


According to the evidence submitted by defendants, PVEP provided plaintiff, a licensed professional physician, with his work assignments and scheduling at the hospital. In contrast, the hospital did not directly hire plaintiff for ER assignments and could not fire plaintiff from PVEP. If the hospital was not satisfied with a PVEP employee, its only option was to contact PVEP and require that that person be removed from the ER. Further, according to PVEP?s agreement with the hospital, the hospital paid PVEP for plaintiff?s services, and PVEP paid plaintiff for services rendered in the ER.


The physician who incorporated PVEP and executed its agreement with the hospital stated in his deposition that the memorandum executed by plaintiff was intended "to remind [the physicians] that they were independent contractors." Plaintiff?s own expert witness also stated that "[plaintiff] was not an employee of the hospital."


In response, plaintiff emphasized portions of the agreement between PVEP and the hospital, arguing that these provisions established the hospital?s control over ER physicians and that the hospital agreed to provide office space, furniture, and equipment. However, read in context, those provisions do not support an employment relationship. We thus conclude as a matter of law that plaintiff was an independent contractor.


Our conclusion is consistent with the "corporate practice of medicine" doctrine articulated by the supreme court in the context of respondeat superior. Under that doctrine, a corporation such as a hospital cannot be licensed to practice medicine and thus cannot command or forbid any act by a doctor in the practice of medicine. Its relationship with a doctor providing medical services is necessarily that of an independent contractor. Moon v. Mercy Hospital, 150 Colo. 430, 373 P.2d 944 (1962); Nieto v. State, 952 P.2d 834 (Colo. App. 1997), rev?d on other grounds, 993 P.2d 493 (Colo. 2000).


The one exception to the doctrine, which applies to physician-formed professional services corporations, is not relevant here because the hospital is not such a corporation. See generally ?12-36-134, C.R.S. 2000; Russell v. Pediatric Neurosurgery, P.C., 15 P.3d 288 (Colo. App. 2000)(cert. granted December 18, 2000).


Accordingly, the trial court correctly granted summary judgment on plaintiff?s Title VII claim.


II. Section 1981


Plaintiff next contends that 42 U.S.C. ?1981 does not require proof that he was an "employee," as defined in Title VII, and that the trial court erred in failing to consider the implications of the hospital bylaws, which plaintiff alleges constituted a contract between plaintiff and the hospital, giving grounds for a ?1981 claim. We disagree.


Under 42 U.S.C. ?1981(a), "[a]ll persons within the jurisdiction of the United States shall have the same right in every State . . . to make and enforce contracts," which includes the "making, performance, modification, and termination of contracts, and the enjoyment of all benefits, privileges, terms, and conditions of the contractual relationship." 42 U.S.C. ?1981(b).


When ?1981 and Title VII claims arise from identical facts, the elements of each claim are construed in the same way. Gwin v. Chesrown Chevrolet, Inc., 931 P.2d 466 (Colo. App. 1996)


(citing Skinner v. Total Petroleum, Inc., 859 F.2d 1439 (10th Cir. 1988)).


Therefore, because plaintiff?s Title VII claim fails due to his independent contractor status, his ?1981 claim fails as well. See O?Neal v. Ferguson Construction Co., 237 F.3d 1248 (10th Cir. 2001)(both Title VII and ?1981 require a plaintiff to establish the same prima facie elements); Rice-Lamar v. City of Fort Lauderdale, 232 F.3d 836 (11th Cir. 2000)(elements of a claim of race discrimination under ?1981 are the same as those for a Title VII disparate treatment claim in the employment context); Johnson v. University of Cincinnati, 215 F.3d 561 (6th Cir. 2000)(elements are the same for employment cases stemming from ?1981 and Title VII); Vakharia v. Swedish Covenant Hospital, 190 F.3d 799 (7th Cir. 1999).


Plaintiff, however, contends that he has a contractual relationship with the hospital based upon its bylaws. He claims this is sufficient to give rise to a ?1981 claim independent of an employee-employer relationship. We disagree.


Section 1981 prohibits discriminatory conduct that occurs both before and after the establishment of the contractual relationship. See Perry v. Woodward, 199 F.3d 1126 (10th Cir. 1999)(?1981 centers on the protection of contractual rights; any claim brought pursuant to ?1981 must be supported by an underlying right of the employee to make and enforce contracts).


An employer?s distribution to an employee of documents that contain specific procedures for termination of employment, when relied upon by an employee and supported by the consideration of continued employment, may result in the employer becoming contractually bound to comply with those procedures. See Continental Airlines, Inc. v. Keenan, 731 P.2d 708 (Colo. 1987); Ferrera v. Nielson, 799 P.2d 458 (Colo. App. 1990).


Here, the hospital?s bylaws, under the capitalized heading "PURPOSE AND USE OF MEDICAL STAFF BYLAWS," contain the following disclaimer:

          These Medical Staff Bylaws and the Rules and Regulations do not constitute a contract of any kind whatsoever and any Practitioner who intends that these Bylaws and the Rules and Regulations should constitute a contract must first notify the Hospital and obtain the written consent of the Board. These Bylaws and the Rules and Regulations shall be interpreted, applied and enforced within the sole discretion of the Hospital. (emphasis added)

Plaintiff presented no evidence that he attempted to notify the hospital of his intent to rely upon the bylaws as a contract. Nor is there evidence that he obtained the requisite consent of the board to do so. Thus, the bylaws did not create a contractual relationship between plaintiff and the hospital.


Therefore, plaintiff?s ?1981 claim also fails under his theory that the bylaws created such a relationship.


III. Tortious Interference


Plaintiff next contends that Hicks, in directing PVEP to remove plaintiff from the ER rotation, tortiously interfered with his contract with PVEP. We are not persuaded.


To establish tortious interference with a contract requires that: (1) the plaintiff had a contract with another party; (2) the defendant knew or should have known of such contract?s existence; (3) the defendant intentionally induced the other party to the contract not to perform the contract with the plaintiff; and (4) the defendant?s actions caused the plaintiff to incur damages. Telluride Real Estate Co. v. Penthouse Affiliates, LLC, 996 P.2d 151 (Colo. App. 1999).


Regarding the third element, the interference with a prospective business relationship must be both intentional and improper. Amoco Oil Co. v. Ervin, 908 P.2d 493 (Colo. 1995).


Here, even if plaintiff established the first and second elements of his claim, he provided no evidentiary support for the third element, intentional and improper action by Hicks.


The record reveals that Hicks directed PVEP to remove plaintiff from the emergency room rotation. However, the agreement between the hospital and PVEP states, in pertinent part, that the "Hospital may at any time, require Contractor [PVEP] to remove any of the individual Physicians from the Department coverage schedule." Thus, the hospital, through Hicks, acted properly in exercising its rights under the agreement.


Further, nothing in plaintiff?s agreement with PVEP specifically precluded his removal from the ER rotation. His contract addressed only compensation, holidays, weekends, vacations, and time off.


Therefore, because plaintiff presented no evidence to establish improper action by Hicks, we conclude that the trial court properly entered summary judgment on this claim as well.


IV. Breach of Contract


We also reject plaintiff?s contention that the hospital breached its contract with him by failing to afford him the benefits and protections of its bylaws.


As noted above, the bylaws did not create a contractual relationship between plaintiff and the hospital. However, even if the bylaws were contractually binding upon the hospital, the protective provisions of the bylaws upon which plaintiff relies do not apply here. The procedural rights in the bylaws, which relate to physicians whose right to practice medicine the hospital denies, removes, or restricts, were not implicated by defendants? actions. Plaintiff?s removal from the ER had "no effect on [plaintiff?s] appointment status or clinical privileges" at the hospital.


The procedural rights contained in the bylaws apply only to an adverse recommendation, after investigation by the Medical Executive Committee (MEC), rather than to an action taken by the hospital?s chief executive officer pursuant to an outside contract. Hicks? actions in the present case were exclusively controlled by the terms of the contract between the hospital and PVEP, not hospital bylaws.


V. Good Faith and Fair Dealing


Plaintiff further contends that the district court erred in dismissing his claim for breach of the covenant of good faith and fair dealing. We are not persuaded.


Every contract contains an implied duty of good faith and fair dealing. However, this implied duty may be relied upon only when the manner of performance under a specific contract term allows for discretion on the part of either party; it may not contradict terms or conditions for which the parties have bargained. Amoco Oil Co. v. Ervin, supra.


If a claim based on the violation of an express covenant of good faith is to be recognized, such a claim is a contractual one. Hoyt v. Target Stores, 981 P.2d 188 (Colo. App. 1998).


Here, there was no contract, express or implied, between plaintiff and the hospital concerning his work in the ER. Therefore, no claim for breach of the covenant of good faith and fair dealing may stand. See Hoyt v. Target Stores, supra.


Further, plaintiff?s relationship with the hospital as an ER physician was based solely on the agreement between the hospital and PVEP. As discussed above, that document expressly sets forth the hospital?s right to require PVEP to remove a physician from the ER schedule. Consequently, plaintiff cannot rely on the implied duty of good faith and fair dealing to circumvent terms for which PVEP and the hospital expressly bargained. See generally Grossman v. Columbine Medical Group, 12 P.3d 269 (Colo. App. 1999)(covenant of good faith and fair dealing cannot limit an independent practice association?s right to discharge an independent contractor, where terms for which independent contractor and association bargained allowed such removal).


Therefore, we conclude that summary judgment for the defendants was proper on this claim.


VI. Promissory Estoppel


Finally, we are not persuaded by plaintiff?s contention that the trial court erred in dismissing his claim for promissory estoppel based upon his reliance on the hospital?s bylaws.


Under Colorado law, the elements of a promissory estoppel claim are: (1) the promisor made a promise to the promisee; (2) the promisor should reasonably have expected that the promise would induce action or forbearance by the promisee; (3) the promisee reasonably relied on the promise to the promisee?s detriment; and (4) the promise must be enforced to prevent injustice. Berg v. State Board of Agriculture, 919 P.2d 254 (Colo. 1996).


Here, plaintiff claims on appeal that he agreed to close his internal medicine practice based on his understanding that the hospital bylaws would protect him from indiscriminate termination from the ER. While plaintiff cites portions of the record in support of his claim, he points to nothing in the record that indicates his reliance upon the hospital?s bylaws. The record indicates that it was not until after he lost his ER position that he looked to the bylaws to see if they contained provisions on physician removal that might strengthen his claim against the hospital. See Brighton School District 27J v. Transamerica Premier Insurance Co., 923 P.2d 328 (Colo. App. 1996)(it is not the duty of the reviewing court to search the record for evidence to support bald assertions).


Further, if an employee seeks to rely upon a written policy of the employer as the basis for a promissory estoppel claim, that employee must accept the whole of that policy. The employee may not reject those portions of the policy that may be considered unfavorable. Floyd v. Coors Brewing Co., 952 P.2d 797 (Colo. App. 1997), rev?d on other grounds, 978 P.2d 663 (Colo. 1999).


Here, even if plaintiff had relied upon the bylaws, as noted above, they offer protection only under certain circumstances not present in plaintiff?s situation, i.e., "an adverse recommendation" by the MEC.


Accordingly, the judgment is affirmed.


JUDGE NEY and JUDGE NIETO concur.


These opinions are not final. They may be modified, changed or withdrawn in accordance with Rules 40 and 49 of the Colorado Appellate Rules. Changes to or modifications of these opinions resulting from any action taken by the Court of Appeals or the Supreme Court are not incorporated here.


Return to Court of Appeals or May 10, 2001

M.A.K. v. Rush-Presbyterian St. Luke’s Medical Center

M.A.K. v. Rush-Presbyterian St. Luke’s Medical Center

M.A.K. v. Rush-Presbyterian St. Luke’s Medical
Center, No. 3-99-0618


3rd District, 18 July 2000






M. A. K.,

Plaintiff-Appellant,


v.


RUSH-PRESBYTERIAN ST. LUKE’S MEDICAL
CENTER, d/b/a RUSH BEHAVIORAL HEALTH CENTER DU PAGE,


Defendant-Appellee.

Appeal from the Circuit Court
of the 12th Judicial Circuit, Will County, Illinois


97–L–311


Honorable Thomas M. Ewert, Judge,
Presiding


JUSTICE BRESLIN delivered the opinion of the
court:


Plaintiff filed suit against Rush Presbyterian
St. Luke’s Medical Center (Rush) and Royal Maccabees Life Insurance Company
(Royal Insurance). Plaintiff alleged that Rush breached its physician/patient
relationship with him by releasing his medical records, which contained
information about his treatment for alcohol abuse, to Royal Insurance. The trial
court issued judgment on the pleadings to Rush. We reverse and hold that the
phrase “any physician, medical practitioner, hospital, clinic, health care
facility or other medical or medically related facility,” does not meet the
general designation requirement of the Code of Federal Regulations (Federal
Regulations)(42 C.F.R. ? 1.01 (1993) dealing with the release of alcohol
treatment records.


FACTS


Plaintiff applied for a disability insurance
policy with Royal Insurance. In conjunction with his application, he executed an
authorization for release of his medical records on October 12, 1994. The
authorization provided, in pertinent part, as follows:


“I AUTHORIZE any physician, medical practitioner, hospital,
clinic, health care facility [or] other medical or medically related facility
*** having information available as to diagnosis, treatment and prognosis with
respect to any physical or mental condition and/ or treatment of me *** to
give to [Royal Insurance] *** any and all such information.

***

I UNDERSTAND THAT my *** medical
records may be protected by certain Federal Regulations, especially as they
apply to any drug or alcohol abuse data. I understand that I *** may revoke
this authorization at any time as it pertains to any such drug or alcohol
abuse data by written notification, however, any action taken prior to
revocation will not be affected.”

Royal Insurance
issued a policy to Plaintiff.


Plaintiff was admitted to Rush for alcohol abuse
treatment on January 13, 1995. During his treatment Plaintiff contacted his
insurance agency, Brennan and Stuart (Brennan), about the possibility of filing
a disability claim. Brennan, in turn, contacted Royal Insurance which sent
Plaintiff a preliminary report concerning his potential claim. Plaintiff later
decided not to file a claim and so notified Royal Insurance. Plaintiff was
discharged from Rush approximately 6 weeks after his admission.


In April of 1995, Rush received a copy of
Plaintiff’s medical records release authorization from Royal Insurance. Rush
released the records. Contained in the records released to Royal Insurance was a
notation that Plaintiff stated the onset of his alcohol dependence took place
eight months prior to his admission. In other words, Plaintiff allegedly
admitted to having a problem with alcohol before he applied for the Royal
Insurance policy. After reviewing the records, Royal Insurance determined that
Plaintiff had misrepresented his condition of health when he applied for the
disability policy. Specifically, Plaintiff responded “No” to the following
question: “Has any person proposed for coverage ever: sought advice or treatment
for or been arrested for or been addicted to the use of alcohol or drugs?”.
Given the new turn of events, Royal Insurance canceled Plaintiff’s policy and
refunded his premiums.


Plaintiff filed suit against Rush and Royal
Insurance. He claimed that Rush (1) breached its physician/ client relationship
with him, (2) invaded his privacy and (3) negligently inflicted emotional
distress upon him. Rush did not answer the counts against it, but instead filed
a motion for judgement on the pleadings, alleging that it released Plaintiff’s
records pursuant to a valid authorization. As part of his answer to the motion,
Plaintiff included the affidavit of his attorney who stated that, during a
meeting with the medical director for Rush, Dr. Paul Feldman, Feldman admitted
that Plaintiff’s records should not have been released to Royal Insurance. The
trial court granted Rush’s motion for judgment on the pleadings. Plaintiff later
voluntarily dismissed his claims against Royal Insurance, and he now appeals the
trial court’s issuance of judgment on the pleadings to Rush.


ANALYSIS


According to the Illinois Code of Civil
Procedure, “[a]ny party may seasonably move for judgment on the pleadings.” 735
ILCS 5/2-615(e) (West 1998). When considering such a motion, the court is to
discern whether there is any issue of material fact presented by the pleadings,
and if not, which party is entitled to a judgment as a matter of law. Daymon
v. Hardin County General Hospital,
210 Ill. App. 3d 927, 569 N.E.2d 316
(1991). The only matters to be considered in ruling on the motion are the
allegations of the pleadings. In re Marriage of O’Brien, 247 Ill. App.
3d 745, 617 N.E.2d 873 (1993). Copies of written instruments attached to a
pleading as an exhibit are considered to be a part of the pleading. 735 ILCS
5/2-606 (West 1998). If the pleadings raise an issue of material fact, evidence
must be taken to resolve the issue and judgment may not be entered on the
pleadings. In re Estate of Davis, 225 Ill. App. 3d 998, 589 N.E.2d 154
(1992). We review a trial court’s issuance of a judgment on the pleadings de
novo. New Hampshire Insurance Co. v. Hanover Insurance Co.,
296 Ill. App.
3d 701, 696 N.E.2d 22 (1998).


Plaintiff essentially maintains that the trial
court erred in granting judgment on the pleadings to Rush because it improperly
determined that the authorization executed by the parties was valid. In
particular, Plaintiff argues that issues of fact exist as to whether the
authorization complied with Federal Regulations. The parties do not cite, nor
have we ourselves discovered, any authority interpreting the relevant provisions
of the regulations. This, therefore, is an issue of first impression.


Under Illinois law, medical records such as
those at issue in this case may be disclosed only if the patient gives written
authorization for such a disclosure and that authorization is executed in
compliance with the applicable Federal Regulations. 20 ILCS 301/30-5(bb)(2)(A)
(West 1998). The applicable Federal Regulations require the written
authorization to include (1) the specific name or general designation of the
program or person permitted to make the disclosure; (2) the name or title or the
individual or the name of the organization to which disclosure is to be made;
(3) the name of the patient; (4) the purpose of the disclosure; (5) how much and
what kind of information is to be disclosed; (6) the signature of the patient;
(7) the date the consent is signed; (8) a statement that the consent is subject
to revocation; and (9) the date, event or condition upon which the consent will
expire. 42 C.F.R. subpt. C, ?2.31 (1993).


Plaintiff contests whether the first requirement
of section 2.31 was satisfied by the authorization in this case. The relevant
provision of the authorization refers to the individuals and programs entitled
to make disclosures as “any physician, medical practitioner, hospital, clinic,
health care facility [or] other medical or medically related facility.” The
authorization does not include the specific name of the disclosing program or
individual. We must, therefore, determine if the authorization meets the
“general designation” requirement.


The term “designation” is not defined in the
Federal Regulations. See 42 C.F.R. subpt. B, ?2.11 (1993). Undefined terms of a
statute should be given their ordinary and popularly understood meaning.
Texaco-Cities Service Pipeline Co. v. McGaw, 182 Ill. 2d 262, 695
N.E.2d 481 (1998). “A distinguishing name” is the common definition of the word
“designation.” Webster’s Third New International Dictionary 612 (1986).
Considering the relevant terminology of the authorization, we believe that it is
at best imprecise and far too generic to be considered a designation as required
by the regulations. Because it is apparent that the trial court relied on the
authorization when it granted Rush’s motion for judgment on the pleadings, we
reverse and remand.


We note that our resolution of this issue
involves solely the interpretation of the plain language of the authorization
and is thus an issue of law and not a factual issue as argued by Plaintiff.
Coles-Moultrie Electric Cooperative v. City of Sullivan, 304 Ill. App.
3d 153, 709 N.E.2d 249 (1999). Moreover, our determination on this issue is
dispositive of the appeal. Accordingly, we need not and do not reach the
parties’ remaining arguments.


The judgment of the circuit court of Will County
is reversed and the cause is remanded for further proceedings consistent with
this order.


Reversed and remanded.


HOLDRIDGE and HOMER, JJ.,
concur.

M.A.K. v. Rush Presbyterian St. Luke’s Med. Ctr.,

M.A.K. v. Rush Presbyterian St. Luke’s Med. Ctr.,

M.A.K. v. Rush Presbyterian St. Luke’s Med. Ctr.,

No. 90527 (Ill. Dec. 20, 2001)

A patient brought this action against the medical center at which he was treated
for alcohol dependence alleging that the medical center breached the physician-patient
relationship and invaded his privacy by releasing his medical records to his
insurance carrier without first informing him of its intention to do so and
obtaining his approval. When obtaining insurance coverage, the patient had
previously consented to the release of his records. Reversing the appellate
court’s ruling in favor of the patient, the Illinois Supreme Court held that
the medical center complied with a regulation of the Department of Health and
Human Services that required written consent to a disclosure to include the “specific name
or general designation of the program or person permitted to make the disclosure.”
Accordingly, the consent signed by the patient stated: “I authorize any
physician, medical practitioner, hospital, clinic, health care facility, [or]
other medical or medically related facility . . . .” The court also noted
that the insurance company’s authorization form’s specific mention of alcohol
and drug treatment records should have put the patient on notice that such information
could be released according to the terms of his signed insurance consent form.
Lastly, the court held that, although the insurance company’s consent form was
silent as to whether the form covered records generated subsequent to his signing
of the form, the patient maintained the right to revoke his consent at any time
– but he did not do this.

The question for the future, of course, is what would the HIPAA privacy rule
say?

Luke v. Redlands Cmty. Hosp. (Full Text)

Luke v. Redlands Cmty. Hosp. (Full Text)

Filed 2/10/11 Luke v. Redlands Community Hosp. CA4/2

NOT TO BE PUBLISHED IN OFFICIAL REPORTS

California Rules of Court, rule 8.1115(a), prohibits courts and parties from citing or relying on opinions not certified for
publication or ordered published, except as specified by rule 8.1115(b). This opinion has not been certified for publication

or ordered published for purposes of rule 8.1115.

IN THE COURT OF APPEAL OF THE STATE OF CALIFORNIA

FOURTH APPELLATE DISTRICT

DIVISION TWO

Plaintiff and Appellant,

HAROLD LUKE,

v.

REDLANDS COMMUNITY HOSPITAL,

Defendant and Respondent.

E046969

(Super.Ct.No. SCVSS123244)

OPINION

APPEAL from the Superior Court of San Bernardino County. Joseph R. Brisco,

Judge. Reversed.

Ackerman, Cowles & Associates and Richard D. Ackerman for Plaintiff and

Appellant.

McDermott Will & Emery, Thomas A. Ryan and Jessica J. Thomas for Defendant

and Respondent.

1

INTRODUCTION

Harold Luke, M.D., (Dr. Luke) is a board certified family practice physician who

was a member of the medical staff of Redlands Community Hospital (RCH or the

hospital) for 25 years, until 2002 when the hospital suspended his privileges.1

On September 12, 2002, one of Dr. Luke’s nursing home patients, 76-year-old

M.E., was admitted to RCH in the final stages of a terminal illness. Two days later, he

died. After his death, what began as a dispute between Dr. Luke and a nurse over the

dose of morphine administered in the final hours of the patient’s life—and which of the

two of them was authorized to adjust his intravenous (IV) line—erupted into a full-scale

confrontation between the hospital and Dr. Luke. Eventually, the RCH Board of

Directors (the hospital board) terminated Dr. Luke’s medical staff privileges, and the

Medical Board of California (State Medical Board) decided to revoke his license to

practice medicine.

However, after San Bernardino County Coroner Dr. Frank Sheridan (Dr. Sheridan)

issued a third death certificate for M.E. and gave the State Medical Board additional

information about the toxicology report upon which the amended (second) death

1 Born in China, English is Dr. Luke’s second language. He came to the United

States when he was 19 years old, graduated from college in Massachusetts in 1968, and
received his medical degree from Loma Linda University in 1972. He was first certified
by the American Board of Family Practice in 1978. By 2002, he had been recertified
three times, most recently in 2000. Before the events giving rise to this case, he had
never been the subject of a complaint filed with the State Medical Board or with the
medical staff office of RCH. He has never been sued for malpractice.

2

certificate had been based, the State Medical Board rescinded its revocation decision.2

Instead, on April 10, 2006, it issued Dr. Luke a “Public Reprimand” for failure to

“maintain adequate and accurate records in his care of [M.E.]”

On June 24, 2005, Dr. Luke filed a Code of Civil Procedure section 1094.5

petition for a writ of administrative mandate (1094.5 petition) seeking to compel the

hospital board to reinstate his privileges. On April 25, 2007, San Bernardino County

Superior Court Judge Bob N. Krug granted the 1094.5 petition and remanded the matter

to RCH for reconsideration in light of the third death certificate and the State Medical

Board’s decision not to revoke Dr. Luke’s license. The court retained jurisdiction for

purposes of review of the hospital board’s reconsideration.3

On December 17, 2007, the hospital board reaffirmed its decision to terminate

Dr. Luke’s privileges. At a return hearing on July 21, 2008, the trial court, with San

Bernardino County Superior Court Judge Joseph R. Brisco presiding, denied the writ.

This appeal followed.

2 Over a period of two years, there were three death certificates: the first, on May 12,

2003, listed the causes of M.E.’s death as “sepsis,” “pneumonia,” “advanced
cardiomyopathy,” and “Guillain Barre Syndrome” (GBS); the second, an amendment to the
first, on August 13, 2003, listed the causes of death as “morphine toxicity” and “homicide,”
by “physician administered overdose of morphine”; and the third and final death certificate, a
further amendment issued on January 24, 2006, listed the cause of death as “undetermined.”

3 On June 29, 2007, Dr. Luke filed a notice of appeal to Judge Krug’s writ order with

this court. On August 2, 2007, we dismissed the appeal without prejudice. When a trial
court retains jurisdiction while remanding a matter to an administrative agency for further
hearing, the order is not a final appealable order. (Village Trailer Park, Inc. v. Santa Monica
Rent Control Bd. (2002) 101 Cal.App.4th 1133, 1139-1140.)

3

Dr. Luke argues here, as he did below, that the underlying peer review and

hospital board proceedings were unfair and the findings unsupported by substantial

evidence.

The case reaches us seven years after the initial event, having generated over

7,000 pages of legal records. In an effort to determine whether the proceedings below

were fair and, if so, whether there was substantial evidence to support the hearing bodies’

findings and actions, we have undertaken a close review of the record. We answer the

first, dispositive, inquiry in the negative.

FACTS AND PROCEDURAL HISTORY4

Because our conclusion that the underlying proceedings were unfair is closely

related to details of the original facts and the sequence of subsequent events, we recite

them at some length.

M.E.’s Admission and Hospital Course:

The parties agree that when M.E. was transferred from a local nursing home to the

emergency room of RCH on September 12, 2002, he was a very sick man. He had been

admitted to Loma Linda University Medical Center (LLUMC) four times that year, and

the admission to RCH was his second to that facility that month.

4 The facts are taken from the appellate record documents and transcripts, as well

as the clerk’s transcript in this case. With some repetition as necessary to maintain
clarity, we have recited events in chronological order of their occurrence wherever
possible, even when they became evident at different points in the proceedings.

4

Robert A. Klein, M.D., who examined M.E. in consultation at the nursing home

the day before his admission to RCH, described his physical condition in detail. The

patient lay in bed with “head hyperextended, mouth hanging open.” He had “lower facial

weakness” and a protruding tongue. He had “minimal ability to nod the head yes or no,”

with “moderate weakness of the arms with decreased muscle tone,” and “marked

weakness of the legs.” He had some sensation to pinprick in his arms and in his legs

above the knees, but none below the knees. He had no reflexes in his arms, knees, or

ankles.5

M.E.’s condition had not improved by the next day, when he was taken to RCH

with a complaint of respiratory distress. Emergency treatment record notes of September

12, 2002, show that he had a feeding tube, a Foley catheter in his bladder, a pacemaker,

was unresponsive, and appeared chronically ill. His past history, later confirmed by his

son J.E. to investigators from the State Medical Board, included repeated bouts of

pneumonia; a heart attack requiring resuscitation and bypass surgery; kidney stones; and,

most recently, GBS. After contracting “beret [sic] [in May 2002, he] just kept getting

worse and worse and worse . . . weaker and weaker and sicker and sicker and sicker and

sicker and sicker.” When J.E. saw his father in the emergency room, M.E. was in pain

5 Dr. Klein believed that M.E. was suffering from “chronic inflammatory

demyelinating polyneuropathy” (CIDP), rather than GBS, as previously diagnosed.
Dr. Klein indicated M.E.’s condition could be treated with intravenous immunoglobulin
(IVIG). Dr. Luke’s first discharge summary, dictated on September 17, 2002, said that M.E.
had been given IVIG at LLUMC during an earlier admission, with “some improvement.”
Dr. Luke’s second discharge summary, dictated on October 18, 2002, said that IVIG had
been considered at LLUMC, but was not given because of the patient’s renal problems.
M.E.’s neurologic condition had instead been treated with “plasmapheresis.”

5

and suffering from a severe, deep cough: “every breath was torture.” M.E. also had

“dysphagia” and “dysphasia” (difficulty swallowing and speaking), and a

“stage 3 decubitus” with “clear foul smelling drainage” on his “coccyx” (a deep

bedsore on his tailbone).

M.E.’s “Advance Health Care Directive” (Prob. Code, § 4701) named his children

as surrogate healthcare decision makers. On admission, the patient and his family

confirmed his “DNR” (do not resuscitate) status. J.E. and his sister wanted their father

made comfortable with fluids and morphine, but otherwise given no life-sustaining

treatment.

M.E. was diagnosed with “sepsis” (bacteria or their toxins in blood) and

“pneumonia” and admitted to RCH by Dr. Luke, who had been overseeing his care in

recent months. Initial treatment included the placement of an IV line through which

antibiotics, a medication to support blood pressure (dopamine), and morphine for pain

and respiratory distress, were infused. Oxygen was administered via a nonrebreather

mask (NRM) and blood and urine cultures were ordered.6 The preliminary report on the

blood culture was positive, as was a chest X-ray, which showed “[w]orsening . . . left

lower lung infiltrate with effusion.” Initially, M.E. was to be admitted to a “partial”

intensive care unit (ICU) or telemetry unit (where patients’ vital signs are electronically

monitored), but, for reasons not stated in the record, he was sent to a regular floor, where

electronic monitors were not used.

6 The NRM has been included with the records sent to us.

6

Dr. Luke’s orders on September 13, 2002, included one to discontinue the

dopamine “per family request” and one for the administration of an “MS drip” at a rate of

“1-2 mg/hour.”7 Nursing notes of September 12 and 13, 2002, indicated that the

morphine drip was adjusted to “15 cc” (1.5 mg) per hour and that the patient did not

appear to be in pain. Nursing notes for September 12, 13, and 14, indicated that he

continued to receive oxygen via the NRM.

Sometime in the early morning hours of September 14, 2002, apparently in

response to a request from a nurse concerned about the patient’s dropping blood sugar,

Dr. Luke ordered feedings through M.E.’s gastric tube. When J.E. was informed of this,

he adamantly requested that the feedings be stopped and said that he did not want

Dr. Luke to “come near his father.” Dr. Luke spoke to the family and acceded to their

request to discontinue tube feedings, but continued to check on M.E. throughout the day.

Thereafter, the family refused medications other than morphine and refused to allow the

nurses to take M.E.’s vital signs. Nurses who checked him on September 14, 2002, did

visual assessments of his status but, apparently, did not lift the NRM to directly observe

his face.

In the afternoon of September 14, 2002, Dr. Luke wrote two additional orders

regarding morphine: (1) to increase the dosage to “5 mg/hour for pt comfort,” and (2) to

increase the drip rate to “50 cc/hour.” The “50 cc/hour” order was noted as “done.” The

7 As used throughout the record, “MS” is an abbreviation for morphine sulfate, or

morphine; “mg” is an abbreviation for milligrams, a unit of weight; and “cc” is an
abbreviation for cubic centimeter, a unit of volume.

7

first nursing note referencing the increase was written by Nurse Thomas and indicated

that the morphine rate had been increased to “5mg/hour” at 2:00 p.m. In a progress note

at 3:00 p.m.,8 Dr. Luke described M.E. as “comatose” and “not responsive” and indicated

that he would give “MS for comfort.”

According to later testimony by Nurse George, Dr. Luke interrupted the nursing

shift change report about 3:20 p.m. and asked her to increase the morphine dose to

“5cc/hr.” She wanted to wait until the report was finished, but Dr. Luke insisted that it be

increased immediately, and she made the change at 3:25 p.m. At 4:05 p.m., the unit

secretary called Dr. Luke’s second order to Nurse George’s attention. Alarmed, she

telephoned him. The doctor confirmed that the order was for “50cc/hr,” said that he had

already increased the rate himself, and told her to forward the new order and his notes to

the pharmacy. Still concerned, at 4:20 p.m., Nurse George called her supervisor, Nurse

Parenteau. Nurse Parenteau told Nurse George that he had seen doses of that magnitude

before, that the doctor must see something she did not, and to continue the infusion as

ordered.

Dr. Luke pronounced M.E. dead at 5:05 p.m. Following Nurse Parenteau’s

instructions, Nurse George left the IV morphine line in place, removing it some unknown

number of hours later.

8 The medical and legal records variously use both military (24-hour) and civilian

(12-hour) time designations. For convenience and uniformity, we will use civilian time
throughout this opinion, even when the original designations are in military time.

8

case.

Events Following M.E.’s Death:

Almost immediately, people at the hospital began to contact each other about the

Within minutes, Nurse Parenteau called Risk Manager Pam Loscutoff (Loscutoff)

to ask whether M.E.’s death would be a “coroner’s case.” Loscutoff , who had worked at

RCH for 14 years, the last five in risk management, and in law firms for 14 years before

that, advised Nurse Parenteau to call Dr. Theodore Shankel (Dr. Shankel) with this

question. Dr. Shankel was “Chairman of the Medicine Department.” When Nurse

Parenteau called Dr. Shankel to ask if the coroner should be notified, Dr. Shankel said,

“No, I don’t think so. I wouldn’t notify the Coroner.”

At 6:35 p.m., “Gretta O. Cook” (Cook) sent an e-mail to “Timothy E. Norris”

(Norris), stating that increasing morphine from five milligrams per hour to 50 milligrams

per hour was “not making the patient comfortable.” It was “euthanasia.”9 Cook’s e-mail

ended with “[q]uite frankly, this is not the kind of liability to which the hospital wants to

be exposed.”

Shortly after midnight on Sunday, September 15, 2002, about an hour after her

shift ended, Nurse George recorded nursing notes for M.E.’s chart and documented her

version of the afternoon’s events in an e-mail. This e-mail was forwarded to Loscutoff at

11:39 a.m., on Monday, September 16, 2002.

9 Cook and Norris are not clearly identified in the record, but may have been

members of the pharmacy staff.

9

After Nurse Parenteau’s call on Saturday night, Loscutoff contacted several

people: she called Quality and Medical Staff Services Director Cathleen Bell (Bell) to

advise her of the situation; she interviewed Nurse George; still concerned that the case

might be a homicide, she consulted with legal counsel about how to notify the coroner;

she called the coroner’s office; and she spoke to Dr. Luke, who told her that he had used

morphine for compassionate care, not to assist a suicide. Had he wanted to assist a

suicide, he said, he would have used potassium chloride to stop the heart.

Loscutoff documented Dr. Luke’s statement in a handwritten note and relayed it to

Bell, Dr. Shankel, and Dr. Carolann Rosario (Dr. Rosario), RCH’s chief of staff and chair

of the Medical Executive Committee (MEC).

On Monday, September 16, 2002, after talking with Dr. Rosario, Loscutoff, Bell,

and legal counsel,10 Dr. Shankel reviewed M.E.’s hospital chart and called Dr. Luke on

the telephone to discuss the case. In a memorandum dictated right after their

conversation, Dr. Shankel wrote that Dr. Luke had said he increased the dose because the

family was upset that M.E. had not passed away after they refused other treatment.

“[T]he family was unhappy because their family member was still alive and . . . they

wanted the morphine drip increased and he increased the morphine drip.”

On Tuesday, September 17, 2002, Drs. Shankel and Rosario met in Bell’s office

with Bell and Loscutoff. Together they decided that Dr. Luke posed an imminent threat

10 The identities of the attorneys or law firms consulted by Loscutoff and

Dr. Shankel are not specified in the record.

10

of harm to patients, and that his hospital privileges should be summarily suspended.

Their assessment of danger was based on Dr. Shankel’s memorandum.

In the days following his death, M.E.’s body was kept at the hospital in

anticipation of action by the coroner’s office. After an initial review of M.E.’s record,

Dr. Sheridan concluded that, in view of M.E.’s well-documented diseases and terminal

condition, an autopsy was not indicated. However, after Loscutoff asked Dr. Sheridan to

look again and, particularly, to review the medication administration record, Dr. Sheridan

ordered a blood sample to rule out death from morphine toxicity. The sample was taken

by a San Bernardino County Coroner’s Office employee on September 18, 2002, four

days after M.E.’s death. Because San Bernardino County did not have the capability to

do postmortem blood tests, the sample was sent to the County of San Diego Department

of the Medical Examiner’s toxicology laboratory (San Diego laboratory) for analysis. At

some point in this process, but apparently in the San Diego laboratory and unbeknownst

to anyone in the San Bernardino County Coroner’s Office, the form indicating the site

from which the sample had been obtained was changed from “aorta” to “peripheral.”11

11 The “aorta” is the largest artery in the body and exits directly from the heart.

The femoral artery is a large “peripheral artery” that transmits blood to the leg. The
femoral artery is the site where most blood samples are drawn. (See About.com Web
site, [as of Feb. 10, 2011].)

11

Meanwhile, Drs. Shankel and Rosario called a special meeting of the MEC on

September 19, 2002.12 At the meeting, the MEC formalized Dr. Luke’s suspension and

appointed a special subcommittee (the MEIC) to investigate the matter and make

recommendations for corrective action.13 Dr. Luke attended the September 19 meeting.

He told the MEC that he had increased the dose of morphine because when he examined

M.E., the patient was in distress and grimacing under the NRM. After the second

increase, M.E. had given him a smile. Dr. Luke did not explain why he had failed to

document the signs of distress in the chart. The minutes of the meeting indicated that the

coroner was reviewing M.E.’s medical records and the blood to determine the cause of

death and that a report could be expected in about three weeks.

The MEC met for a second time on the evening of September 24, 2002.14 Earlier

that day, Dr. Luke had written two letters reiterating what he had told Loscutoff on

September 16 and the MEC members at the September 19 meeting. The first letter,

addressed to Dr. Rosario, said that his comfort care for M.E. had been misinterpreted as

assisted suicide and requested that the suspension be terminated. The second letter,

12 Members of the MEC included, among others, Drs. Shankel, Rosario, and

Pranav Mehta, and Bell. All were to become witnesses to the judicial review committee
(JRC).

13 The MEIC members were Drs. Mehta, Ivan Maeda, Paul Ennis, Dennis

Hilliard, and Monroe Seiberling. Dr. Mehta was in an independent private practice in
Redlands. Dr. Seiberling was a partner in the Beaver Medical Group (BMG). The status
of the other physicians in relationship to BMG is unclear.

14 Attorney Peter Rank of the K&R Law Group was also present at the September

24 meeting.

12

addressed to Drs. Rosario and Shankel, said, “I did not intend to do anything to endanger

the health of the patient. Neither would I ever terminate a patient’s life on a family

relative’s order or wishes.” He had increased the morphine because M.E. was “in distress

and gasping for air under the [NRM].” After the increase, the patient, who could not

speak or move, had given him a big smile. At the end of the meeting, the MEC voted to

terminate Dr. Luke’s suspension effective the next day, September 25, 2002, pending the

report of the MEIC.

On October 29, 2002, the San Bernardino County Coroner’s Office received the

toxicology report from the San Diego laboratory. At some point, the result was conveyed

by telephone to Loscutoff. Loscutoff was later unable to remember the date she received

the verbal report.

On November 14, 2002, in a “confidential” report to the MEC, the MEIC

summarized its findings: (1) the tenfold increase in morphine dosage, from five to 50

milligrams per hour, was “clearly outside the realm of good judgment or any MS

administration protocol for the terminally ill patient”; (2) Dr. Luke’s intention in ordering

the increase was not only to provide pain relief or patient comfort. He was “under

pressure by the family” and the increase was “also intended to hasten the patient’s death”;

and (3) Dr. Luke had “demonstrated a lack of concern that his decision-making was in

error and inappropriate.” The MEIC recommended that, for the next six months, all of

Dr. Luke’s hospital admissions be subject to concurrent proctoring by another physician

and that the pharmacy alert a proctor whenever Dr. Luke prescribed a narcotic. In

13

addition, within six months, Dr. Luke was to take continuing medical education (CME)

courses in the “use of narcotics for pain relief and end-of-life care.”15 When the action

became final, a report would be filed with the State Medical Board.

On November 15, 2002, the day after the MEIC’s confidential report to the MEC,

San Bernardino County Supervising Deputy Coroner Randall Emon (Emon) called

Loscutoff to say that the cause of death listed on M.E.’s death certificate would be “acute

morphine toxicity.” Shortly after that call, a supervising investigator from the State

Medical Board, Kathleen Nicholls (Nicholls), called Bell to say that the coroner’s office

had reported the same information to them: that the patient had received a “lethal” dose

of morphine, “ten times the usual dose.” Nicholls said the State Medical Board would be

conducting its own investigation into the matter.16

As soon as Bell received the call from Nicholls, she called Dr. Rosario and they

scheduled another meeting of the MEIC for December 3, 2002. At the meeting, Bell told

the MEIC members about the calls from the coroner’s office and the State Medical

Board. The MEIC members, who had initially intended to proctor Dr. Luke themselves,

were very concerned about “the logistics of concurrent proctoring” and with their own

15 On November 13, 2002, Dr. Luke completed a one-hour CME course on “End

of Life Care” at St. Bernardine Medical Center. On February 1, 2003, also at St.
Bernardine, he attended a six-hour pain management seminar.

16 The State Medical Board’s case synopsis said the toxicology report said that

M.E. had received “ten times the legal limit” of morphine.

14

potential legal liability. Unanimously, they decided to withdraw the offer to proctor and

to advise the MEC to suspend Dr. Luke’s privileges.

In the interim between the November 15 and December 3 meetings of the MEIC,

on November 20, 2002, Dr. Rosario wrote Dr. Luke a letter informing him of the findings

and recommendations of the MEC. Dr. Rosario’s letter said that the MEC had adopted

the MEIC’s findings that Dr. Luke had increased the morphine dose for “a terminally ill

patient who subsequently expired,” and had changed the IV rate himself without first

including or notifying the registered nurse assigned to care for the patient. The MEC had

also adopted the MEIC’s recommendations regarding proctoring, pharmacy notification,

and CME requirements. The letter stated that, when final, the action would require

reports to the State Medical Board and to the National Practitioner Data Bank (NPDB),17

and that Dr. Luke had a right to request a hearing. The letter did not mention the MEIC

finding that Dr. Luke had been under pressure from M.E.’s family and had acted

intending to hasten the patient’s death.

On December 16, 2002, Dr. Luke retained physician/attorney Philip S. Cifarelli

(Cifarelli) and requested a JRC hearing to dispute the MEC’s action.

17 National Practitioner Data Bank for Adverse Information on Physicians and

Other Health Care Practitioners. (See 42 U.S.C. §§ 11131–11137; 45 C.F.R. §§ 60.1–
60.14 (2008).)

15

After Dr. Luke requested a hearing, Bell “secured” M.E.’s medical records for a

second time.18 Reviewing them sometime in early January 2003, she discovered that

Dr. Luke had dictated two discharge summaries: one on September 17, 2002, and

another on October 18, 2002. Both discharge summaries were in the hospital’s computer

system, but only the second, which appeared to be longer than the first, was signed and in

the chart.19

Bell reported her discovery that there were two discharge summaries to David

Stanley (Stanley), the RCH Director of Health Information Management, to the State

Medical Board, to legal counsel, and to the MEC. On January 7, 2003, Stanley spoke to

Dr. Luke. Dr. Luke told Stanley that the first discharge summary had been inadequate so

he had prepared another. He neither confirmed nor denied having removed the first one

from the chart.

18 She later testified that she had first “secured” and copied the medical records

on September 27, 2002. The location of M.E.’s medical records at various times while
this case was pending is unclear. Apparently, on September 16, 2002, they were in Bell’s
office where Dr. Shankel reviewed them. Dr. Luke later wrote that he did not have them
available the following day when he dictated the first discharge summary.

19 The second discharge summary said that Dr. Klein’s recommended treatment

for CIDP, “IVIG,” had been considered during M.E.’s admission to LLUMC, but not
actually given, as had been stated in the first summary. In addition, the second discharge
summary repeated the statements Dr. Luke had made to Loscutoff on September 16,
2002, to the MEC on September 19, and in his letters to Drs. Shankel and Rosario on
September 24: that he had increased the morphine dose because he had seen that M.E.
was in distress under the NRM. Finally, the second discharge summary stated that M.E.
had received morphine in the past and “would have developed a tolerance” such that a
higher dose “would be necessary. . . .”

16

Three days later, on January 10, 2003, the MEC notified Dr. Luke in a second

letter that his medical staff privileges at RCH had been summarily suspended as of that

date. All the recommendations in the letter of November 20, 2002, including concurrent

proctoring, were being withdrawn as “insufficient to adequately protect patients in the

hospital.” The assessment of “immediate danger” to patients was based on Dr. Luke’s

treatment of M.E. as related by Dr. Shankel in his September 16, 2002, memorandum.

The second letter added, “We have received evidence from the San Bernardino County

Coroner’s Office that there was a toxic level of morphine in the patient’s system. We

have also received evidence that indicates that you have inappropriately altered the

medical record of this patient.” The second letter stated that there would be another

meeting of the MEC on January 16, 2003, “to review and consider [the] suspension.”

On January 22, 2003, the MEC sent Dr. Luke a third letter. This letter notified

him that, as of January 16, his medical staff privileges had been suspended for one year.

Although not so specified, as findings the third letter said: he had administered morphine

to a terminally ill patient who subsequently expired; he had increased the dose from one

to five to 50 milligrams per hour, a dose that was “clearly outside the standard of care or

any known MS administration protocol for the terminally ill patient”; he had changed the

rate of the IV without first notifying the registered nurse; the county coroner had found

that the patient’s death resulted from morphine toxicity; he had inappropriately amended

the medical record by substituting a revised discharge summary “substantially after the

17

events described”; and he had “demonstrated a lack of recognition and understanding that

[his] decision-making was in error and inappropriate.”

The third letter informed Dr. Luke that he could reapply for privileges between

July 15, 2003, and January 15, 2004, conditioned upon his taking and passing approved

courses in end-of-life care, pain management, medical ethics, and medical record

documentation. Reinstatement would depend in part on his providing evidence of his

current status with the State Medical Board and any evidence discovered in its

investigation. Compliance with the imposed requirements would not guarantee

reinstatement. If he failed to request or receive a termination of the suspension by

January 15, 2004, his privileges would be terminated.

On or about May 7, 2003, and in accordance with sections 7.3-2 to 7.3-5 of the

hospital bylaws, the MEC recommended and the hospital board appointed a hearing

officer, Jay Christensen of Christensen & Auer (the hearing officer), and a committee of

five physician members of the RCH medical staff (the JRC) to hear the matter.

Drs. Douglas C. Brockmann, Manuel A. Cantun, James R. Dexter, Chang Wang, and

Heather West were the physicians appointed to the JRC. A week earlier, on April 28,

Cifarelli had sent opposing counsel and the hearing officer a letter objecting to the

inclusion of “two of the three members” of the JRC because of their membership in

BMG, the same medical group as Dr. Shankel, a witness against his client. On May 5,

the law firm representing the MEC opposed the disqualifications of Drs. Dexter and

18

Brockmann in a letter to Cifarelli and the hearing officer. Challenge to the two members

was deferred to voir dire.

On May 12, 2003, three days before the JRC hearings began, the San Bernardino

County Department of Public Health issued the first death certificate for M.E, listing

sepsis, pneumonia, cardiomyopathy, and GBS as the causes of his death. On May 22,

2003, in answer to an inquiry from State Medical Board investigator Nicholls, Emon said

the coroner’s office was waiting for the State Medical Board’s decision to complete an

amendment to the death certificate.

The JRC Hearings:

The JRC met on 11 evenings between May 15, 2003 and April 29, 2004. At the

first session, the parties stipulated that the MEC’s letter of January 22, 2003, would

constitute the “notice of charges.”

May 15, 2003

Voir dire

As the hearings opened, and after questioning the five panel members about their

relationships to four of the MEC’s scheduled witnesses—BMG physicians Shankel,

Rosario, Seiberling, and Klein—Cifarelli formally objected to the presence of

Drs. Dexter and Brockmann on the panel. Like Dr. Shankel, Dr. Dexter was a pulmonary

critical care specialist. He had been a BMG partner since 1989 and had known and

worked with Dr. Shankel for “more than 10 years.” Dr. Brockmann was an

anesthesiologist who provided pain management services at the hospital and at the Inland

19

Surgery Center. Dr. Brockmann had been a BMG partner since 1993. It was likely,

counsel argued, that as longtime colleagues and business partners with reciprocal

fiduciary duties, it would be difficult for the two panel members to be objective and to

rely solely on evidence presented during the hearing. Drs. West, Cantun, and Wang were

unrelated to BMG, and Cifarelli did not object to them.

Counsel for the MEC, Peter Roan (Roan) asked panel members if they could be

fair and impartial, and each responded in the affirmative. Roan then argued that BMG

was too big for the relationships between Drs. Dexter and Brockmann and the four

witnesses to present a risk of prejudice. “[T]here’s many, many physicians on this staff

[who] are affiliated with [BMG]. That in and of itself does not demonstrate bias.”

Learning from Dr. Dexter that there were approximately 140 physicians in the group, the

hearing officer overruled Cifarelli’s objections: “I don’t believe that their association as

partners in this very large medical group gives rise to an impression of bias or prejudice,

and they’ve indicated that they are not biased.”

Dr. Shankel

Dr. Shankel testified that he had learned of the incident from “Richard” (Nurse

Parenteau), had “reviewed the chart,” and had spoken with the “medical staff office” and

“risk management,” before he called Dr. Luke on September 16, 2002. Dr. Shankel

verified the information in his September 16, 2002, memorandum: that after speaking

with family members, Dr. Luke said he had placed M.E. on “comfort care.” All of

M.E.’s medications were discontinued and he was “started on a morphine drip.” The

20

family became angry “that M.E. was still living,” so Dr. Luke increased the rate of the

morphine drip. Dr. Shankel could not remember Dr. Luke saying anything during their

telephone conversation about the patient’s having been in pain or distress as a reason for

the increase.

Dr. Shankel said he had never seen a morphine dose as high as 50 milligrams per

hour and had never seen a dose increased so quickly. In his view, this amount and rate of

increase did not comport with the standard of care at RCH or with the comfort measures

only protocol, which was “available to all physicians who want to use it” as “a guideline

for titrating a morphine drip if somebody has requested or the family has requested

comfort care.”20

Because of time constraints, cross-examination of Dr. Shankel was deferred to a

later session.

July 8, 2003

Nurse Parenteau

Nurse Parenteau testified, as recounted ante, about his telephone conversations

with Loscutoff, Nurse George, and Dr. Shankel. When Nurse George called him about

Dr. Luke’s morphine orders, he told her that he knew of patients on doses of 150 or 200

milligrams, that the doctor may have seen something that she did not see, and for her not

20 The comfort measures only protocol is referred to in a variety of ways at

different points in the record. We will call it either by its printed title “the comfort
measures only protocol” or “the protocol.” According to a notation on the copy in our
record, the protocol was approved in September 2001 and revised in August 2002, about
one month before this case.

21

to worry about the amount. Loscutoff had advised him to call Dr. Shankel, who had said

he did not think the coroner needed to be notified about the case.

Nurse Parenteau knew about the hospital’s comfort measures only protocol but

was unfamiliar with its details. When he needed information about it, he called the ICU.

Risk Manager Loscutoff

Loscutoff confirmed that after talking to Nurse Parenteau, she had called legal

counsel to find out how to notify the coroner because she was concerned that the case

might be a homicide. On “Tuesday or Wednesday” (Sept. 17 or 18, 2002), she had

spoken to M.E.’s son and daughter. They were unhappy that their father’s body was not

being released, but were not upset with Dr. Luke’s care.

In the weeks after the postmortem blood sample was taken, Loscutoff had made a

number of calls to the coroner’s office trying to get the toxicology report. Emon had

eventually responded and told her that the coroner’s office had received the report and

that it showed “10 times the normal amount [of morphine].” Loscutoff was uncertain of

the date of Emon’s call, but knew it was “quite a long time” before December 26, 2002,

the day her office obtained a facsimile copy.

September 29, 2003

Admission of the amended (second) death certificate

The third session of the JRC hearing began with argument by Cifarelli that the

August 13, 2003, amendment to M.E.’s death certificate should not be admitted into

evidence. The amended (second) death certificate changed M.E.’s cause of death from

22

“pneumonia” and other disease conditions to “homicide” by “physician administered

overdose of morphine.”

In a written motion signed on September 29, 2003, Cifarelli had characterized the

amended (second) death certificate as both prejudicial and irrelevant to the charges

against his client as specified in the January 22, 2003, letter. If the amended certificate

was admitted, Cifarelli intended to call Emon and a forensic pathologist as witnesses.

Roan answered that the amended (second) death certificate was “certainly probative of

the issues and the charges involving this particular patient, and it should be admitted.”

The amended (second) death certificate was admitted.

Dr. Shankel

Dr. Shankel was recalled and examined first by Roan about the hospital’s comfort

measures only protocol. The protocol, Dr. Shankel testified again, was available for use

“to give a physician guidance on comfort care.” On cross-examination, Dr. Shankel said

that “Dr. Dexter was one of the physicians involved in” the development of the protocol,

but he did not recall anyone else who had been involved. As far as Dr. Shankel knew, the

protocol was “on the computer” along with other protocols and policies but had not been

distributed to the medical staff or discussed in any medical staff meetings. He thought

the nursing staff was familiar with it.

Dr. Shankel said that he had reviewed M.E.’s chart before he called Dr. Luke on

September 16, 2002, when they spoke for “a matter of minutes.” He had dictated the

memorandum of their conversation right after they hung up. He was certain he had not

23

misunderstood Dr. Luke on the telephone. Dr. Luke had said he increased the morphine

dose because “the family was unhappy because their family member was still alive.”

Dr. Shankel did not recall that the patient had been started on morphine on September 12,

not September 14 as stated in his memo. Dr. Shankel did not speak to Dr. Luke in

person, did not review M.E.’s chart with Dr. Luke, did not show his memorandum of

their conversation to Dr. Luke, and did not speak to M.E.’s family.

Director of Health Information Management David Stanley

Stanley was in charge of medical records and transcription at RCH. Stanley

confirmed that there were two discharge summaries for M.E. in the hospital’s computers,

one (unsigned) dictated on September 17, 2002, and one (signed by Dr. Luke) dictated on

October 18, 2002, but that only the latter was in the chart. Because it was signed, the

second discharge summary was the only official discharge summary. Stanley testified

that doctors who made corrections to medical entries, including discharge summaries,

were supposed to amend rather than replace the first entry.

September 30, 2003

Dr. Mehta

Dr. Mehta was a family physician in private practice and chairman of the family

medicine department at RCH. Dr. Mehta was on the MEC and had been the chair of the

MEIC. The MEIC met four times. After much discussion, members had concluded that

the increase in morphine dosage from five to 50 milligrams without titration was outside

the standard of care for physicians practicing at RCH. The MEIC did not recommend

24

immediate suspension of Dr. Luke’s hospital privileges because members thought that,

with proctoring, his prescribing habits could be changed.

Dr. Luke had told MEC members on September 19, 2002, that he had increased

the morphine to provide palliative and comfort care, and that he did not believe

Dr. Shankel’s memo of their telephone conversation was accurate. At first, the five

physicians on the MEIC had intended to proctor Dr. Luke themselves. However, after

they received a verbal report that the coroner planned to list M.E.’s cause of death as

“acute morphine toxicity,” they decided proctoring was too difficult and their legal

liability was too great. The impending report “played a big part in [their] decision-

making. [¶] . . . [¶] Because here we have a case where the death has occurred . . .

intentionally from overdose of morphine.”

In Dr. Mehta’s opinion, it was not possible to see a patient’s facial grimacing

through an NRM because “[i]t is all fogged up and really you can’t see that well.”

Dr. Rosario

Dr. Rosario was an internal medicine specialist and a partner and colleague of

Dr. Shankel at BMG. As chair of the MEC, she had participated in the various decisions

regarding the suspension of Dr. Luke’s privileges. Dr. Rosario, who had also been a

registered nurse for 14 years before becoming a physician, said she found no

documentation of any respiratory distress or pain in the nursing notes that would justify

the use of morphine. She believed that none had ever been needed.

25

On cross-examination, Dr. Rosario acknowledged that this was the first time a

problem with Dr. Luke’s care had ever come to the attention of the MEC. She said that

Dr. Luke told the MEC members that he had lifted the patient’s NRM and observed signs

of distress that no one else had seen. Dr. Rosario agreed that the nurse’s notes did not

indicate anywhere that the NRM had been removed to evaluate the patient’s respiratory

status. At first, the MEC members had not wanted to “end his career” on the basis of a

single incident and believed they could work with him and avoid reporting the incident

“as an 805.”21 On further examination, however, it seemed that Dr. Luke did not

understand the community standard of care regarding morphine dosage or the ethics of

medical record documentation. It was a surprise to Dr. Rosario when the death certificate

showed “sepsis” as the cause of M.E.’s death because someone at the hospital had

received a verbal report from the coroner’s office indicating that the cause of death would

be given as morphine toxicity. After learning that the coroner was going to list morphine

toxicity as the cause of death, the MEIC members decided proctoring was too difficult

and would subject them to liability and recommended to the MEC that Dr. Luke’s

privileges be suspended.

Because of the amended (second) death certificate, Dr. Rosario believed that M.E.

died from morphine toxicity.

21 Business and Professions Code section 805.

26

October 2, 2003

Dr. John Hsu22

Dr. Hsu was an anesthesiologist and specialist in pain management in private

practice, who was called as an expert witness by the MEC. Dr. Hsu was aware of recent

recommendations by the Joint Commission on Accreditation of Healthcare Organizations

and the American Medical Association regarding the use of high-dose morphine and

appropriate management of pain and suffering in dying patients, and agreed that doses of

morphine as high as 150 milligrams per hour were being used in these circumstances.

However, because neither pain nor respiratory distress had been documented in the chart,

he did not believe the increase in the dose used for M.E. was appropriate or within the

standard of care. Dr. Hsu knew of physicians who adjusted IV infusion rates themselves.

Based on the level of morphine in M.E.’s postmortem toxicology report, Dr. Hsu

believed M.E. had died from morphine toxicity.

Nurse George

Nurse George testified that M.E. was “nonverbal” and had not complained to her

of pain when she cared for him on either September 13 or 14, 2002. She had increased

the rate of M.E.’s morphine to “5 cc’s per hour” at 3:35 p.m. She had no explanation for

the fact that a nurse on the previous shift had indicated that the morphine had been

increased to five milligrams at 2:00 p.m. Her assessment of M.E. had been “visual.” To

22 The reporter’s transcript shows the spelling “S H U.” Dr. Hsu’s curriculum

vitae shows “HSU.”

27

her, the patient “seemed calm,” there was “no moaning,” and she did not see him

“squinting” or “flailing” his arms. Nurses do not usually remove a patient’s NRM when

assessing a patient. After M.E. died, the IV lines were left in place for several hours; she

did not remember when the morphine pump had been turned off.

Quality and Medical Staff Services Director Bell

Bell confirmed some details of the MEC and MEIC meetings with Drs. Rosario

and Shankel. When the coroner’s office first called and asked if the hospital was going to

report the matter to the State Medical Board, she and Loscutoff did not respond because

they wanted to think about it more. However, when State Medical Board investigator

Nicholls told her that the coroner’s office had already reported the matter and said that

M.E. “had received 10 times the usual dose of morphine,” she notified Dr. Rosario and

the MEIC reconvened.

Bell discovered early in January 2003 that there were two discharge summaries.

When she saw the first discharge summary, it was not signed. The proper procedure for

changing a dictated medical record entry was to dictate an addendum to the original.

When counsel for Dr. Luke attempted to question Bell about her relationship to

Dr. Dexter, whom she said she knew “very well,” and about whether she had ever worked

for BMG, the hearing officer deflected the inquiry: “Counsel . . . this line of questioning

is really more appropriate to voir dire, which you’ve already had . . . .”

28

December 1, 2003

Dr. Ronald Katz

A physician and professor of anesthesiology at the University of California at Los

Angeles and University of Southern California, Dr. Katz had testified in other cases

where doctors were being prosecuted for murder for giving dying patients too much

morphine.

Morphine, Dr. Katz said, is a “first-line drug” for the treatment of pain and

respiratory distress. Dr. Luke’s use of morphine for M.E. had been within the standard of

care; an increase from five to 50 milligrams per hour was not unusual; Dr. Katz had seen

doses of 100 to 300 milligrams per hour. Postmortem morphine levels are essentially

“worthless” because morphine leeches from tissue into blood after a person dies, making

blood levels falsely high. The only accurate postmortem blood levels are those in

“vitreous humor,” which was not obtained in this case.23

According to Dr. Katz, Dr. Shankel’s September 16, 2002, memorandum was

inaccurate in three ways: (1) it stated that M.E.’s morphine drip was started on

September 14, 2002, when it was actually started on September 12; (2) it stated that the

family was angry with Dr. Luke, when J.E. had denied this; and (3) it stated that Dr. Luke

first increased the morphine and then wrote the order, when Dr. Luke had told him those

events occurred in reverse order.

23 Vitreous humor is “the clear colorless transparent jelly that fills the posterior

chamber of the eyeball.” (See Princeton University WordNet Web site,
[as of Feb. 10, 2011].)

29

Dr. Katz believed M.E. died from “multiorgan failure,” not “morphine toxicity.”

December 2, 2003

Dr. Raffi Simonian

Raffi Simonian, Pharm.D., was the Director of the Pharmacy at the University of

California at San Diego hospital.

Based on the fact that M.E. had been on morphine for two days and that the

increase to five milligrams per hour did not relieve the symptoms of distress observed by

Dr. Luke, Dr. Simonian believed M.E. was morphine tolerant. Dr. Simonian testified that

postmortem morphine blood levels are unreliable.

In Dr. Simonian’s opinion, there was generally a significant problem with

physicians “undertreating” pain in dying patients.

Dr. Simonian testified about a number of published studies demonstrating that,

because of their intense fear and anxiety, patients facing imminent death are able to

tolerate much higher doses of morphine—up to 350 milligrams per hour and 1,120

milligrams per day—without suffering the respiratory depression that might occur in

other patients.

30

December 4, 200324

Dr. Ben Rich

Ben Rich, J.D., Ph.D., was a bioethics professor at the University of California at

Davis. Dr. Rich testified that the “principle of double effect” can justify the use of a

high-risk medical intervention in an actively dying patient when the potential benefit

outweighs the risk of a bad side effect, and the benefit is what the doctor intends to

confer. In response to questions from Dr. Dexter, Dr. Rich discussed the various forms

of euthanasia, all of which, by definition, require intent to bring about someone’s death.25

In Dr. Rich’s opinion, Dr. Luke’s actions did not amount to euthanasia under any

definition because the evidence showed that he intended to relieve M.E.’s suffering, not

bring about his death.

Dr. Henrik de Jager

Henrik de Jager, M.D., a specialist in ear, nose, and throat surgery, had been a

RCH medical staff member since 1977, when he first became acquainted with Dr. Luke.

He had referred patients to Dr. Luke over the years because he knew him as “a

competent, empathetic physician with a good reputation in the community.” Dr. Luke’s

24 Cifarelli attempted to call Dr. Stanisai, an RCH medical staff physician and

longtime colleague of Dr. Luke, to testify as to his client’s character for truthfulness,
which he felt was a central issue in the hearing. However, the hearing officer excluded
the witness on the grounds that Dr. Stanisai’s testimony would be irrelevant and a waste
of time.

25 The categories are voluntary passive, voluntary active, nonvoluntary passive,

and involuntary or criminal.

31

practice was “heavy . . . in the geriatric area.” There was much competition for elderly

and Medicare patients, and at one time, there had been many solo general practitioners in

the Redlands area who cared for them. However, because of competition from large

managed-care groups, most of these private practice physicians had left and their patients

had been taken over by large groups: “In this town it’s [BMG].” Dr. de Jager had never

seen or heard of the RCH comfort measures only protocol; to his knowledge, it had never

been discussed in any medical staff or in-house service meetings.

Between December 2003 and January 2004 Sessions

In a January 5, 2004, letter, Cifarelli requested the hearing officer’s help in

obtaining the testimony of Emon and Dr. Sheridan about the amended (second) death

certificate. Cifarelli had arranged to have them appear, but the two had failed to show up

as scheduled and, thereafter, had not returned his telephone calls. In a letter dated

January 8, 2004, Roan responded that he considered their testimony “unnecessary”

because the cause of M.E.’s death was “an interesting side issue,” but “unimportant” to

the reasons for Dr. Luke’s discipline by the MEC. The central issue, Roan stated, was

whether Dr. Luke’s actions in increasing the rate of administration of morphine “1000%”

comported with professional standards at the hospital, and testimony by the coroner and

deputy coroner was “simply not probative” of those issues.

32

January 15, 2004

Dr. Solomon Liao

Solomon Liao, M.D., was an assistant clinical professor and hospitalist at the

University of California at Irvine Medical Center and was board certified in “[i]nternal

medicine, geriatrics medicine, and hospice and palliative medicine.” Dr. Liao testified

about Dr. Luke’s overall management of M.E., about the use of NRM’s and morphine,

about the two discharge summaries, about M.E.’s pain, about the nurses’ inability to

detect respiratory distress, and about the likely cause of M.E.’s death.

Dr. Liao believed that Dr. Luke’s management of M.E. at RCH from September

12 to September 14, 2002, had been appropriate in that it included pharmacological

(opioid) and nonpharmacological (visits and discussions with patient and family)

interventions and comfort care.

NRM’s are used for the sickest patients because they provide the highest possible

concentration of oxygen short of intubation. The NRM was appropriate for M.E. because

of his shortness of breath, hypoxia, sepsis, and multisystem organ failure. It is necessary

to remove the NRM to observe facial expressions, especially in a patient whose face is

partially paralyzed. Dr. Luke had told Dr. Liao that he removed the NRM when he

examined M.E.

Morphine is the drug of choice for patients in respiratory distress. Dr. Luke’s use

of morphine, including his increase in the dosage from five to 50 milligrams to relieve

respiratory distress, pain, and anxiety in a patient dying from multisystem organ failure

33

and untreated sepsis, was appropriate. Fifty milligrams per hour was medically

acceptable for a patient like M.E., as was Dr. Luke’s having adjusted the IV himself

when a nurse was not available to do so.

In Dr. Liao’s opinion, the two discharge summaries were not significantly

different. Additions in the second discharge summary included a statement that a

“50 cc dose” of morphine was not unusual, that the patient was in respiratory distress and

gasping for air under the NRM, that the patient smiled after the increased dose, that the

patient showed no signs of morphine toxicity, that the nursing supervisor had told the

nurse that he had seen rates as high as “150 cc’s per hour,” and that Dr. Luke believed the

patient would have developed a tolerance to morphine because he had been receiving it

continuously. The word “shocky” in the second summary meant essentially the same

thing as the words “septic shock” in the first summary.

M.E., Dr. Liao said, had several reasons for pain and a significant condition that

kept him from communicating that pain. Facial weakness made it difficult for him to

demonstrate commonly seen signs like “grimacing or knitting of the eyebrows.”

Similarly, M.E. was “an endstage neurological patient . . . [who] oftentimes do not have

the . . . strength to demonstrate accessory muscle use,” which “typically nurses look for

when they look for labored breathing.”

As Dr. Liao testified, Dr. Dexter asked him several questions, first posing a

hypothetical about whether an 80 milligram “bolus” of morphine would be a

reasonable dose of morphine in a patient who had been on five or six days of morphine

34

at a rate of one to two milligrams per hour. Dr. Dexter said he thought that whether

euthanasia had been committed was “the question,” and he queried Dr. Liao as to how

one could distinguish between “active euthanasia and comfort measures.” “[I]f you look

just at the documents in the chart and then add Dr. Shankel’s note, that would suggest

family-instigated active euthanasia.”

Dr. Liao responded by noting that Dr. Luke had instituted curative measures,

including tube feedings and IV antibiotics: “That’s not the pattern . . . of a physician who

wanted to perform active euthanasia.” Dr. Liao would not expect a physician to do such

a thing by infusion, and “certainly not write it into the chart.” Health care professionals

who euthanize patients generally do it in “secret, without discussion with a patient’s

family” and by means of boluses rather than by drip.

In Dr. Liao’s opinion, the postmortem toxicology report was of “[n]o clinical

significance whatsoever,” and M.E. had not died from morphine toxicity. He “died from

sepsis and multiorgan failure.”

Nurse Caron Goller

Caron Goller, R.N., was employed by Hoag Memorial Hospital in the neurological

and neurosurgical units. Nurse Goller had seen morphine doses as high as 300

milligrams per hour administered by IV drip to dying patients.

35

April 28, 2004

Admission of additional documents

At the beginning of this session, Cifarelli offered the transcript of the State

Medical Board’s March 18, 2003, interview with J.E. into evidence, while Roan offered a

copy of the State Medical Board’s “Accusation” (filed 2/18/04). The hearing officer

ruled both documents admissible for any purpose, including for impeachment and for

their substance.

The “Accusation”

The accusation charged Dr. Luke with four violations of the Business and

Professions Code: gross negligence (§ 2234, subd. (b)), repeated negligent acts (§ 2234,

subd. (c)), acts of dishonesty (§ 2234, subd. (e)), and failure to maintain accurate and

adequate records (§ 2266). The first three charges were based on allegations that he:

(A) “intentionally and deliberately hastened the death of a terminally ill patient by

administering a lethal dose of morphine sulfate”; (B) “administered a lethal dosage of

morphine sulfate to a terminally ill patient without a documented medical necessity”; and

(C) “failed to inform the Records Department of [RCH] of his intention to dictate a

second discharge summary on the patient, or of his intention to substitute the second

discharge summary for the first discharge summary.” The accusation based the fourth

charge on a failure “to maintain adequate and accurate medical records on patient [M.E.],

as more particularly alleged in paragraph 5, above.” The relevant part of paragraph 5

specified that Dr. Luke’s statements that he increased the morphine dose because the

36

patient ‘“was in distress and gasping for air under the [NRM],’” and that the increase

“was necessary because the patient had developed a tolerance,” were not documented in

the medical record.

J.E.’s interview with the State Medical Board

In the interview, J.E. stated that he had had many conversations with M.E. and

knew that his father “wished not to suffer.” He reiterated M.E.’s extensive medical

history and ill condition, which included extreme difficulty breathing and a severe cough

on the day he was admitted to RCH. After morphine was started, the cough abated, M.E.

calmed down and breathed easier, and smiled and held hands with family members.

During the day on September 14, 2002, Dr. Luke was “in and out” of M.E.’s room

several times to check on him. Neither J.E. nor any member of the family ever expressed

anger that their father was still living or put pressure on Dr. Luke to increase the

morphine.

Dr. Cyril Wecht

Cyril Wecht, M.D., J.D., was the Allegheny County Coroner in Pittsburgh,

Pennsylvania, and in private practice as a forensic pathologist. Dr. Wecht had published

hundreds of articles in his field and had performed about 15,000 autopsies.

In Dr. Wecht’s opinion, the postmortem blood sample must have been obtained

from central (heart) blood because it would have been extremely difficult to get blood

from a peripheral source on the body of a person who had been dead for several days.

IV morphine will continue infusing after death if the line is left open because “there’s no

37

venous pressure to overcome.” The fact that morphine is redistributed from tissue into

blood and from peripheral blood into central blood after death, in conjunction with the

fact that the IV lines were not removed, meant that the morphine level in the toxicology

report was of no credible value in ascertaining the cause of death.

To Dr. Wecht, the fact that an autopsy had not been performed was “abominable”

and “an atrocious example of poor medical-legal investigation by an official

governmental agency.” “For a medical examiner to sign a case like this out as a

homicide without having done an autopsy is malpractice . . . .” When Dr. Dexter asked

how an autopsy would have helped determine the cause of death, Dr. Wecht answered

that gross and microscopic tissue examination could have more accurately measured the

degree of sepsis and pneumonia, as well as the severity of M.E.’s heart disease. In

addition to a more accurate drug level, the effect of morphine on the brain might also

have been seen.

In Dr. Wecht’s opinion, M.E. died of “multiorgan system failure.”

April 29, 2004

Dr. Luke’s failure to testify

At the beginning of the final session, Cifarelli told the hearing officer and the

panel that, because of the language in the amended (second) death certificate, he had

advised his client not to testify. Instead, Cifarelli offered a declaration by Dr. Luke

explaining his position. Roan objected, and the hearing officer ruled the document

inadmissible, reasoning that it would be “patently unfair” to allow a declaration by a

38

witness who was present and could testify and be cross-examined by counsel and the

panel members. The hearing officer suggested that in closing argument, counsel should

“provide any guidance . . . on any inferences that can or should not be drawn from

Dr. Luke’s decision not to testify . . . .” Dr. Luke was not called by either side and did

not testify.

Closing arguments

Roan for the MEC

Roan first asserted that the case was not about moral and ethical issues related to

euthanasia, not about physician assisted suicide, and not even about whether an overdose

of morphine had caused M.E.’s death. It was about Dr. Luke’s judgment in administering

a “lethal dose” of morphine to a “frail, elderly patient” and then “redoing the discharge

summary to add information in an apparent attempt to justify the unjustifiable . . . .”

Counsel told the panel that the information in the memo from “Ted” Shankel was “the

best evidence you have” of Dr. Luke’s intentions: He “succumbed to the pressures

brought to bear on him by the family and . . . administered the lethal dose of morphine.”

Roan compared the two discharge summaries and described the second as an

“alteration of the medical record.”

Counsel said that the MEC had not received any evidence that Dr. Luke had

attempted to comply with the CME requirements.26 Instead, he had “hired counsel and

26 It is not clear whether counsel was aware of the CME courses Dr. Luke had

completed.

39

decided to challenge those actions.” The fact Dr. Luke had chosen not to testify at the

hearing meant either that he had provided false information to all his own experts and

now “feared” cross-examination or that, if he testified, he would do so “falsely.”

Summing up, Roan compared Dr. Luke to Dr. Jack Kevorkian.27 “[A]t least

Dr. Kevorkian devised methods where the persons who were looking to commit suicide

performed the last act that would result in their death. Here patient ME didn’t perform

that last act. It was Dr. Luke that performed it.”

Cifarelli for Dr. Luke

Cifarelli told the panel members again, “as an officer of the court,” he had advised

his client not to testify because of the “opinions and conclusions expressed in the

amended [second] death certificate.” He urged them not to draw negative conclusions

from the fact that Dr. Luke was following his advice and reminded them that Emon and

Dr. Sheridan had ignored repeated requests to appear and testify.

Cifarelli reiterated M.E.’s wishes, expressed to his son and to his physician, that

he not suffer “an agonizing death” and emphasized that this was what his client had been

trying to prevent.

Counsel pointed out that Dr. Shankel’s testimony had been contradicted by M.E.’s

family and by Dr. Luke. He repeated his objections to Drs. Dexter and Brockmann

27 Jack Kevorkian, M.D., is a right-to-die activist best known for publicly

championing a terminal patient’s right to die via physician-assisted suicide. (See
Biography.com Web site, , [as of Feb. 10, 2011].)

40

having been on the panel, stressing their long professional relationships and personal

friendships with Dr. Shankel as well as what counsel considered specific evidence of

Dr. Dexter’s lack of objectivity.

The JRC Decision:

The JRC found the MEC recommendations of January 16, 2003, to suspend

Dr. Luke’s hospital privileges “reasonable and warranted.” A report of the decision was

transmitted to Dr. Luke on May 28, 2004.

Regarding the use of morphine: the JRC’s findings differed somewhat from the

charge in the MEC’s letter of January 22, 2002. The JRC found that Dr. Luke had

increased the morphine dose from five to 50 milligrams per hour without properly

titrating the dose, and that the increase was a violation of the “standard of practice at this

facility for end of life, comfort care medical management[,]” rather than, “outside of any

known MS protocol for the terminally ill patient.” In the JRC’s view, the increase would

have been justified only if Dr. Luke had properly determined that M.E. was morphine

tolerant by doubling the dose at 30-minute intervals and “evaluating the resulting affect

[sic] on the patient’s pain, discomfort or distress.”28 Because Dr. Luke had failed to

contemporaneously document the patient’s pain or respiratory distress, the increase was

also outside the standard of care.

28 These criteria are those specified in the preprinted physician orders for nurses

in the comfort measures only protocol. (See fn. 42, infra.)

41

Regarding the IV pump: the JRC found that, although it would have been better if

Dr. Luke had “consulted with other caregivers” before adjusting the machine, he was

qualified to do so.

Regarding the toxicology report: the JRC found “[i]t is undisputed that the

County Coroner’s Office did determine that M.E. had received a lethal dose of morphine.

Indeed, the Coroner’s offices issued a revised death certificate identifying the cause of

M.E.’s death as physician administered morphine.” The decision acknowledged that “the

level of morphine . . . as measured by the Coroner’s office may have been unreliable” and

that “the evidence was inconclusive as to whether M.E., in fact, received a lethal dose of

morphine” as stated on the amended (second) death certificate. Nonetheless, the JRC

concluded, “it [is] much more likely than not that Dr. Luke administered a potentially

lethal dose of morphine to M.E. in response to actual or perceived pressure from M.E.’s

family.”

Regarding the second discharge summary: the decision devoted its longest section

to a discussion of this issue, concluding that Dr. Luke had “violated an Administrative

Policy on Medical Record Documentation” by failing to identify the second summary as

an addendum to the first one. The revised summary, the decision stated, was not

prepared “‘in or around the time services were actually rendered’” and appeared to have

been “intended to ress Dr. Luke’s position in an on-going disciplinary action.”

Because of his silence in the face of a question from the Director of Health Information

Management, and because “he chose not to testify during the hearing” and “be cross-

42

examined on this point” the JRC found it “substantially more likely than not” that

Dr. Luke had removed the initial discharge summary from the chart himself.

Finally, the JRC decision affirmed that its hearings had been fair in that Dr. Luke

had received “adequate notice” of the charges against him and had been afforded “ample

opportunity” to respond, and that the hearing had been conducted “in accordance with the

Medical Staff bylaws.” The report acknowledged that Dr. Luke had objected to the

appointments of Drs. Dexter and Brockmann because they “are both partners in a large

medical practice group in which a key witness, Dr. Shankel, is also a partner.” However,

it concluded that Drs. Dexter and Brockmann would “derive no personal, financial or

professional benefit from the outcome of the hearing” and had “no bias or prejudice

against Dr. Luke.” “[T]he fact that they are partners in a medical group with well over

100 other physicians including Dr. Shankel, does not suggest that they have been unduly

influenced by Dr. Shankel.”

Each of the JRC panel members signed the report separately. Dr. Dexter,

chronologically the second panel member to sign the report,29 added a handwritten

comment to his signature page: “Dr. Dexter would benefit from Dr. Luke remaining on

staff as Dr. Luke has historically referred patients for critical care consultation to him.”

The statement was not on any of the individual signature pages signed by panel members

29 Dr. Wang signed on May 19, Dr. Dexter on May 24, Dr. West on May 26, and

Drs. Cantun and Brockmann on May 27, 2004.

43

other than Dr. Dexter, but was included in the printed report, which stated that it had been

“adopted by unanimous vote of the members of the [JRC].”

Internal Appeal:

On June 7, 2004, Dr. Luke appealed the JRC decision to a seven-member “Appeal

Board,” appointed by the hospital board from among its members. Only one of the seven

was a physician. Attorney Donald A. Goldman of McDermott, Will, and Emery, was

selected as the “presiding officer.” Oral argument was held on November 17, 2004.

In the internal appeal, Dr. Luke continued to maintain that the JRC proceedings

had been unfair because of the inclusion of Dr. Shankel’s friends and colleagues,

Drs. Dexter and Brockmann, on the panel. Dr. Dexter, in particular, had worked closely

with Dr. Shankel on an ongoing basis for many years and because of that relationship

could not be reasonably expected to be a “fair and impartial” judge of the facts.

In addition, Dr. Luke argued, for various reasons, that the evidence presented at

the hearing was insufficient to support the panel’s conclusions.

On December 3, 2004, the appeal board affirmed the findings and decision of the

JRC. The process, the recommendation stated, had provided Dr. Luke with procedural

fairness and the decision of the JRC was supported by substantial evidence. The

inclusion of Drs. Dexter and Brockmann on the panel had not rendered the process unfair

because Dr. Luke failed to show that either doctor would gain any direct financial benefit

from the outcome of the hearing. The fact that Dr. Dexter asked “difficult” questions

during the JRC hearings did not demonstrate “even the probability of unfairness . . . .”

44

On January 6, 2005, the hospital board adopted the recommendation of the appeal

board, and issued a final decision terminating Dr. Luke’s privileges. On January 28,

2005, the action was reported to the NPDB.

The Concurrent State Medical Board Investigation:

The investigation by the State Medical Board, which continued throughout the

period of the JRC hearings, was opened upon the referral from the coroner’s office when,

on November 15, 2002, “Emon . . . hand delivered the case and related documents.” The

investigation report was signed on August 13, 2003, the date the coroner issued the

amended (second) death certificate.

On February 18, 2004, three months before the JRC reached a decision, the

Deputy State Attorney General Samuel Hammond filed the “Accusation” against

Dr. Luke on behalf of the State Medical Board. As already stated ante, the accusation

charged the doctor with gross negligence, repeated negligent acts, acts of dishonesty, and

failure to maintain accurate and adequate records.

State Medical Board Administrative Law Judge James Ahler heard the matter in a

series of sessions in May and June 2005. Dr. Sheridan, who testified on May 24, 2005,

said that he had not performed an autopsy because M.E.’s underlying illnesses were well

documented and “[w]e knew that he was actually in a terminal state.” Dr. Sheridan also

confirmed that the phenomenon of postmortem redistribution makes drug levels in blood

taken from the heart less reliable than those in peripheral blood and particularly difficult

45

to interpret. “Because if there is going to be a discrepancy, the heart will always be

higher.”

Nonetheless, based on the morphine level in the toxicology report from the San

Diego laboratory, it was Dr. Sheridan’s opinion that M.E. had died from “acute morphine

toxicity.” It was because of the toxicology report that he had amended M.E.’s first death

certificate. Dr. Sheridan did not know why so much time had elapsed between his

office’s receipt of the toxicology report and the issuance of the amended (second) death

certificate or why the certificate had been amended only after receipt of the State Medical

Board’s report.30

Emon testified two days after Dr. Sheridan, on May 26, 2005. He too could not

explain why the amended (second) death certificate had not been issued until the exact

date the State Medical Board report was signed. Emon acknowledged, however, that his

office had waited to issue the amended certificate until it learned the State Medical

Board’s position in the case. In response to queries from Judge Ahler, Deputy Attorney

General Samuel Hammond, and Cifarelli, Emon admitted that he did not know the site on

the body of the deceased from which the blood sample for the toxicology test had been

drawn. The form said “peripheral,” but he thought the actual site may have been written

on the vial.

30 The coroner’s office received the toxicology report on October 29, 2002. The

death certificate was amended on August 13, 2003, the day the State Medical Board
issued its report.

46

On June 22, 2005, Judge Ahler submitted a decision proposing to revoke

Dr. Luke’s license, the State Medical Board’s most severe penalty, effective September 6,

2005.31 On August 19, 2005, Dr. Luke wrote a detailed personal letter to the State

Medical Board, explaining his actions in the case and requesting a reconsideration of the

proposed decision. On September 14, 2005, the State Medical Board agreed to

reconsider the matter.

On January 18, 2006, Dr. Sheridan wrote a second addendum report regarding the

death certificate for M.E., changing the cause of death from “morphine toxicity” to

“undetermined.” This addendum or “third” death certificate explained that the source of

the blood drawn from M.E.’s body was central rather than peripheral and that the form

had apparently been changed by an employee at the San Diego laboratory. The level of

morphine in M.E.’s postmortem blood sample, as reported by the San Diego laboratory,

was about “three times” the level generally considered toxic. After reconsideration “at

considerable length” and “[w]eighing all the elements of the case,” including the history

of the patient’s illness, the events leading up to his death, the high level of morphine, the

possibility of postmortem redistribution, and the fact that the morphine pump had been

left on for an undetermined amount of time following death, Dr. Sheridan concluded that

the appropriate action was to change the cause and manner of death to reflect uncertainty.

31 Disciplinary measures the State Medical Board may take against a licensee, in

descending order of severity, include: revocation, suspension, probation with monitoring,
public reprimand with required educational courses, and “any other action” deemed
proper. (Bus. & Prof. Code, § 2227, subd. (a)(1) – (a)(5).)

47

On February 2, 2006, the State Medical Board, with Judge Ahler again presiding,

heard oral argument at the reconsideration hearing. On March 10, 2006, the State

Medical Board issued a final “Decision After Reconsideration.” The decision stated that

Dr. Luke had committed a “simple departure from the standard of care by increasing the

morphine sulfate drip infusion . . . from 5 mg./hour to 50mg./hour without gradually

titrating the dose . . . .” The evidence had not established gross negligence, dishonesty, or

repeated acts of negligence. However, there was cause to discipline Dr. Luke because he

“failed to maintain adequate and accurate records” regarding the care of M.E. For this

failure, the State Medical Board issued Dr. Luke a “Public Reprimand” and imposed a

requirement that he enroll in and complete a course in medical record keeping.

The 1094.5 Petition:

Meanwhile, on June 24, 2005, two days after Judge Ahler submitted his original

proposed decision, Dr. Luke filed an amended 1094.5 petition. On November 14, 2005,

the hospital filed an opposition.

The 1094.5 petition argued again that the proceedings below had been unfair

because Drs. Dexter and Brockmann had been allowed to remain on the JRC panel

despite their close relationship with Dr. Shankel, the key witness against Dr. Luke. The

three physicians were “friends and colleagues as well as partners in practice.” As a

result, Dr. Luke argued, Drs. Dexter and Brockmann could not be “fair, unbiased, and

impartial” when evaluating Dr. Shankel’s evidence. The 1094.5 petition cited Business

and Professions Code section 809.2, which requires JRC panel members to be “unbiased

48

individuals who shall gain no direct financial benefit from the outcome.” (Bus. & Prof.

Code, § 809.2, subd. (a).) The petition also suggested that the provision had been

violated because BMG was in direct economic competition with Dr. Luke’s Quality

Medical Group.

As part of the 1094.5 petition, Dr. Luke submitted evidence, discovered during

and after the State Medical Board hearings, that the blood sample for the report issued by

the San Diego laboratory had in fact been drawn from central rather than peripheral

blood, and that the reported morphine level was therefore unreliable. The 1094.5 petition

noted that the level had been relied upon by the coroner as the basis for the amended

(second) death certificate, by the JRC in its findings related to Dr. Luke and the standard

of care, and by the State Medical Board in its investigations. In addition, rather than

conduct an independent investigation, the coroner had relied improperly on the State

Medical Board’s decision.

In opposition, the hospital maintained that the proceedings had been fair because

Drs. Dexter and Brockmann were associated with Dr. Shankel in a very large medical

group and would gain no direct financial benefit from the outcome of this case. The new

evidence of the source of the blood used to determine the morphine level was not relevant

because the JRC decision had acknowledged that the toxicology report might be wrong

and that the evidence was “‘inconclusive’” as to whether M.E. had in fact received a

lethal dose of morphine or had died from a morphine overdose. Thus, “the JRC did not

rely on the Coroner’s report in making its determination.”

49

On April 25, 2007, having heard oral argument from both parties on December 29,

2006, Judge Krug denied the 1094.5 petition on grounds that Dr. Luke was prejudiced by:

Dr. Shankel testifying as a witness at the JRC hearing; the exclusion of character

witnesses; or the admission of Dr. Shankel’s memorandum.32 In the court’s view, the

fact that Dr. Shankel “was in a business partnership with two of the board members was

not an indication of any prejudice.”33

However, the court found merit in Dr. Luke’s arguments about new evidence.

Judge Krug issued a peremptory writ of mandate commanding the hospital board to

reconsider its decision to terminate Dr. Luke’s medical staff privileges in light of the

evidence regarding the source of blood for the toxicology report and in light of the State

Medical Board’s decision not to revoke his license. If, after consideration of these two

items, the hospital board reaffirmed its decision to revoke Dr. Luke’s privileges, it was to

state specific concerns about his remaining on staff.

Judge Krug admonished the parties about how to proceed: “Now if the [hospital]

board follows the Court’s order in reconsideration of this matter as it is ordered to do, it is

to make specific findings if they decide to continue with the suspension of Dr. Luke as to

why they are suspending him, what particular concerns they have regarding his staying

on the staff, and what remedies should be taken.” The court also advised Dr. Luke to

32 The reporter’s transcript of the oral argument appears to be mislabeled as

December 29, 2007, rather than December 29, 2006.

33 The court appears to have meant JRC “panel” members, not “board” members.

50

cooperate, without resistance, in whatever supervision or proctoring program the hospital

might impose.

The court retained jurisdiction for purposes of review of the hospital board’s

reconsideration decision.

The Hospital Board Proceedings on Remand:

The hospital board held the reconsideration hearing on November 29, 2007.

Richard Ackerman represented Dr. Luke.34 The 12-member board included three

physicians and nine nonphysicians. Roan again represented the MEC. Thomas A. Ryan

of McDermott, Will, and Emery, represented the hospital. As the hearing opened,

hospital board chairperson Patricia Gilbreath announced, “I’m the hearing officer.” Ryan

introduced himself and spoke three more times during the hearing: twice regarding the

numbering of exhibits, and once to agree that Ackerman’s argument would count as an

objection raised in the record. The hearing consisted only of oral argument by counsel.35

Ackerman’s substantive arguments were that the defective toxicology report had

formed the foundation of the amended (second) death certificate, which had, in turn,

fueled suspicion that his client had intentionally killed M.E. Counsel noted that the State

34 Cifarelli, who died in April 2008, was apparently ill. (See The Cifarelli Law

Firm Web site, [as of
Feb. 10, 2011].)

35 Ackerman made two unfair procedure arguments: (1) that he had not been

informed beforehand of the hospital board’s intended action at the remand hearing as
required by the Business and Professions Code; and (2) that Ryan, rather than Gilbreath,
was actually functioning as the hearing officer, and that as a paid advocate for the
hospital, he could not be neutral.

51

Medical Board had found Dr. Luke guilty only of a “records keeping infraction.” Finally,

he argued that conformity to Judge Krug’s order meant that the hospital board must

consider what present danger, if any, the hospital board believed Dr. Luke posed to

patients.

Roan answered that neither the toxicology report nor the State Medical Board’s

decision had any relevance to its review of the matter, which should be based only on

substantial evidence to support the prior decisions. Counsel emphasized the differences

between the first and second discharge summaries and Dr. Luke’s lack of cooperation

with the MEC recommendations: he had done “nothing” counsel said, in the intervening

five years, “no [CME] and no end of life care, none in managing narcotics in such

patients, none. He didn’t do any of it. He chose, he made a judgment not to do it.”36

Thus, counsel argued, Dr. Luke continued to “pose a threat to the life or well-being of

patients in the hospital.”

On December 27, 2007, the hospital filed a return to the 1094.5 petition stating

that it had followed the court’s command and decided to again uphold the JRC decision

and to affirm its own earlier decision to revoke Dr. Luke’s privileges. In the hospital

board’s opinion, neither the revised death certificate nor the State Medical Board’s

decision affected its conclusion that Dr. Luke posed an ongoing danger to patients. The

revised death certificate did not change the hospital board’s decision because the JRC

36 Again, it is unclear whether Roan was aware of the pain management and end-

of-life courses Dr. Luke had completed at St. Bernardine Medical Center in November
2002 and February 2003.

52

decision had acknowledged that the cause of death was uncertain. The State Medical

Board’s decision did not affect the hospital board’s decision because it had an

“independent duty” to determine whether Dr. Luke should remain on staff.

The hospital board remained concerned about: (a) Dr. Luke’s improper record

keeping, particularly the existence of the two discharge summaries; (b) evidence of his

improper administration of morphine shown by the lack of documentation of pain in the

nursing notes, Dr. Shankel’s testimony regarding his telephone call with Dr. Luke during

which Dr. Luke had said he increased the morphine because the family was upset that

M.E. was still alive, and Dr. Luke’s failure to follow the titration schedule outlined in the

comfort measures only protocol; and (c) Dr. Luke’s lack of cooperation with the MEC’s

recommendations and his failure to attend the reconsideration hearing.

On June 19, 2008, with Judge Brisco presiding, the parties presented oral

argument at a return hearing on the 1094.5 petition. Regarding due process, Judge Brisco

commented, “I can’t see that Dr. Luke’s due process rights have been violated. I mean,

he’s had more than, what, how many—three, four hearings?” On July 21, 2008, the court

denied the 1094.5 petition.

Dr. Luke filed a notice of appeal on October 24, 2008. Briefing was complete on

August 17, 2009.

DISCUSSION

Throughout this case, Dr. Luke has maintained that the proceedings below were

unfair. With little variation, he has rested his argument on two major points: (1) the

53

likelihood of adjudicator bias on the parts of Drs. Dexter and Brockmann because of their

close professional, business, and personal relationships to the primary witness against

him; and (2) the detrimental effect of unreliable reports from the coroner’s office.

Because we find merit in these arguments and the answer to the question of

fairness dispositive, we do not reach either party’s many other concerns regarding

substantial evidence to support the JRC and the hospital board’s decisions or any of their

respective public policy concerns.37

Relevant to the question of fairness, we consider, in the following order:

(1) background information about the relationship between hospitals and medical staff;

(2) state and federal law pertaining to the peer review process; (3) Code of Civil

Procedure section 1094.5; and (4) due process and adjudicator bias issues specific to this

case.

37 For example, we either do not reach or do not find persuasive Dr. Luke’s
suggestion that the change of position by the coroner’s office and the State Medical
Board was based on “exculpatory” evidence or “vindicated” his actions; or that it is
necessarily against public policy for the hospital to be involved at all in treatment
decisions between physicians and their dying patients. We also see no prejudice to
Dr. Luke from the exclusion of character evidence, which came in anyway with the
testimony of Dr. de Jager. Nor do we agree with the hospital’s own public policy
argument that a physician is not authorized to “take any affirmative action in trying to
alleviate the pain” of a patient who has refused other medical treatment “particularly
where it would hasten death.” We do agree, however, that hospitals have the authority to
“regulate their medical staffs to ensure competent staffing.”
Because it is unclear from the record or the parties’ briefs what role his law firm
had or later assumed in relationship to RCH, we also do not address attorney Goldman’s
role as hearing officer at the internal appeal hearing or Dr. Luke’s argument that it
constituted a conflict. Ryan’s role at the hospital board’s rehearing was de minimis.

54

The Relationship Between Hospitals and Medical Staff:

Under California law, every acute care hospital must have an “organized medical

staff responsible to the governing body for the adequacy and quality of the care rendered

to patients.” (Cal. Code Regs., tit. 22, § 70703, subd. (a); see also Smith v. Selma

Community Hospital (2008) 164 Cal.App.4th 1478, 1482 (Smith); Mileikowsky v. West

Hills Hospital & Medical Center (2009) 45 Cal.4th 1259, 1267 (Mileikowsky).) The

medical staff is a self-governing association and a separate legal entity from the hospital.

(Medical Staff of Doctors Medical Center in Modesto v. Kamil (2005) 132 Cal.App.4th

679, 685.) Its purpose is to oversee physicians who practice at the hospital.

(Hongsathavij v. Queen of Angels etc. Medical Center (1998) 62 Cal.App.4th 1123, 1130,

fn. 2 (Hongsathavij).) Medical staff responsibilities include the adoption of written

bylaws that establish formal procedures for appointing and reappointing staff physicians

and other practitioners and a means of enforcement of those bylaws. (Cal. Code Regs.,

tit. 22, § 70703, subd. (b).) “In other words, the bylaws must establish a peer review

process.” (Smith, at p. 1482.)

The Peer Review Process:

Peer review is grounded in both state and federal law. At all levels, procedural

and substantive fairness are required.

Federal Law

Finding that “medical malpractice and the need to improve the quality of medical

care” had become nationwide problems, that could be “remedied through effective

55

professional peer review,” in 1986 the United States Congress enacted the Health Care

Quality Improvement Act (the Act). (42 U.S.C. § 11101 et seq.) Under the Act, such a

review is to be taken, among other things, “after a reasonable effort to obtain the facts of

the matter,” and “after adequate notice and hearing procedures are afforded to the

physician involved or after such other procedures as are fair to the physician under the

circumstances . . . .” (42 U.S.C. § 11112, subd. (a)(1), (a)(2), italics added.)

The Act established a databank (the NPDB) to which health care entities

(including hospitals, insurance companies, & state medical boards) must report medical

malpractice payments and adverse actions taken against a physician’s clinical privileges.

A hospital must check the NPDB every two years for information about physicians

currently on its staff. (42 U.S.C. §§ 11135-11137.) Failure to report or to inquire is

punishable by a fine of up to $10,000 for each offense as well as loss of immunity from

civil damages. (42 U.S.C. § 11131, subd. (c).) Because of these monitoring and

disclosure requirements, a negative report to the NPDB can have a devastating

“snowball” effect on a physician’s career. (Merkel, Physicians Policing Physicians: The

Development of Medical Staff Peer Review Law at California Hospitals (2004) 38 U.S.F.

L.Rev. 301, 304, 318.)

Purpose and History

State Law

Concerned about “possible adverse interpretations by the courts,” California

elected to opt out of the federal statute and in 1989 designed its own peer review system,

56

codified in Business and Professions Code sections 805 through 809. (Bus. & Prof.

Code, § 809, subd. (a)(2); see also Smith, supra, 188 Cal.App.4th at p. 1519, fn 22.)

The primary purpose of the peer review process in California is to protect the

people of the state from substandard care by incompetent physicians. (Mileikowsky,

supra, 45 Cal.4th at p. 1267, citing Bus. & Prof. Code, § 809, subd. (a)(4), (a)(6).) A

second purpose is to protect hospitals from exposure to malpractice liability.

(Mileikowsky, at p. 1267.) A third purpose, “also if not equally important, is to protect

competent practitioners from being barred from practice for arbitrary or discriminatory

reasons.” (Ibid.)

The state’s system “recognizes not only the balance between the rights of the

physician to practice his or her profession and the duty of the hospital to ensure quality

care, but also the importance of a fair procedure, free of arbitrary and discriminatory

acts.” (Unnamed Physician v. Board of Trustees (2001) 93 Cal.App.4th 607, 616-617

(Unnamed Physician); see also Kaiser Foundation Hospitals v. Superior Court (2005)

128 Cal.App.4th 85, 97.)

Business and Professions Code section 805

Business and Professions Code section 805 specifies that adverse actions against a

physician’s medical staff privileges must be reported to the State Medical Board “within

15 days after the effective date . . . [¶] . . . [r]estrictions are imposed . . . for a medical

disciplinary cause or reason,” or if a “summary suspension . . . remains in effect for

[more than] 14 days.” (Bus. & Prof. Code, §§ 805, subds. (b)(3), (e).) As with the

57

NPDB at the federal level, every institution granting or renewing staff privileges for any

physician must request a report from the State Medical Board to determine if a Business

and Professions Code section 805 report has been filed. (Bus. & Prof. Code, § 805.5.)

Persons responsible for filing Business and Professions Code section 805 reports are:

“The chief of staff of a medical or professional staff or other chief executive officer,

medical director, or administrator of any peer review body and the chief executive officer

or administrator of any licensed health care facility.” (Bus. & Prof. Code, § 805,

subd. (b).)

Business and Professions Code section 809

Business and Professions Code sections 809 though 809.2 outline the specific

requirements of the peer review process. Incorporation of the statutory provisions into

the medical staff bylaws is mandatory, not advisory or discretionary. (Bus. & Prof. Code,

§ 809, subd. (a)(8)); Unnamed Physician, supra, 93 Cal.App.4th at p. 622; Sahlolbei v.

Providence Healthcare, Inc. (2003) 112 Cal.App.4th 1137, 1147 [Fourth Dist., Div.

Two].) Subject to the requirements of the statute, through which the Legislature has

delegated to the private sector to provide fairly conducted peer review, a hospital’s

bylaws govern the proceedings. (Payne v. Anaheim Memorial Medical Center, Inc.

(2005) 130 Cal.App.4th 729, 739, fn. 5; Kaiser Foundation Hospitals v. Superior Court,

supra, 128 Cal.App.4th at p. 97; Unnamed Physician, at p. 622.)

Business and Professions Code section 809.2 specifies that a peer review hearing

“shall be held . . . before a trier of fact, which shall be an arbitrator or arbitrators selected

58

by a process mutually acceptable to the licentiate and the peer review body, or before a

panel of unbiased individuals who shall gain no direct financial benefit from the

outcome, [and] who have not acted as an accuser, investigator, factfinder, or initial

decisionmaker in the same matter.” (Bus. & Prof. Code, § 809.2, subd. (a), italics added.)

Business and Professions Code sections 809.4 and 809.8, respectively, provide for the

possibility of internal appeal rights and the availability of judicial review via Code of

Civil Procedure section 1094.5.

The fact that a physician has been accorded all of the procedural rights specified in

the bylaws does not necessarily make the process fair. (Payne v. Anaheim Memorial

Medical Center, Inc., supra, 130 Cal.App.4th at p. 742, fn. 7.) In addition to unbiased

adjudicators, “[A] basic ingredient of the ‘fair procedure’ required . . . is that an

individual who will be adversely affected by a decision be afforded some meaningful

opportunity to be heard in his defense.” (Pinsker v. Pacific Coast Society of

Orthodontists (1974) 12 Cal.3d 541, 555.)

Code of Civil Procedure section 1094.5

Code of Civil Procedure section 1094.5 provides, in relevant part:

“(a) Where the writ is issued for the purpose of inquiring into the validity of any

final administrative order or decision . . . .

“(b) The inquiry . . . shall extend to the questions whether the respondent has

proceeded without, or in excess of jurisdiction; whether there was a fair trial; and

whether there was any prejudicial abuse of discretion. Abuse of discretion is established

59

if the respondent has not proceeded in the manner required by law, the order or decision

is not supported by the findings, or the findings are not supported by the evidence.

[¶] . . . [¶]

“(d) . . . [I]n cases arising from private hospital boards, . . . abuse of discretion is

established if the court determines that the findings are not supported by substantial

evidence in the light of the whole record. . . .

“(e) Where the court finds that there is relevant evidence that, in the exercise of

reasonable diligence, could not have been produced . . . at the hearing before respondent,

it may enter judgment . . . remanding the case to be reconsidered in light of that

evidence . . . .

“(f) . . . Where the judgment commands that the order or decision be set aside, it

may order the reconsideration of the case in the light of the court’s opinion and judgment

and may order respondent to take such further action as is specifically enjoined upon it by

law, but the judgment shall not limit or control in any way the discretion legally vested in

the respondent.” (Italics added.)

Scope and Standard of Review:

Scope

In reviewing an order regarding a 1094.5 petition, an appellate court does not

review the trial court’s ruling, but the final administrative decision. In doing this, “we

consider all relevant evidence in the administrative record.” (TG Oceanside, L.P. v.

City of Oceanside (2007) 156 Cal.App.4th 1355, 1371.)

60

The task involves two questions: (1) whether the proceedings before the hearing

panel and any appellate review bodies were fair; and (2) whether, if so, substantial

evidence supported the findings. (Code Civ. Proc., § 1094.5, subd. (b); Yaqub v. Salinas

Valley Memorial Healthcare System (2004) 122 Cal.App.4th 474, 483; Cipriotti v. Board

of Directors (1983) 147 Cal.App.3d 144, 154; Yakov v. Board of Medical Examiners

(1968) 68 Cal.2d 67, 72.)

Standard of Review

Determination of whether proceedings were fair is a question of law upon which

we exercise our independent judgment. (Ellison v. Sequoia Health Services (2010) 183

Cal.App.4th 1486, 1496; Sinaiko v. Superior Court (2004) 122 Cal.App.4th 1133, 1141.)

Mere technical compliance is not sufficient to ensure fairness. “‘Due process requires a

fair trial before an impartial tribunal . . . due process is not interested in mere technical

formalism. It is the substance that is determinative of whether due process has been

afforded.’” (Ventimiglia v. Board of Behavioral Sciences (2008) 168 Cal.App.4th 296,

310.) While the required independent review of fairness and due process issues is not a

“‘trial de novo’ . . . the court renders its independent judgment on the basis of the

administrative record plus such additional evidence as may be admitted under [Code of

Civil Procedure] section 1094.5, subdivision (e).” (Pomona Valley Hospital Medical

Center v. Superior Court (1997) 55 Cal.App.4th 93, 101.)

During oral argument, counsel for the hospital suggested that our tentative opinion

“shot at the wrong target” by focusing on questions of fairness rather than on substantial

61

evidence to support the underlying factual charges against Dr. Luke. In counsel’s

opinion, the appropriate standard of review is stated in Hongsathavij, supra, 62

Cal.App.4th 1123. We disagree.

On the issue of fairness, Hongsathavij is not apt here. Hongsathavij dealt with the

appropriate standard (substantial evidence) to be used by a reviewing court to determine

whether a hospital’s board of directors, in turn, had used the correct standard in reviewing

a peer review body’s decision on a substantive issue (whether a physician had abandoned

a patient by admitting her to the hospital and then refusing to treat her for financial

reasons). (Hongsathavij, supra, 62 Cal.App.4th at pp. 1135-1138.) Similarly, neither

Kumar v. National Medical Enterprises, Inc. (1990) 218 Cal.App.3d 1050 nor Huang v.

Board of Directors (1990) 220 Cal.App.3d 1286 (Huang)—the two cases upon which

Hongsathavij primarily relied—dealt with fairness issues analogous to ours. Kumar

concerned the requirement that administrative remedies must be exhausted before a party

may seek relief in the courts. (Kumar, at pp. 1056-1057.) Huang concerned the standard

of review to be used by a hospital board in reviewing the factual findings of a judicial

review committee. (Huang, at pp. 1295-1296.)

The hospital’s brief is structured much like its oral argument, concluding that

Dr. Luke “has received more than a fair hearing, as he had several fair opportunities to

present his position on the charges against him.” Unfortunately, on this point, the

hospital is simply wrong.

62

Two factors—a mislabeled and very possibly erroneous laboratory test, and the

composition of the JRC—virtually guaranteed that Dr. Luke had no significant

opportunity to “be fully and fairly heard before an impartial decisionmaker.” (Catchpole

v. Brannon (1995) 36 Cal.App.4th 237, 245 (Catchpole), overruled in part on another

ground as stated in People v. Freeman (2010) 47 Cal.4th 993, 1006, fn. 4.) Once the

amended (second) death certificate was admitted, stating that the cause of M.E.’s death

was “homicide” due to a “physician-administered” overdose of morphine, it became

impossible for Dr. Luke to testify in his own defense in the administrative hearing. And,

whether all of his adjudicators were impartial is, at best, seriously open to question.

Fair Procedure, Due Process, and Adjudicator Bias:

Because hospital staff privileges represent a fundamental, vested right, an

individual physician who is being divested of this right by expulsion from a hospital staff

is “entitled to a fair procedure by which to challenge the action taken.” (Lasko v. Valley

Presbyterian Hospital (1986) 180 Cal.App.3d 519, 528; see also Anton v. San Antonio

Community Hospital (1977) 19 Cal.3d 802, 825.) A basic requirement of fair procedure

is that adjudicators must be fair and impartial or unbiased. While “a trier of fact does not

have to be completely indifferent to the general subject matter of the claim presented to

be impartial” (Cohan v. City of Thousand Oaks (1994) 30 Cal.App.4th 547, 559), it is still

the case that “due process requires fair adjudicators in courts and administrative tribunals

alike.” (Haas v. County of San Bernardino (2002) 27 Cal.4th 1017, 1024-1025 (Haas);

63

see also Rosenblit v. Superior Court (1991) 231 Cal.App.3d 1434, 1448; Goldberg v.

Kelly (1970) 397 U.S. 254, 267, 271).)

“The distinction between fair procedure and due process rights appears to be one

of origin and not of the extent of protection afforded an individual; the essence of both

rights is fairness.” (Applebaum v. Board of Directors (1980) 104 Cal.App.3d 648, 657

(Applebaum).) “Whatever disagreement there may be in our jurisprudence as to the

scope of the phrase ‘due process of law,’ there is no dispute that it minimally

contemplates the opportunity to be fully and fairly heard before an impartial

decisionmaker.” (Catchpole, supra, 36 Cal.App.4th at p. 245.) “Due process . . . always

requires . . . a fair hearing before a neutral or unbiased decision maker.” (Nightlife

Partners, Ltd. v. City of Beverly Hills (2003) 108 Cal.App.4th 81, 90.)

In Pacific Etc. Conference of United Methodist Church v. Superior Court (1978)

82 Cal.App.3d 72, 86-87 (Pacific), Division One of this district reviewed a number of

cases relating to adjudicator bias and discussed its definitions and manifestations at some

length. “Bias is defined as a mental predeliction [sic] or prejudice; a leaning of the mind;

‘a predisposition to decide a cause or an issue in a certain way, which does not leave the

mind perfectly open to conviction.’ [Citation.] Bias or prejudice consists of a ‘mental

attitude or disposition of the judge towards a party to the litigation, . . .’ [¶] . . . ‘Bias

equates here with partiality. . . .’ [¶] . . . ‘Prejudice imports the formation of a fixed

anticipatory judgment . . . although it does not necessarily indicate any ill feeling.’”

64

(Id. at pp. 86-87; see also Evans v. Superior Court (1930) 107 Cal.App. 372, 380;

Adoption of Richardson (1967) 251 Cal.App.2d 222, 232.)

Partiality or bias toward a particular view or party can be based on a variety of

factors. Some, like direct financial benefit from the outcome of the case, or prior

involvement “as an accuser, investigator, factfinder, or initial decisionmaker,” are explicit

in the statute. (Bus. & Prof. Code, § 809.2, subd. (a).) However, personal embroilment

in the dispute may also disqualify the results reached by an administrative body.

(Applebaum, supra, 104 Cal.App.3d at p. 657.)

Code of Civil Procedure section 170.1 outlines the grounds for the disqualification

of judges and other “dispute resolution neutral[s],”38 and is enlightening on what kinds of

relationships may affect an adjudicator’s ability to be impartial in a proceeding. These

include: family connections; a close relationship to a material witness; close and recent

professional relationships; financial interest in the subject matter of the proceeding or a

fiduciary relationship to a party (Code Civ. Proc., § 170.1, subd. (a)(1)(A-B), (a)(5)); or

any situation where “[a] person aware of the facts might reasonably entertain a doubt that

the judge would be able to be impartial” (Code Civ. Proc., § 170.1, subd. (a)(6)(A)(iii)).

38 A “‘[d]ispute resolution neutral’” is an arbitrator, mediator, temporary judge,

referee, special master, neutral evaluator, settlement officer, or settlement facilitator.
(Code Civ. Proc., § 170.1, subd. (a)(8)(B)(iii).) Code of Civil Procedure section 170.1 is
also applicable to administrative hearing officers. (Andrews v. Agricultural Labor
Relations Bd. (1981) 28 Cal.3d 781, 794, superseded by statute on a different point as
stated in Catchpole, supra, 36 Cal.App.4th at p. 246; Gray v. City of Gustine (1990) 224
Cal.App.3d 621, 632.)

65

Pecuniary Interest

Dr. Luke’s challenge to Drs. Dexter and Brockmann is based first on their alleged

financial interest in the matter being adjudicated.

It has long been established under both state and federal law that when an

adjudicator has a pecuniary interest in the outcome of the proceedings, the possibility of

bias is “‘too high to be constitutionally tolerable.’” (Haas, supra, 27 Cal.4th at p. 1027;

see also Tumey v. Ohio (1927) 273 U.S. 510, 533-535; Gibson v. Berryhill (1973) 411

U.S. 564, 578-579 (Gibson).) “Not only is a biased decisionmaker constitutionally

unacceptable but ‘our system of law has always endeavored to prevent even the

probability of unfairness.’” (Withrow v. Larkin (1975) 421 U.S. 35, 47; see also Haas, at

p. 1026.) The standard for measuring the impropriety of pecuniary interest is “whether

the adjudicator’s financial interest would offer a possible temptation to the average

person as judge not to hold the balance nice, clear and true.” (Haas, at p. 1026; see also

Aetna Life Ins. Co. v. Lavoie (1986) 475 U.S. 813, 824-825.) “[T]he risk of bias caused

by financial interest need not manifest itself in overtly prejudiced, automatic rulings in

favor of the party who selects and pays the adjudicator. The ‘possible temptation’

[citation] not to be scrupulously fair, alone and in itself, offends the Constitution.”

(Haas, at p. 1030.)

In Gibson, the United States Supreme Court affirmed a district court’s conclusion

that, because of a possible pecuniary interest in the reduction of competition, it was

constitutionally impermissible for a state optometry board composed only of private

66

practice optometrists to judge whether the licenses of optometrists employed by corporate

entities (which made up almost half of all licensed optometrists in the state) should be

revoked. “It is sufficiently clear from our cases that those with substantial pecuniary

interest in legal proceedings should not adjudicate these disputes.” (Gibson, supra, 411

U.S. at p. 579.) “It has also come to be the prevailing view that ‘most of the law

concerning disqualification because of interest applies with equal force to . . .

administrative adjudicators.’ (K. Davis, Administrative Law Text § 12.04, p. 250

(1972).” (Ibid.)

In Haas, the California Supreme Court affirmed a decision by this court that the

procedure used by a government agency in selecting a hearing officer who was hired and

paid by the agency to adjudicate a case in which it was a party was unconstitutional.

(Haas, supra, 27 Cal.4th at pp. 1029-1030.) The court reasoned that, like a direct-fee

system long rendered obsolete in other state and federal cases, the system used by the

county gave hearing officers an incentive—or what would be an appearance of an

incentive to an average person as judge—to favor frequent litigants. (Id. at pp. 1026,

1028-1029.) The hearing officer in Haas had a direct pecuniary interest in future

commissions from the agency. (Id. at pp. 1020-1021.) Such “outcome-dependant

compensation” is unacceptable. (Id. at p. 1028.)

Here, while there was possibly a measure of pecuniary interest in play, evidence

that any particular JRC panel member’s income was directly dependent on the outcome

67

of the decision in the manner prohibited by Business and Professions Code section 809.2

or by Gibson or Haas was scanty.

There is no doubt that BMG is a very large—perhaps even dominant—player in

the Redlands medical practice market. This was evident from the May 5, 2003, letter

written by the firm representing the MEC, opposing the disqualification of Drs. Dexter

and Brockmann. According to the letter, because of the great difference in the relative

sizes of their practice groups, the two physicians could not possibly be prejudiced against

Dr. Luke. BMG’s size was confirmed at voir dire by Dr. Dexter, who told the hearing

officer that there were about 140 physicians in the group. According to Dr. de Jager’s

unreed testimony, BMG’s dominance was related to the loss of a number of solo

practitioners who, like Dr. Luke, had formerly cared for elderly patients in the area.

In addition, Dr. Dexter’s note specifying that he would benefit by keeping

Dr. Luke on staff because Dr. Luke referred patients to him demonstrated that, on some

level, there was a financial relationship between Dr. Luke’s practice and benefit to BMG,

or at least to Dr. Dexter. No doubt Dr. Dexter meant to suggest that any bias he might

harbor would have worked in Dr. Luke’s favor. However, such a referral pattern also put

Dr. Dexter in a position to know the volume and value of Dr. Luke’s practice and, thus,

the potential benefit of eliminating him from the medical staff. Since BMG was in

competition with Dr. Luke’s group, even if the latter group was very small by comparison

to the former, it is not impossible that the competition was important to BMG. The fact

that a “Goliath” is big does not mean that a “David” is insignificant.

68

Nonetheless, there is little overt evidence that the challenged physicians were

motivated by direct pecuniary interest or were in some way consciously acting on behalf

of the financial interest of their group. Unlike the hearing officer in Haas, the JRC panel

members were not paid for their service. (Haas, supra, 27 Cal.4th at p. 1021.) And

unlike the optometry board in Gibson, their decision would not have eliminated half their

competitors. (Gibson, supra, 411 U.S. at p. 578.) Beyond Dr. Dexter’s disclaimer, there

was no evidence that their individual incomes, the income of their colleague Dr. Shankel,

or the overall income to the group, would change, or by how much, if BMG captured all

of Dr. Luke’s patient admissions and generated critical care consultations to Drs. Dexter,

Shankel and/or Brockmann on each of them.39

Personal and Professional Interest

While bias stemming from an adjudicator’s pecuniary interest is the factor most

often considered destructive of impartiality, personal or professional embroilment in the

dispute may have the same effect. (Applebaum, supra, 104 Cal.App.3d at p. 657; Code

Civ. Proc., § 170.1.) Business and Professions Code section 809.2 mandates that the trier

of fact in a peer review hearing “shall” either be “selected by a process mutually

acceptable to the licentiate and the peer review body” or be an “unbiased individual[]

who shall gain no direct financial benefit from the outcome” and who has not been

39 M.E. was apparently initially scheduled for admission to an ICU-type unit, but

instead was sent to a regular hospital floor, but there is no evidence in the record that the
change in assignment would have had any financial effect on the income of BMG or
Dr. Dexter.

69

involved in the same matter as the “accuser, factfinder, or decisionmaker.” (Bus. & Prof.

Code, § 809.2, subd. (a).)

In interpreting the meaning and effect of a statute, our task is to give significance

to every word, to harmonize provisions, and to avoid interpreting any provisions or words

as surplusage. (Sahlolbei v. Providence Healthcare, Inc., supra, 112 Cal.App.4th at

p. 1150; Weinberg v. Cedars-Sinai Medical Center (2004) 119 Cal.App.4th 1098, 1114;

Mir v. Charter Suburban Hospital (1994) 27 Cal.App.4th 1471, 1483.) Under these

principles, we must assume that the Legislature included the word “unbiased” to indicate

that physician adjudicators in peer review cases must, as nearly as possible, be unbiased

for any reason, not only because of the possibility of direct financial gain or prior

involvement in the case. Although the section specifies various grounds which may

generate bias, we do not find it an exhaustive list. There would be no need for the

adjective if the itemized factors were the only possible grounds for bias. Race, ethnicity,

gender, national origin, language impediments, and disability status are all possible

sources of bias, for example, even though they are not mentioned in the statute.

There is little doubt that the trier of fact in this case was not selected by a process

mutually acceptable to Dr. Luke and the MEC. That the trier of fact may not have been

unbiased is also a possibility. Inexplicably, the relevant provision of RCH’s medical staff

bylaws omits the word “unbiased” and so fails to provide for the contingency of bias

based on factors other than financial interest and prior involvement in the case. The

bylaw reads simply: “The [JRC] members shall gain no direct financial benefit from the

70

outcome, and shall not have acted as accusers, investigators, fact finders, and initial

decision makers . . . in the consideration of the matter . . . .” (RCH Medical Staff Bylaws

and General Rules and Regulations (rev. 1/2003) (RCH bylaws) § 7.3-5, p. 60.)40

Despite the omission, however, the bylaws provide for an alternative pool of potential

panel members and, thus, implicitly recognize that the selection of a panel of unbiased

individuals may be difficult. “In the event it is not feasible to appoint a judicial review

committee from the active Medical Staff, the Medical Executive Committee may appoint

members from other staff categories or practitioners who are not members of the Medical

Staff.” (RCH bylaws § 7.3-5.)

It is true that there is more flexibility in the rules requiring disqualification in

administrative proceedings than in court proceedings, and a claim of possible bias must

“‘overcome a presumption of honesty and integrity in those serving as adjudicators.’”

(Haas, supra, 27 Cal.4th at p. 1026; Withrow v. Larkin, supra, 421 U.S. at p. 47.) It is

also true that there was no evidence—and we do not suggest—that any of the panel

members in this case lacked integrity. However, in our view, several factors combined so

as to create an appearance of bias and “a possible temptation to the average [physician] as

judge not to hold the balance nice, clear and true.” (Haas, at p. 1026.) These included

the close personal and professional relationship between Drs. Dexter and Shankel, the

history of the development of the comfort care protocol and its use at the hearing, and

40 RCH’s medical staff bylaws were approved in July 2002 and revised in January

2003, as this case was framing up. Because we do not have any earlier versions, we
cannot tell what, if any, changes were made at that time.

71

direct evidence of Dr. Dexter’s fixed leaning of mind and predisposition to decide the

issue in a certain way. Any one of these factors, standing alone, might not have been

enough to generate an appearance of unfairness or a temptation “not to be scrupulously

fair.” (Id. at p. 1030.) Together they did.

The first indication of possible professional bias lay in the MEC’s selection of

physicians for the JRC. By virtue of his position as “Chairman of the Medicine

Department,” Dr. Shankel was responsible, along with other physicians on the MEC—

including chairperson Dr. Rosario, who was also a BMG partner—for choosing the

members of the panel. Per se, there was nothing wrong with this procedure. The MEC

and the hospital board had discretion under the peer review statute and the related RCH

bylaw to choose the JRC panel members; the mere exercise of that discretion did not

necessarily give rise to an appearance of bias. (Bus. & Prof. Code, § 809.2, subd. (a);

RCH bylaws § 7.3-5.) Nevertheless, because of his relationship to Dr. Shankel, the

choice of Dr. Dexter was problematic.

Dr. Shankel was more than an adverse witness and an MEC member; he was also

the primary physician investigator of the matter and the chief witness in the case against

Dr. Luke. And Dr. Dexter was Dr. Shankel’s longtime, close colleague. It is clear from

the record that the two were not, as counsel for the MEC argued or inferred to the hearing

officer at voir dire, to the hospital board during the internal appeal, and to trial Judges

Krug and Brisco, simply loosely associated members of a very large, 140-physician

group. They had worked together for years as specialists in pulmonary critical care, a

72

highly technical area of medicine. It appears from the record that there were only three

such specialists on the RCH staff at the time. The appointment of a close specialist

colleague of Dr. Shankel’s to a judicial committee before which he was set to testify as a

material adverse witness created a strong appearance—and perhaps even a probability—

of professional and personal bias.41

Counsel for Dr. Luke made several, ultimately unsuccessful, attempts to draw the

potential for conflict arising from the relationship between the physicians to the attention

of the hearing officer: first in his prehearing letter and later at voir dire. In adopting the

argument of the MEC and denying the motion to replace the two, the hearing officer

stated that he had inquired, separately, of each panel member, before voir dire began, and

all had said they were not biased or prejudiced. However, “if the juror honestly, but

falsely, believes he/she is impartial, no amount of questioning will lead to an admission

of bias.” (People v. Diaz (1984) 152 Cal.App.3d 926, 939.) And tenacious voir dire in a

situation where the hearing officer has examined peer review committee members off the

record and formed an opinion that they are not biased, can be particularly fraught with

peril. “The person whose rights are being determined should not be placed in a position

of being required to object and thereby spur hostility” (Hackethal v. California Medical

Assn. (1982) 138 Cal.App.3d 435, 444 [Fourth Dist., Div. Two]), or to “risk the wrath of

41 We express no opinion about Dr. Brockmann on this point. There was no

evidence that he had ever practiced with Drs. Shankel and Dexter in pulmonary critical care.

73

those sitting in judgment by challenging their representation of impartiality” (Rosenblit v.

Superior Court, supra, 231 Cal.App.3d at p. 1448).

A second area suggesting “personal embroilment in the dispute” and an

appearance of professional bias, relates to the production and use of the comfort measures

only protocol. The protocol was repeatedly referenced by counsel for the MEC to show

that Dr. Luke’s management of M.E.’s morphine administration violated the standard of

care.42 In his testimony to the JRC, Dr. Shankel said that Dr. Dexter was “involved” in

the protocol’s development, and that he did not know anyone else who was involved.

Under these circumstances, while it would not be unnatural for Dr. Dexter to measure

Dr. Luke’s treatment decisions by a protocol he had been involved in creating, even to an

average observer the possibility creates an appearance of professional bias.

The other problem with the protocol was that, despite RCH’s position that it

defined the standard of morphine administration for all medical personnel at the hospital,

it does not seem ever to have been actively brought to the attention of either the medical

or nursing staff. The Chairman of the Medicine Department, Dr. Shankel, did not know

if it had been disseminated to the medical staff or discussed at medical staff meetings, but

42 The protocol has two parts: a preprinted progress note and a set of preprinted

orders for increasing the morphine for patients with DNR orders. Both parts require a
physician’s signature, but the orders appear to delegate evaluations of pain and distress,
upon which increases in morphine doses are to be based, to a nurse. If, as in this case, a
physician is directly monitoring the patient, it is not clear that, or how, the preprinted
orders apply. Dr. Luke had apparently been checking M.E.’s status continually
throughout the day, while Nurse George had just come on duty for her shift and was in
“report” when Dr. Luke wrote his orders. It is not evident that the protocol would have
been appropriate in these circumstances.

74

thought maybe the nursing staff knew about it. Dr. de Jager had never seen or heard of it.

Nurse Parenteau was unfamiliar with it and called the ICU when he wanted information

about it. If the protocol was meant to represent an absolute rule for morphine

administration for both physicians and nurses throughout the facility, as the hospital

argues, it is difficult to explain why it had not been more widely distributed.

Dr. Shankel’s statements that the protocol was for the “guidance” of physicians “who

want to use it,” indicates use of that the protocol was subject to physician discretion in

any given case.

We are aware that some courts have held that “[i]n administrative proceedings, ‘a

party claiming that the decision maker was biased must show actual bias, rather than

[just] the appearance of bias, to establish a fair hearing violation[,]’ [and that] ‘the mere

suggestion or appearance of bias is not sufficient.’” (Weinberg v. Cedars-Sinai Medical

Center, supra, 119 Cal.App.4th at p. 1115; see also Southern Cal. Underground

Contractors, Inc. v. City of San Diego (2003) 108 Cal.App.4th 533, 549; Hongsathavi,

supra, 62 Cal.App.4th at p. 1142.) Here, however, Dr. Dexter’s remarks and questions

throughout the hearing tended to show that he harbored a “leaning of the mind” and a

predisposition to decide important issues in the case “in a certain way.” (Pacific, supra,

82 Cal.App.3d at pp. 86-87.)

In telling Dr. Liao that whether euthanasia had been committed was “the

question,” Dr. Dexter demonstrated that he believed that the fundamental issue in the

case was not whether Dr. Luke had simply raised a morphine dose with accelerated or

75

improper titration, but whether he did it in order to kill his patient. Dr. Dexter’s belief

that this was the central issue was evident at several points in the proceedings. He posed

a counterfactual hypothetical to Dr. Liao, asking whether a “bolus” of 80 milligrams of

morphine—an amount we find nowhere in the record—was an appropriate dose. He

opined that “the documents in the chart,” combined with “Dr. Shankel’s note,” indicated

that Dr. Luke had committed “family-instigated active euthanasia.” Evidence to the

contrary appeared to carry little weight, including the fact that family members and

Dr. Luke had all repeatedly denied such a purpose.

The court in Pacific summarized its position as follows: “‘“The truth of few, if

any, ultimate ‘facts’ of human existence are established to that point of complete

certitude which eliminates all plausible doubt. A fact as difficult of ascertainment as any

person’s ‘prejudice’ is seldom, if ever, proven so completely that reasonable persons

might not still disagree. And the mere allegation or good faith belief that a fact is true

may be sufficient to cause reasonable doubt. Since the legitimacy of the Court’s role is

essentially a perception of the people, in whose secure confidence the courts must remain

if their powers are to be maintained, it follows that merely probable or even alleged facts

or a good faith belief in such facts may be sufficient to disqualify a judge.”’” (Pacific,

supra, 82 Cal.App.3d at p. 88.) “No persuasive reason exists to treat administrative

hearing officers,”—in this case JRC panel members—“differently.” (Haas, supra, 27

Cal.4th at p. 1025.) The position of physician adjudicators in peer review proceedings is

clearly analogous to the role of judges in courts of law as described in Pacific: their

76

legitimacy lies in the perception of their neutrality to the average observer or member of

the discerning public. (Pacific, at pp. 87-88.) Dr. Dexter’s open articulation of his belief

that Dr. Luke had killed M.E. at the behest of family members undermined his

appearance of neutrality.

Effect of the Toxicology Report and Amended (Second) Death Certificate:

More pernicious than the possibility or appearance of bias on the part of any single

adjudicator was the probability of pervasive bias generated by the unreliable toxicology

report and the amended (second) death certificate based on that report.

“Due process questions are raised when the administrative agency’s initial view

of the facts based on evidence derived from nonadversarial processes as a practical or

legal matter forecloses fair and effective consideration of the merits at an adversary

hearing leading to the ultimate decision.” (Applebaum, supra, 104 Cal.App.3d at

pp. 657-658.)

Despite its ultimate acknowledgment that the morphine level might be unreliable,

it is clear that the JRC’s initial view of the facts, like that of the MEIC and the MEC, was

based in significant part on evidence (the toxicology report and the amended (second)

death certificate that the report generated); derived from a nonadversarial process

(laboratory testing of a mislabeled specimen); that as a practical matter foreclosed a fair

and effective consideration of the merits (of Dr. Luke’s observation of M.E.’s condition

and his decision to increase the dose of morphine at an accelerated rate); at the

77

evidentiary and adversarial hearings (of the MEC, MEIC, and JRC); that led to the

ultimate decision (by the hospital board).

RCH’s argument—that the JRC decision’s acknowledgment that the toxicology

report and amended (second) death certificate might be unreliable meant that it had not

relied upon them, and that therefore the hospital board did not need to do more than

reaffirm its own previous decision—ignores the practical realities of the documents’

effect and dodges the essence of Judge Krug’s writ order.

A close look at the timeline of events shows that the report and the amended

(second) death certificate based upon the report influenced every level of investigation

and decision from the beginning of the case.

Inception of the Order for the Toxicology Test

After Cook’s e-mail suggested that Dr. Luke’s treatment amounted to euthanasia

rather than comfort care and could result in liability for the hospital, Loscutoff became

concerned that a homicide had been committed.43 Thereafter, the risk manager actively

sought an order for a blood test and made repeated calls to the coroner’s office until it

was ordered. M.E.’s body was then held at the hospital until September 18, 2002, four

days after his death, so that the sample could be drawn. When the MEC met for the first

43 In 2001, the California Legislature increased the fines for a responsible

individual’s failure to file a Business and Professions Code section 805 report by a factor
of 10: from $10,000 to $100,000 for a “willful” or “intentional” failure; and from $5,000
to $50,000 for a failure due to any other reason. (Bus. & Prof. Code, § 805, subds. (k),
(l); see former Bus. & Prof. Code, § 805 subds. (g), (h), Stats. 2001, ch. 614, § 2.) It is
unclear whether Cook was referring to liability for these penalties, or to the possibility of
a civil lawsuit by M.E.’s family, or to possible criminal liability.

78

time the next day, September 19, its minutes specified that the coroner was reviewing

“the blood” to determine the cause of death and that the result could be expected in about

three weeks.

Subsequently, Bell and Loscutoff made sustained efforts to obtain a copy of the

toxicology results. When Loscutoff received the verbal report of the results from the

coroner’s office, she notified Drs. Rosario and Shankel, who called additional meetings

of the MEC and MEIC. At the JRC hearing, Loscutoff said that she could not remember

when she received the verbal report, beyond the fact that it was “quite a long time” before

she received the faxed copy on December 26, 2002. However, from testimony by

Drs. Rosario and Mehta, it appears that Loscutoff most likely received and transmitted

the verbal report to the MEIC some time before November 14, 2002.

Effect on the MEIC

For the MEIC, the projected cause of the patient’s death based on the toxicology

report was pivotal. It was not, as later characterized by counsel for the MEC, merely

“unimportant” or “an interesting side issue.” The timing and draconian nature of the

committee’s recommendations indicate that they were based largely upon the toxicology

report and impending changes to the death certificate, not upon anything that had

occurred up to that point.

At no point in the initial investigations did Dr. Luke deny that he had increased the

morphine from 5 to 50 milligrams per hour and readily admitted that he had adjusted the

IV infusion rate himself. Dr. Shankel had talked to Dr. Luke and dictated the

79

memorandum of their telephone conversation three days before he and the other members

of the MEC met for the first time. Despite all this, once he explained his observations of

the patient’s condition and his reasons for the increase, Dr. Luke’s privileges were

restored less than a week after they had been suspended.

Five weeks after the restoration—sometime between the day (Oct. 29, 2002) that

Dr. Sheridan’s office received the toxicology results from the San Diego laboratory and

conveyed the information to Loscutoff, and the day (Nov. 14, 2002) it issued its first

report—the MEIC adopted a different stance. When MEIC committee members learned

that the coroner intended to list the cause of death as “homicide,” proctoring had become

too difficult and legal liability too great, “[b]ecause here we have a case where the death

has occurred . . . intentionally from overdose of morphine.”

It is evident that it was the toxicology report and planned amendment to the death

certificate—not the increased rate of morphine administration, not the fact that the family

had allegedly pressured him, not the fact that Dr. Luke had turned up the IV without

notifying the nurse assigned to the case, and not even the fact that he had dictated a

second discharge summary (which was unknown at the time)—that spurred the

recommendation for an immediate and long-term suspension of his hospital privileges.

The recommendation was not simply a proctoring and continuing education

requirement with which Dr. Luke stubbornly and unreasonably refused to cooperate.

Because of state and federal reporting requirements, the extended suspension would

almost certainly have affected all of his other hospital affiliations, his ability to obtain

80

malpractice insurance, and possibly his ability to receive payments for treatment of

Medicare patients. (Bus. & Prof. Code, §§ 805, subds. (b)(3), (e); 805.5; 809, subd.

(a)(9)(B); 42 U.S.C. 11131 et seq.; Merkel, Physicians Policing Physicians, supra,

38 U.S.F. L.Rev. at p. 304.) He thus had little choice but to contest the suggestion that he

had raised the morphine dose for a dying patient beyond that recommended by “any

known protocol” in order to kill him.

Effect on the MEC and the JRC Hearing

As the JRC proceedings unfolded, it became clear that it was not only the MEIC

that considered the toxicology report and the cause of death of great significance. It was

the MEC that sought admission of the amended (second) death certificate. And it was

counsel for the MEC who asked almost every MEC witness for an opinion as to the cause

of death. Because of the toxicology report, Drs. Hsu, Rosario, and Mehta all believed

that M.E. had died from a morphine overdose rather than from multisystem organ failure.

It is true that after Drs. Katz and Simonian questioned the laboratory results, the

MEC began to minimize the significance of the cause of death and to discount the

importance of Dr. Sheridan’s testimony. But in closing argument, the MEC returned to

the issue by pointedly comparing Dr. Luke, unfavorably, to Dr. Kevorkian: “[A]t least

Dr. Kevorkian devised methods where the persons who were looking to commit suicide

performed the last act that would result in their death. Here patient M.E. didn’t perform

that last act. It was Dr. Luke that performed it.” This was not merely an argument about

81

a local standard of practice for morphine titration. It was an accusation of intentional

killing.

Effect on Dr. Luke and His Attorney

Dr. Luke and his counsel were also affected by the toxicology report and changes

to the death certificate. As he admitted early on to the MEC, and as later found by the

State Medical Board, he had failed to properly record his observations of M.E.’s

condition or his reasons for increasing the rate of morphine administration. And,

although unknown to the MEIC or the MEC on November 14 or 15, 2002, or even on

December 3, he had dictated a second discharge summary a month after the first in an

apparent effort both to make corrections and to create the omitted chart notes after the

fact.44 He put into the second summary all the things about M.E.’s condition and his

reasons for accelerating the rate of morphine administration that he had told Loscutoff on

September 16, told the MEC on September 19 and 24, and the MEIC in his meetings with

44 In his letter to the State Medical Board requesting reconsideration of the plan to
revoke his license, Dr. Luke claimed that he dictated the first summary from memory at a
time when he did not have the chart available, and that he dictated the second summary
after he had it in hand. We do not address the hospital’s arguments that there is no
evidence that Dr. Luke was ever denied access to M.E.’s chart except to note that the
doctor’s claim that the chart was unavailable to him on September 17, 2002, when he
dictated the first version of the discharge summary, is not inconsistent with other
information in the record. Bell had M.E.’s chart in her office for Dr. Shankel to review
on the 16th. According to her testimony, she also “secured” and copied it on September
27 and again at the end of December. There is no indication of where the chart was in the
intervening time period or exactly when it was returned to the medical records
department. In view of these uncertainties, and in view of the absence of any specific
number of days for discharge summary dictation specified in the relevant hospital
policies (RCH Adm. Policy Nos. A10, A19; Gen. Rules & Regs. §§ 8.2, 8.3), it is unclear
whether the second summary was dictated “substantially after” the events described.

82

them. But it was only after the toxicology results became known, along with the fact that

the coroner was going to list the cause of death as “homicide,” that Dr. Luke retained

counsel. From that point on, because of the language in the amended (second) death

certificate, his attorney would not let him testify.45 This opened the way for opposing

counsel to argue that all of Dr. Luke’s statements had been and would continue to be

false and that he was a physician of the Kevorkian variety.

Effect on the State Medical Board

As noted ante, at the hearing before the State Medical Board on May 24, 2005,

Dr. Sheridan acknowledged the postmortem redistribution phenomenon and stated that it

is necessary to be “especially cautious” in interpreting postmortem blood levels of

morphine because, when the sample is taken from the heart rather than from a peripheral

site, the heart will always be higher. Nonetheless, based on the toxicology report whose

credibility he had just discounted, Dr. Sheridan testified that he believed M.E. had died

from an overdose of morphine rather than from his underlying diseases. Nine months

later, in January 2006, realizing that the blood sample was actually taken from a central

rather than a peripheral site, Dr. Sheridan changed his mind and issued what amounted to

a third death certificate. As a result, the State Medical Board reversed its decision to

revoke Dr. Luke’s license.

45 At oral argument, counsel for the hospital appeared to acknowledge that, given
the circumstances, his attorney’s refusal to allow Dr. Luke to testify was appropriate.

83

RCH is correct that it was not required to adopt the State Medical Board’s findings

and was not bound by its decision. RCH is also correct that a peer review committee

dealing with hospital privileges and a State Medical Board dealing with licensure issues

use different, escalating, standards of proof when considering charges against a

physician. (Ettinger v. Board of Medical Quality Assurance (1982) 135 Cal.App.3d 853,

856.) But Judge Krug ordered the hospital board to consider the State Medical Board’s

decision not to adopt its findings. The order made sense because, on a general level, both

entities have as concurrent goals the protection of patients and fairness to practitioners;

their proceedings and findings are thus not unrelated. In this particular case, both entities

conducted investigations and, as we have seen, freely exchanged information; both relied

upon the coroner’s laboratory report and opinion as to the cause of the patient’s death;

and both considered the cause of death significant to their ultimate decisions.

Moreover, unlike the JRC and the hospital board, the State Medical Board had

interviewed Dr. Luke directly and had heard testimony and obtained written evidence

from the coroner and deputy coroner. And unlike the JRC and the hospital board, the

State Medical Board had already held a rehearing. As a result, the State Medical Board

had accumulated significant evidence that was relevant to the peer review issues, even if

its decision about licensure was not controlling.

84

Summary

The toxicology report and the amended (second) death certificate were so

intimately entwined with actions and decisions in this case as to undermine the fairness of

the peer review proceedings and hospital board decisions. The effect was completely

separate from, and in addition to, the potential for individual adjudicator bias based on

business, personal, or professional relationships.

CONCLUSION

The task before this court in reviewing a matter with medical and legal issues of

the magnitude and complexity present in this case has not been easy. Even without the

cumulative effect of factors suggesting a possibility of adjudicator bias, the influence of a

death certificate based upon a mislabeled and very possibly erroneous laboratory report,

rendered the proceedings unfair. As a result, the accused physician did not have the

meaningful “opportunity to be fully and fairly heard before an impartial decisionmaker”

that fair procedure and due process require. (Catchpole, supra, 36 Cal.App.4th at

p. 245.) Accordingly, the hospital board’s reaffirmation of the JRC decision cannot

stand.

The question now is what is to be done. At oral argument, counsel for Dr. Luke

urged us to grant his petition for a writ of mandate ordering an unconditional

reinstatement to the RCH hospital staff. Counsel argued that too much time has passed

for his client ever to receive a fair hearing and that the expense and burden involved in

retaining new experts and witnesses is so great as to work additional unfairness. Counsel

85

for the hospital, on the other hand, urged us to either affirm Judge Briscoe’s denial of the

petition for a writ of mandate or to simply remand the matter to the hospital board for a

second reconsideration. Board members, he believed, would be happy to take any

“additional evidence” Dr. Luke might wish to present.

We find none of these suggestions appropriate. A fair peer review hearing before

an unbiased and impartial fact finder is what is required. (Bus. & Prof. Code, § 809.2,

subd. (a).) As we have determined, Dr. Luke has not yet had such a hearing, which can

only be held before a full complement of his peers. Neither the hospital board (which

included only three physicians), nor the internal appeal body (which included only one

physician), are adequate for such a hearing. (Bode v. Los Angeles Metropolitan Medical

Center (2009) 174 Cal.App.4th 1224, 1235-1236.) Under the relevant statute,

interpretive case law, and RCH medical staff bylaws, these bodies are bound by a

“substantial evidence” standard of review and cannot not sit as triers of fact. (Code Civ.

Proc., § 1094.5 subd. (d); Huang, supra, 220 Cal.App.3d at p. 1293; RCH bylaw 7.5-6

(a).) Accordingly, we will instruct the hospital to provide Dr. Luke with a fair peer

review hearing, not simply another reconsideration by a board composed largely of lay

persons bound by a deferential standard of review.

Although the procedural posture of this case is somewhat different, our reasoning

is similar to that of the court in Applebaum: “Since we [reverse] the judgment on the

basis of fair procedure defects in the administrative process,” where the “fatal flaw in the

proceedings before us was the lack of impartiality in the fact-finding process,” combined

86

with the effect of unreliable evidence obtained from a nonadversarial process, this is the

only remedy. (Applebaum, supra, 104 Cal.App.3d at pp. 657-658, 660-661.)

We emphasize that we do not intend our order to infringe upon the hospital’s

legally vested discretion, as provided for Code of Civil Procedure section 1094.5,

subdivision (f), and in sections 809 through 809.8 of the Business and Professions Code,

to exclude from its staff physicians that it has properly concluded, after fair proceedings,

do not meet its standards. “Fair hearings,” however, “are not a matter of discretion but

are required by law.” (Applebaum, supra, 104 Cal.App.3d at p. 661.)

At oral argument, the parties indicated that they had tried to resolve this dispute

before reaching us; we trust that these efforts were made in good faith and will continue.

If, however, they remain unable to reach resolution and choose to proceed to a new peer

review hearing, the hospital is to provide Dr. Luke with a new hearing officer and an

unbiased panel of impartial physician adjudicators unrelated to any material witness.

Otherwise, we do not specifically direct the parties how to proceed in structuring

the fair hearing, but note that there are sections of the RCH bylaws, like section 7.3-5

(specifying that adjudicators may be selected from outside the hospital’s medical staff);

section 7.5-7 (providing for more than one hearing under unusual circumstances, as when

ordered by a court); and section 7.7 (providing for expunction of a staff member’s

credentialing file); that may aid them to achieve the required result. The parties may, of

course, find others that are also relevant.

87

DISPOSITION

The judgment is reversed. Consistent with the views expressed in this opinion, the

trial court is ordered to issue a writ of mandate compelling respondent Redlands

Community Hospital afford appellant Dr. Harold Luke a fair hearing.

In the interests of justice, the parties are each to bear their own costs on appeal.

NOT TO BE PUBLISHED IN OFFICIAL REPORTS

RAMIREZ

P. J.

We concur:

KING

MILLER

J.

J.

88

M.A.K. v. Rush-Presbyterian St. Luke’s Medical Center

M.A.K. v. Rush-Presbyterian St. Luke’s Medical Center

Docket No. 90527-Agenda 28-May 2001.

M.A.K., Appellee, v. RUSH-PRESBYTERIAN-ST.-LUKE’S
MEDICAL CENTER, d/b/a Rush Behavioral Health
Center-Du Page, Appellant.

Opinion filed December 20, 2001.

JUSTICE GARMAN delivered the opinion of the court:

Plaintiff, M.A.K., filed a complaint in the circuit court of Will
County against defendants, Rush-Presbyterian-St. Luke’s Medical
Center (Rush) and Royal Maccabees Life Insurance Company
(Royal), alleging that Rush had improperly released certain
medical records to Royal, pursuant to a written consent signed by
plaintiff. The circuit court granted judgment on the pleadings to
Rush. Thereafter, plaintiff voluntarily dismissed his action as to
Royal and appealed the circuit court’s order. The appellate court
reversed and remanded (316 Ill. App. 3d 156). We granted Rush’s
petition for leave to appeal (177 Ill. 2d R. 315) and we now
reverse the judgment of the appellate court.

BACKGROUND

In count I of his second amended complaint, plaintiff alleged
that Rush had breached the physician-patient relationship by
releasing his records without first advising plaintiff of its intention
to do so and obtaining his approval. In count II, for invasion of
privacy, plaintiff alleged that Rush had wrongfully released his
medical records without his prior authorization or consultation.
Count III alleged negligent infliction of emotional distress.

The allegations of the complaint show that on January 13,
1995, plaintiff was admitted to Rush’s Behavioral Health
Center-Du Page (Behavioral Health Center) for alcohol
dependence. He was discharged on March 2, 1995. In October
1994, plaintiff had applied to Royal for a disability income
insurance policy. Royal issued the policy. While receiving
treatment at Rush, plaintiff contacted his insurance agent about
filing a claim for benefits under the policy. After receiving a claim
form from Royal, plaintiff notified Royal in February 1995 that he
would not be filing a claim. In April 1995, Rush received from
Royal a written consent signed by plaintiff, dated October 12,
1994, to release plaintiff’s medical and nonmedical information to
Royal. The records that Rush released to Royal included plaintiff’s
records of alcohol-dependence treatment. After receiving
plaintiff’s medical records from Rush, Royal cancelled plaintiff’s
disability policy.

The written consent signed by plaintiff was entitled
“AUTHORIZATION AND ACKNOWLEDGEMENT” (hereafter
authorization) and stated in pertinent part as follows:

“I AUTHORIZE any physician, medical practitioner,
hospital, clinic, health care facility, [or] other medical or
medically related facility[ ] *** having information
available as to diagnosis, treatment and prognosis with
respect to any physical or mental condition and/or
treatment of me *** and any other non-medical
information of me *** to give to Royal *** any and all
such information.

I UNDERSTAND the purpose of this authorization is
to allow Royal *** to determine eligibility for life or
health insurance or a claim for benefits under a life or
health policy. ***

I UNDERSTAND THAT my *** medical records may
be protected by certain Federal Regulations, especially as
they apply to any drug or alcohol abuse data. I understand
that I *** may revoke this authorization at any time as it
pertains to any such drug or alcohol abuse data by written
notification ***.

* * *

*** I AGREE this Authorization shall be valid for two
and one half years from [October 12, 1994].”

In the circuit court, Rush filed a motion for judgment on the
pleadings (735 ILCS 5/2-615(e) (West 1998)), arguing that
plaintiff’s executed authorization expressly permitted Rush to
release his medical and nonmedical records to Royal and was
therefore facially valid. Plaintiff argued that the authorization was
not a valid waiver of his right to confidentiality of his medical
records that were not in existence at the time he signed the
authorization and that Rush should have notified plaintiff that
Royal had submitted a request for his medical records. Plaintiff
also filed a reply to Rush’s reply brief in support of its motion for
judgment on the pleadings in which plaintiff included an affidavit
of his attorney, who stated that, during a meeting with Paul
Feldman, the medical director of the Behavioral Health Center,
Feldman admitted that plaintiff’s records should not have been
released to Royal. On December 11, 1997, the circuit court granted
Rush’s motion.

The issue addressed by the appellate court was whether the
authorization complied with the requirement of section 2.31(a)(1)
of the Confidentiality of Alcohol and Drug Abuse Patient Records
regulations (hereafter regulation). Confidentiality of Alcohol and
Drug Abuse Patient Records, 42 C.F.R. ?2.31(a)(1) (2000). The
regulation requires that a written consent for release of alcohol and
drug treatment records give the “specific name or general
designation” of the person or program authorized to make the
disclosure of such records. In reversing the circuit court, the
appellate court relied upon the “plain language” of the
authorization and concluded that the term “general designation”
required something more specific than the phrase “any physician,
medical practitioner, hospital, clinic, health care facility or other
medical or medically related facility.” The court described the
language of the authorization as “at best imprecise and far too
generic to be considered a general designation as that term is
commonly understood and as is required by the regulations.” 316
Ill. App. 3d at 160.

ANALYSIS

I. Standard of Review

Judgment on the pleadings is proper only where no genuine
issue of material fact exists and the moving party is entitled to
judgment as a matter of law. Chicago Title & Trust Co. v. Steinitz,
288 Ill. App. 3d 926, 934 (1997). In ruling on a motion for
judgment on the pleadings, only those facts apparent from the face
of the pleadings, matters subject to judicial notice, and judicial
admissions in the record may be considered. All well-pleaded facts
and all reasonable inferences from those facts are taken as true.
Mt. Zion State Bank & Trust v. Consolidated Communications,
Inc.
, 169 Ill. 2d 110, 115 (1995). Our review is de novo. Board of
Trustees of the University of Illinois v. City of Chicago
, 317 Ill.
App. 3d 569, 571 (2000).

II. Compliance With the Regulation

The regulation implements section 523 of the Public Health
Service Act (Public Health Act) (42 U.S.C. ?290dd-2 (1994)).
That section mandates the confidentiality of alcohol and drug
abuse patient records and prescribes the conditions and manner of
release of such records. It states in pertinent part as follows:

“(a) Requirement

Records of the identity, diagnosis, prognosis, or
treatment of any patient which are maintained in
connection with the performance of any program or
activity relating to substance abuse education, prevention,
training, treatment, rehabilitation, or research, which is
conducted, regulated, or directly or indirectly assisted by
any department or agency of the United States shall,
except as provided in subsection (e) of this section, be
confidential and be disclosed only for the purposes and
under the circumstances expressly authorized under
subsection (b) of this section.

(b) Permitted disclosure

(1) Consent

The content of any record referred to in subsection (a)
of this section may be disclosed in accordance with the
prior written consent of the patient with respect to whom
such record is maintained, but only to such extent, under
such circumstances, and for such purposes as may be
allowed under regulations prescribed pursuant to
subsection (g) of this section.” 42 U.S.C. ??290dd-2(a),
(b) (1994).

Subsection (g) grants authority to the Department of Health
and Human Services (Department) to promulgate regulations to
implement the purposes of the law. 42 U.S.C. ?290dd-2(g) (1994).
The regulation sets forth the requirements of a written consent
authorizing disclosure of a patient’s alcohol or drug abuse
treatment records. That section provides in pertinent part:

“(a) Required elements. A written consent to a
disclosure under these regulations must include:

(1) The specific name or general designation of the
program or person permitted to make the disclosure.

(2) The name or title of the individual or the name of
the organization to which disclosure is to be made.

(3) The name of the patient.

(4) The purpose of the disclosure.

(5) How much and what kind of information is to be
disclosed.

(6) The signature of the patient ***.

(7) The date on which the consent is signed.

(8) A statement that the consent is subject to revocation
at any time except to the extent that the program or person
which is to make the disclosure has already acted in
reliance on it. ***

(9) The date, event, or condition upon which the
consent will expire if not revoked before. This date, event,
or condition must insure that the consent will last no
longer than reasonably necessary to serve the purpose for
which it is given.” 42 C.F.R. ?2.31(a) (2000).

Familiar principles of statutory construction apply to the
interpretation of regulations of an administrative agency. See
Tivoli Enterprises, Inc. v. Zehnder, 297 Ill. App. 3d 125, 132
(1998). The primary rule of statutory construction is to give effect
to the intent of the legislature. Paris v. Feder, 179 Ill. 2d 173, 177
(1997). The best evidence of legislative intent is the language used
in the statute itself and that language must be given its plain and
ordinary meaning. Paris, 179 Ill. 2d at 177. The statute should be
construed as a whole and, if possible, in a manner such that no
term is rendered meaningless or superfluous. Texaco-Cities
Service Pipeline Co. v. McGaw
, 182 Ill. 2d 262, 270 (1998).
Where the meaning of a statute is unclear from a reading of its
language, courts may look beyond the language of the statute and
consider the purpose of the law, the evils it was intended to
remedy, and the legislative history behind it. In re B.C., 176 Ill. 2d
536, 542-43 (1997).

The phrase “general designation” is not defined in the
regulation. The word “general” means “involving, applicable to,
or affecting the whole,” “involving, relating to, or applicable to
every member of a class, kind, or group,” and “concerned or
dealing with universal rather than particular aspects”. Merriam
Webster’s Collegiate Dictionary 484 (10th ed. 1996).
“[D]esignation” is defined as “the act of indicating or identifying,”
and “a distinguishing name, sign, or title.” Merriam Webster’s
Collegiate Dictionary 313 (10th ed. 1996).

Rush argues that the phrase “general designation” is properly
construed to mean “a broad and comprehensive classification of
the programs and persons permitted to make disclosure” of the
patient’s confidential records. Since the terms “physician, medical
practitioner, hospital, clinic, health care facility, and other medical
or medically related facility” constitute such a classification, their
use in the authorization complied with the regulation. Plaintiff, on
the other hand, argues that the phrase requires the authorization to
contain a reference to records of treatment in an alcohol abuse
program.

As the appellate court recognized, this is an issue of first
impression. We have been unable to locate any case that has
addressed the question before us.

On its face, the phrase “general designation” appears to be
vague. The word “general” refers to a broad classification. The
word “designation” refers to either the act of identifying or a
distinguishing name or title. It is unclear how to reconcile these
words. We will therefore look beyond the language of the
regulation to determine the meaning of the phrase “general
designation.”

The original authority for the regulation derives from section
333 of the Comprehensive Alcohol Abuse and Alcoholism
Prevention, Treatment, and Rehabilitation Act of 1970 (Alcohol
Abuse Act) (42 U.S.C. ?4582 (1994)). That section is now section
523 of the Public Health Act (42 U.S.C. ?290dd-3 (1994)).
Congress recognized that, without guarantees of confidentiality,
many individuals would hesitate to seek treatment in alcohol and
drug abuse programs. Whyte v. Connecticut Mutual Life Insurance
Co.
, 818 F.2d 1005, 1010 (1st Cir. 1987). The purpose of enacting
the Alcohol Abuse Act was to facilitate the work of alcohol and
drug treatment centers by assuring the confidentiality of patient
records. United States v. Eide, 875 F.2d 1429, 1436 (9th Cir.
1989). The regulation was originally promulgated in 1975. 40 Fed.
Reg. 27802 (1975). Until 1987, the regulation provided that a
written consent to a disclosure of a patient’s alcohol or drug
treatment records must include the name of the program which
was to make the disclosure. 42 C.F.R. ?2.31(a)(1) (2000). The
regulation was amended in 1987 to its current form. In its
comments explaining the 1987 amendments the Department noted
that:

“The Final Rule retains all elements previously required
for written consent, though in one instance it will permit
a more general description of the required information.
The first of the required elements of written consent in
both the existing and proposed rule ([section] 2.31(a) (1))
asks for the name of the program which is to make the
disclosure. The Final Rule will amend that element by
calling for ‘(1) The specific name or general designation
of the program or person permitted to make the
disclosure.’ This change will permit a patient to consent
to disclosure from a category of facilities or from a single
specified program. For example, a patient who chooses to
authorize disclosure of all his or her records without the
necessity of completing multiple consent forms or
individually designating each program on a single consent
form would consent to disclosure from all programs in
which the patient has been enrolled as an alcohol or drug
abuse patient. Or, a patient might narrow the scope of his
or her consent to disclosure by permitting disclosure from
all programs located in a specified city, from all programs
operated by a named organization, or as now, the patient
might limit consent to disclosure from a single named
facility. (In this connection, the Department interprets the
existing written consent requirements to permit consent to
disclosure of information from many programs in one
consent form by listing specifically each of those
programs on the form.)

This change generalizes the consent form with respect
to only one element without diminishing the potential for
a patient’s making an informed consent to disclose patient
identifying information. The patient is in [a] position to be
informed of any programs in which he or she was
previously enrolled and from which he or she is willing to
have information disclosed.” Confidentiality of Alcohol
and Drug Abuse Patient Records, 52 Fed. Reg. 21,796,
21,799 (June 9, 1987).

After careful consideration, we conclude that the authorization
signed by plaintiff in this case complies with section 2.31(a)(1) of
the regulation. Prior to the 1987 amendments, the regulation
required a written consent to give the specific name of the program
or person permitted to make the disclosure. The intent of the
amendments was to broaden the permissible wording of a written
consent to disclosure of alcohol and drug treatment records. The
amended regulation permits a more general description of the
person or program to make the disclosure. This relaxed
requirement serves the amendments’ stated purpose of relieving
patients of the necessity of executing multiple consent forms or
specifically naming each and every program or person entitled to
make disclosure of alcohol or drug treatment records. The
appellate court’s interpretation of the phrase “general designation”
gives too much emphasis to the word “designation.” In doing so,
the court essentially read the word “general” out of the phrase.
Construing the regulation in this manner undermines the intent of
the 1987 amendments. The authorization here gives a general
classification of the types of entities that are entitled to disclose
plaintiff’s medical and nonmedical information. That is all the
regulation requires.

We note that plaintiff does not argue that he failed to
understand that alcohol treatment records could be disclosed
pursuant to the authorization. Indeed, language in the authorization
specifically refers to alcohol and drug abuse treatment records,
advising plaintiff that such records may be protected by federal
regulations and that he may revoke the authorization at any time
as it pertains to such records. We therefore conclude that the
appellate court erred in finding the authorization invalid under
section 2.31(a)(1) of the regulation.

III. Issues Raised by Plaintiff

In his appellee brief, plaintiff raises additional arguments in
support of the appellate court’s decision. He argues that the
authorization failed to comply with two additional elements of the
regulation. The regulation requires a written consent for release of
alcohol or drug treatment records to state how much and what kind
of information is to be disclosed. 42 C.F.R. ?2.31(a)(5) (2000). It
also requires a written consent to state “[t]he date, event, or
condition upon which the consent will expire if not revoked
before. This date, event, or condition must insure that the consent
will last no longer than reasonably necessary to serve the purpose
for which it is given.” 42 C.F.R. ?2.31(a)(9) (2000). The
authorization states that “any and all” of plaintiff’s medical and
nonmedical information may be released. It also states that the
consent to disclosure will expire 2? years from October 12, 1994.

Plaintiff also argues that, even should we decide that the
authorization is valid, this cause should be remanded to the circuit
court to resolve issues of fact concerning whether Rush violated
its own policies and procedures in releasing plaintiff’s records. In
this argument, plaintiff relies on the alleged statement by Paul
Feldman, the Behavioral Health Center’s medical director, that
Rush should not have released plaintiff’s records.

Finally, plaintiff argues that, as a matter of law, the
authorization was not applicable to medical records not in
existence at the time he signed it.

Rush contends that plaintiff did not raise these arguments in
the circuit or appellate courts. It is not clear from the record that
all of these arguments are waived. After concluding that the
authorization failed to comply with the “general designation”
requirement of the regulation, the appellate court chose not to
address other arguments of the parties. The opinion does not
indicate what those arguments were. In addition, we note that
plaintiff argued in the circuit court that the authorization did not
waive his right to confidentiality of his medical records generated
after he signed the authorization. Regardless, the waiver rule is a
limitation on the parties and not the jurisdiction of this court.
Michigan Avenue National Bank v. County of Cook, 191 Ill. 2d
493, 518 (2000). Under the circumstances, we choose to address
plaintiff’s arguments.

A. Other Requirements of the Regulation

Plaintiff argues that the authorization fails to specify how
much and what kind of information is to be disclosed, as required
by the regulation. The authorization states that it applies to “any
and all such information,” i.e., all medical and nonmedical
information possessed by the entities to make the disclosure.
Plaintiff apparently complains that the authorization’s description
of this information is too broad. He cites, as his sole authority for
this argument, a publication entitled, “Checklist for Monitoring
Alcohol and Other Drug Confidentiality Compliance.” Department
of Health and Human Services Publication No. 18 (SMA)
96-3083 (1996). This publication was published pursuant to a
contract from the Center for Substance Abuse Treatment (Center)
of the Substance Abuse and Mental Health Services
Administration, an agency of the Department, as part of its
Technical Assistance Publication Series. The publication that
plaintiff refers to is Technical Assistance Publication 18 and it
purports to provide a checklist to assist alcohol and other drug
programs and state and other governmental monitoring agencies
in determining whether a breach of patient confidentiality has
occurred under federal law and regulations governing patient
confidentiality.

With regard to section 2.31(a)(5) of the regulation, this
publication states that the information to be released “should be
described as exactly and narrowly as possible in light of the
purpose of the release. Releases for ‘any and all pertinent
information’ are not valid.” Department of Health and Human
Services Publication No. 18 (SMA) 96-3083, Checklist, pt.
A(III)(A), Summary of the Rule.

Plaintiff’s reliance on this publication is misplaced, because
it explicitly states that “[t]he opinions expressed herein are the
views of the authors and do not necessarily reflect the official
position of [the Center] or any other part of the [Department].”
Department of Health and Human Services Publication No. 18
(SMA) 96-3083, Introduction. Thus, it provides no authority for
plaintiff’s contention that the authorization’s description of the
kind and amount of information to be released violates the
regulation. There is no indication in the regulation or in the
Department’s comments to the 1987 amendments that a broad
description of the information to be released is impermissible.

Plaintiff also argues that the authorization does not comply
with section 2.31(a)(9) of the regulation, governing the terms
under which a written consent to disclosure is to expire. Plaintiff
asserts that the authorization’s statement that it is valid for 2?
years from October 12, 1994, goes “substantially” beyond the time
reasonably necessary to serve the purpose for which the
authorization was given. In support of this argument, plaintiff cites
a footnote in another Technical Assistance Publication, entitled,
“Confidentiality of Patient Records for Alcohol and Other Drug
Treatment,” which notes that some states have statutes that
provide for the automatic expiration of written consents after 60
or 90 days. Department of Health and Human Services Publication
No. 13 (SMA) 95-3018 (1994), ch.1 n.11. As with the prior
publication cited by plaintiff, this latter publication expressly
represents only the views of its author. It provides no support for
plaintiff’s argument. The authorization here complied with the
regulation by stating the date upon which it would cease to be
valid. The stated purpose for the authorization was to enable Royal
to determine plaintiff’s eligibility for insurance and to evaluate any
claims made by plaintiff under his insurance policy. We cannot say
as a matter of law that a period of 2? years for the purpose of
evaluating any claims plaintiff might make under the insurance
policy is invalid.

B. Alleged Violation of Rush’s Policies in Disclosing Records

Plaintiff argues that this cause should be remanded for a
determination of whether Rush violated its own policies and
procedures in disclosing plaintiff’s records. Plaintiff relies on an
affidavit of his attorney referring to comments made by Feldman
during a meeting, stating that Rush should not have released the
records. Plaintiff notes that Rush did not challenge the affidavit,
which was attached to a reply to Rush’s reply to plaintiff’s
response to Rush’s motion for judgment on the pleadings.

Plaintiff’s reliance on this affidavit is misplaced. In ruling
upon a motion for judgment on the pleadings, a court may
consider only (1) facts apparent from the face of the pleadings, (2)
matters subject to judicial notice, and (3) judicial admissions in the
record. Mt. Zion State Bank & Trust, 169 Ill. 2d at 115. Extrinsic
evidence may not be considered. Romano v. Village of Glenview,
277 Ill. App. 3d 406, 413 (1995). Accordingly, the affidavit of
plaintiff’s attorney is irrelevant.

C. Validity of Authorization as to Subsequently Generated
Records

Plaintiff argues that, as a matter of Illinois law, the
authorization was not valid to waive his right to confidentiality of
his medical records that were not in existence on the date he
signed it. In support, he cites section 8-2001 of the Code (735
ILCS 5/8-2001 (West 1998)), which requires hospitals to permit
patients, after their discharge from the hospital, to examine and
copy their records. Plaintiff argues that the fact that the right under
this statute to examine and copy records accrues after discharge
from a hospital implies that a consent for release of hospital
records applies only to records in existence at the time the patient
signs the consent. Plaintiff cites no authority supporting his
interpretation of this statute. Section 8-2001 of the Code merely
allows patients access to their hospital records upon discharge.
Nothing in the statute implies that patients may not authorize
disclosure of treatment records that may be generated in the future.

Plaintiff next argues that, since he did not know at the time he
signed the authorization that he would be hospitalized in the future
for alcohol abuse treatment, he could not, by signing the
authorization, have waived his right to nondisclosure of his
records. Thus, without notice from Rush to plaintiff of Royal’s
request for his records, he could not have exercised his right to
revoke the authorization. In support of his argument, plaintiff cites
an Arizona case, Danielson v. Superior Court, 157 Ariz. 41, 754
P.2d 1145 (App. 1987). That case, however, is inapposite, as it
involved a situation in which a physician disclosed his alcohol
treatment records to a state investigatory agency and later sought
to prevent disclosure of those records in a medical malpractice
lawsuit. The appellate court held that the physician had no right to
withhold the records from the agency and that, in such cases, a
voluntary disclosure cannot be considered a waiver of the right to
invoke the confidentiality privilege in the future. Danielson, 157
Ariz. at 48, 754 P.2d at 1152. In the instant case, plaintiff had the
right not to sign the authorization and he maintained the right to
revoke it at any time. Plaintiff points to no authority for the
proposition that he could not waive his confidentiality privilege as
to subsequently generated medical records and we reject his
argument.

CONCLUSION

We hold that the circuit court did not err in entering judgment
on the pleadings in favor of Rush. We therefore reverse the
appellate court’s judgment and affirm that of the circuit court.




Appellate court judgment reversed;

circuit court judgment affirmed.

JUSTICE FREEMAN, specially concurring:

The majority holds that an authorization for release of medical
records executed by plaintiff, M.A.K., in favor of plaintiff’s
insurance carrier, Royal Maccabbes Life Insurance (Royal
Insurance), is valid. Consequently, defendant, Rush-Presbyterian-St. Luke’s Medical Center (Rush-Presbyterian), is not liable to
plaintiff for the release of plaintiff’s medical records to Royal
Insurance. I strongly disagree with the majority’s conclusion that
the authorization is valid. The authorization does not comply with
federal regulations concerning the release of alcohol- or drug-abuse treatment records. However, I join in the result reached by
the majority because I believe plaintiff cannot maintain a private
damages action where such action is grounded upon a violation of
the federal regulations.

BACKGROUND

In October 1994, plaintiff applied for a disability insurance
policy with Royal Insurance. In connection with the application,
plaintiff executed an authorization for release of medical records.
Plaintiff thereby authorized any “physician, medical practitioner,
hospital, clinic, health care facility [or] other medical or medically
related facility *** having information available as to diagnosis,
treatment and prognosis with respect to any physical or mental
condition and/or treatment” to release such information to Royal
Insurance. The purpose of the authorization was to allow Royal
Insurance “to determine eligibility for life or health insurance or
a claim for benefits under a life or health policy.” Plaintiff agreed
that the authorization would be valid for 2? years from October
12, 1994.

On January 13, 1995, plaintiff was admitted to Rush-Presbyterian’s Behavioral Health Center-Du Page (Behavioral
Health Center) for alcohol dependence. Plaintiff was released from
the program on March 2, 1995. Plaintiff considered filing a claim
with Royal Insurance for the treatment he received at the
Behavioral Health Center. He contacted his insurance agent and
requested a claim form. However, plaintiff later determined not to
file a claim, and so informed Royal Insurance.

In April 1995, Royal Insurance forwarded a copy of the
authorization to Rush-Presbyterian and requested the release of
plaintiff’s medical records. Rush-Presbyterian released plaintiff’s
records to Royal Insurance, including records of plaintiff’s
treatment for alcohol dependence. The records contained a
notation that the onset of plaintiff’s alcohol dependence took place
eight months prior to his admission to the Behavioral Health
Center. Royal Insurance cancelled plaintiff’s policy and refunded
his premiums.

Plaintiff filed suit against Rush-Presbyterian and Royal
Insurance. Plaintiff alleged that Rush-Presbyterian breached the
physician-patient relationship by releasing his records without first
advising plaintiff that it intended to do so. Plaintiff also sought
damages for breach of privacy and negligent infliction of
emotional distress. The trial court entered judgment on the
pleadings in favor of Rush-Presbyterian.

ANALYSIS

A. General Designation

In enacting the Alcoholism and Other Drug Abuse and
Dependency Act (the Illinois Act) (20 ILCS 301/1-1 et seq. (West
1994)), the Illinois legislature recognized the ills attendant to drug
and alcohol abuse and the need for coordinated efforts in treatment
and rehabilitation:

“Legislative Declaration. The abuse and misuse of
alcohol and other drugs constitutes a serious public health
problem the effects of which on public safety and the
criminal justice system cause serious social and economic
losses, as well as great human suffering. It is imperative
that a comprehensive and coordinated strategy be
developed under the leadership of a State agency and
implemented through the facilities of federal and local
government and community-based agencies *** to
empower individuals and communities through local
prevention efforts and to provide intervention, treatment,
rehabilitation and other services to those who misuse
alcohol or other drugs *** to lead healthy and drug-free
lives and become productive citizens in the community.”
20 ILCS 301/1-5 (West 1994).

A key provision in the treatment of alcohol and drug abuse is
maintaining the confidentiality of the patient’s records. To that
end, section 30-5 of the Illinois Act provides in part,

“(bb) Records of the identity, diagnosis, prognosis or
treatment of any patient maintained in connection with the
performance of any program or activity relating to alcohol
or other drug abuse or dependency education, early
intervention, intervention, training, treatment or
rehabilitation which is regulated, authorized, or directly or
indirectly assisted by any Department or agency of this
State or under any provision of this Act shall be
confidential and may be disclosed only in accordance with
the provisions of federal law and regulations concerning
the confidentiality of alcohol and drug abuse patient
records as contained in 42 U.S.C. Sections 290dd-3 and
290ee-3 and 42 C.F.R. Part 2.” 20 ILCS 301/30-5(bb)
(West 1994).

Section 30-5 lists certain exemptions to the confidentiality
requirement not applicable here. 20 ILCS 301/30-5(bb)(1) (West
1994). Section 30-5 also provides that, if the information at issue
is not exempt, a disclosure can be made only

“(A) with patient consent as set forth in 42 C.F.R.
Sections 2.1(b)(1) and 2.31, and as consistent with
pertinent State law.

(B) for medical emergencies as set forth in 42 C.F.R.
Sections 2.1(b)(2) and 2.51.

(C) for research activities as set forth in 42 C.F.R.
Sections 2.1(b)(2) and 2.52.

(D) for audit evaluation activities as set forth in 42
C.F.R. Section 2.53.

(E) with a court order as set forth in 42 C.F.R. Sections
2.61 through 2.67.” 20 ILCS 301/30-5(bb)(2) (West
1994).

Lastly, section 30-5 provides that “[a]ny person who discloses the
content of any record referred to in this Section except as
authorized shall, upon conviction, be guilty of a Class A
misdemeanor.” 20 ILCS 301/30-5(bb)(5) (West 1994).

As noted in the provisions cited above, the Illinois Act
specifically and extensively refers to the federal law and
regulations concerning alcohol- and drug-abuse treatment.
Looking to federal law, the Public Health Service Act (the federal
Act) (42 U.S.C. ?201 et seq. (1994)) protects the confidentiality of
records of “the identity, diagnosis, prognosis, or treatment of any
patient which are maintained in connection with the performance
of any program or activity relating to substance abuse education,
prevention, training, treatment, rehabilitation, or research, which
is conducted, regulated, or directly or indirectly assisted by any
department or agency of the United States.” 42 U.S.C. ?290dd-2
(1994), formerly 42 U.S.C. ?290ee-3 (1988). Such records may be
disclosed “in accordance with the prior written consent of the
patient with respect to whom such record is maintained, but only
to such extent, under such circumstances, and for such purposes as
may be allowed under regulations prescribed pursuant to
subsection (g) of this section.” 42 U.S.C. ?290dd-2(b)(1) (1994).

The regulations prescribed for the disclosure of a patient’s
alcohol- or drug-abuse treatment records require that the written
consent include “[t]he specific name or general designation of the
program or person permitted to make the disclosure.” 42 C.F.R.
?2.31(a)(1) (2000). The written consent must also include “[t]he
date, event, or condition upon which the consent will expire if not
revoked before. This date, event, or condition must insure that the
consent will last no longer than reasonably necessary to serve the
purpose for which it is given.” 42 C.F.R. ?2.31(a)(9) (2000).

In the present case, plaintiff authorized any “physician,
medical practitioner, hospital, clinic, health care facility [or] other
medical or medically related facility *** having information
available as to diagnosis, treatment and prognosis with respect to
any physical or mental condition and/or treatment” to release such
information to Royal Insurance. The majority finds this
authorization complied with the requirement of the federal
regulations that a written consent include “[t]he specific name or
general designation of the program or person permitted to make
the disclosure.” 42 C.F.R. ?2.31(a)(1) (2000).

Initially, the majority refers to Merriam-Webster’s Collegiate
Dictionary for definitions of the words “general” and
“designation.” The majority notes that the word ” ‘general’ “
means ” ‘involving, applicable to, or affecting the whole,’ “
” ‘involving, relating to, or applicable to every member of a class,
kind, or group.’ ” Slip op. at 6, quoting Merriam Webster’s
Collegiate Dictionary 484 (10th ed. 1996). Also, the majority notes
that the word “designation” is defined as ” ‘the act of indicating or
identifying,’ ” and ” ‘a distinguishing name, sign, or title.’ ” Slip
op. at 6, quoting Merriam Webster’s Collegiate Dictionary 313
(10th ed. 1996). The majority concludes,

“On its face, the phrase ‘general designation’ appears to
be vague. The word ‘general’ refers to a broad
classification. The word ‘designation’ refers to either the
act of identifying or a distinguishing name or title. It is
unclear how to reconcile these words. We will therefore
look beyond the language of the Regulation to determine
the meaning of the phrase ‘general designation.’ ” Slip op.
at 6.

The majority next refers to the 1987 amendments to the
federal regulations governing written consents. 40 C.F.R. ?2.31
(2000). Prior to 1987, the regulations required that a written
consent include the name of the program which was to make the
disclosure. The regulations, as amended, require that the written
consent include “[t]he specific name or general designation of the
program or person permitted to make the disclosure.” The
comments to the amendments explain,

” ‘This change will permit a patient to consent to
disclosure from a category of facilities or from a single
specified program. For example, a patient who chooses to
authorize disclosure of all his or her records without the
necessity of completing multiple consent forms or
individually designating each program on a single consent
form would consent to disclosure from all programs in
which the patient has been enrolled as an alcohol or drug
abuse patient. Or, a patient might narrow the scope of his
or her consent to disclosure by permitting disclosure from
all programs located in a specified city, from all programs
operated by a named organization, or as now, the patient
might limit consent to disclosure from a single named
facility. ***

This change generalizes the consent form with respect
to only one element without diminishing the potential for
a patient’s making an informed consent to disclose patient
identifying information. The patient is in [a] position to be
informed of any programs in which he or she was
previously enrolled and from which he or she is willing to
have information disclosed.’ ” Slip op. at 7-8, quoting
Confidentiality of Alcohol and Drug Abuse Patient
Records, 52 Fed. Reg. 21,796, 21,799 (June 9, 1987).

In light of these comments, the majority concludes,

“The intent of the amendments was to broaden the
permissible wording of a written consent to disclosure of
alcohol and drug treatment records. The amended
regulation permits a more general description of the
person or program to make the disclosure. This relaxed
requirement serves the amendments’ stated purpose of
relieving patients of the necessity of executing multiple
consent forms or specifically naming each and every
program or person entitled to make disclosure of alcohol
or drug treatment records. The appellate court’s
interpretation of the phrase ‘general designation’ gives too
much emphasis to the word ‘designation.’ In doing so, the
court essentially read the word ‘general’ out of the phrase.
Construing the regulation in this manner undermines the
intent of the 1987 amendments. The authorization here
gives a general classification of the types of entities that
are entitled to disclose plaintiff’s medical and nonmedical
information. That is all the regulation requires.” Slip op.
at 8.

The majority fails to consider, however, that the phrase
“general designation” is used in conjunction with the word
“program.” The regulations require that the written consent
include “[t]he specific name or general designation of the
program” permitted to make the disclosure. (Emphasis added.) 42
C.F.R. ?2.31 (2000). Although the regulations do not define the
phrase “general designation,” the regulations define the word
“program.” The regulations provide,

Program means:

(a) An individual or entity (other than a general medical
care facility) who holds itself out as providing, and
provides, alcohol or drug abuse diagnosis, treatment or
referral for treatment; or

(b) An identified unit within a general medical facility
which holds itself out as providing, and provides, alcohol
or drug abuse diagnosis, treatment or referral for
treatment; or

(c) Medical personnel or other staff in a general medical
care facility whose primary function is the provision of
alcohol or drug abuse diagnosis, treatment or referral for
treatment and who are identified as such providers.”
(Emphasis in original.) 42 C.F.R. ?2.11 (2000).

The definition of the word “program” narrows the breadth of the
term “general designation.” As defined in the regulations, a
program is an entity “other than a general medical care facility.”
The regulations further provide that a program is a unit within a
general medical facility “which holds itself out as providing, and
provides, alcohol or drug abuse diagnosis, treatment or referral for
treatment,” and which is identified as such. Lastly, the regulations
state that a program may also consist of medical personnel or other
staff identified as providers of treatment for alcohol or drug abuse.

In the present case, the authorization plaintiff gave to Royal
Insurance is overly broad. It does not refer to any particular
medical practitioner or medical program involved in the treatment
of alcohol or drug abuse. For that reason, the authorization fails to
comply with the requirements of the regulations. Instead, the
authorization makes available any and all records of medical
treatment plaintiff received from any “medical or medically related
facility.” The authorization thus contemplates the release of all
treatment records gathered by medical or medically related
facilities. Indeed, in my estimation, the authorization encompasses
records from any facility with a medically related purpose. No
record can be safely excluded under such a broad authorization.

In my view, the majority ignores the word “program” in
construing the phrase “general designation.” Moreover, in
construing the phrase “general designation,” the majority seems to
read the word “designation”out of the regulation. The majority
faults the appellate court because that court “essentially read the
word ‘general’ out of the phrase.” Slip op. at 8. However, the
majority commits the same type of error in reading the word
“designation” out of the phrase.

The majority also fails to give proper consideration to the
purpose of the federal Act. In Ellison v. Cocke County, 63 F.3d
467, 470-71 (6th Cir. 1995), the court explained,

“The underlying purpose of the Drug Abuse Office and
Treatment Act of 1972, from which the confidentiality
provision of the antecedent Section 290ee-3 derived, was
‘to bring about the most effective deployment of federal
resources against the devastating growth of drug abuse in
the United State.’ [Citation.] The thrust of the Act was
wholly administrative and bureaucratic: to coordinate
federal drug abuse prevention efforts. [Citations.]

The confidentiality of medical records maintained in
conjunction with drug treatment programs was essential
to that endeavor. Congress felt that ‘the strictest
adherence’ to the confidentiality provision was needed,
lest individuals in need of drug abuse treatment be
dissuaded from seeking help.”

The federal Act limits disclosure of a patient’s records to releases
made with the prior written consent of the patient. Even with a
written consent, however, disclosure is limited to “such extent,
under such circumstances, and for such purposes as may be
allowed under regulations prescribed pursuant to subsection (g)”
of the section. 42 U.S.C. ?290dd-2(b)(1) (1994). In turn,
subsection (g) provides,

“The Secretary shall prescribe regulations to carry out the
purposes of this section. Such regulations may contain
such definitions, and may provide for such safeguards and
procedures *** as in the judgment of the Secretary are
necessary or proper to effectuate the purpose of this
section, to prevent circumvention or evasion thereof, or to
facilitate compliance therewith.” 42 U.S.C. ?290dd-2(g)
(1994).

The regulations are thus intended to further the purpose of the Act.

As noted above, the authorization plaintiff executed is quite
broad. It authorizes the release of records of plaintiff’s treatment
at hospitals, clinics, health-care facilities, and other medical or
medically related facility. To uphold the validity of such an
authorization eviscerates the confidentiality provision and
countermands the purpose of the federal Act.

The majority relies upon the 1987 amendments to the
regulations and the purpose therefor to support the conclusion that
the authorization is valid. The majority reasons,

“The amended regulation permits a more general
description of the person or program to make the
disclosure. This relaxed requirement serves the
amendments’ stated purpose of relieving patients of the
necessity of executing multiple consent forms or
specifically naming each and every program or person
entitled to make disclosure of alcohol or drug treatment
records.” Slip op. at 8.

Without questioning the majority’s view of the 1987 amendments,
one wonders whether an amendment adopted for the convenience
of patients should be interpreted in such a manner as to deprive the
patients of the confidentiality of records that the legislature
endeavored to protect in the first place. The purpose of the
regulations is subordinate to the purpose of the federal Act. The
regulations are intended to further the federal Act and cannot exist
without reference to the Act and the purpose of the Act.

B. Time Reasonably Necessary

As noted above, the written consent must contain “[t]he date,
event, or condition upon which the consent will expire if not
revoked before. This date, event, or condition must insure that the
consent will last no longer than reasonably necessary to serve the
purpose for which it is given.” 42 C.F.R. ?2.31(a)(9) (2000).

The authorization plaintiff gave was for a period of 2? years
from October 12, 1994. Plaintiff argues that a period of 2? years
is substantially longer than the time period contemplated in the
regulation. The majority rejects plaintiff’s argument. The majority
states,

“The authorization here complied with the regulation by
stating the date upon which it would cease to be valid.
The stated purpose for the authorization was to enable
Royal to determine plaintiff’s eligibility for insurance and
to evaluate any claims made by plaintiff under his
insurance policy. We cannot say as a matter of law that a
period of 2? years for the purpose of evaluating any
claims plaintiff might make under the insurance policy is
invalid.” Slip op. at 11.

The majority ignores the fact that plaintiff did not make a
claim for the treatment he received at the Behavioral Health
Center. Thus, the more appropriate question here is whether a
period of 2? years to determine plaintiff’s eligibility for insurance
is excessive. In light of the federal Act’s purpose, I believe that the
time period at issue was not reasonably necessary to determine
plaintiff’s eligibility for insurance coverage.

I also believe that it is more appropriate to decide the question
of reasonableness on the facts of each case. Factors such as the
length of the policy may well inform the determination as to
reasonableness. The majority holds, as a matter of law, that a
period of 2? years is valid for the purpose of evaluating a claim.
Will this time period now become an industry standard? I, for one,
question the wisdom of such a pronouncement.

C. Cause of Action

In count I of his complaint, plaintiff alleged that Rush-Presbyterian breached the physician-patient relationship by
releasing his records without first advising plaintiff that it would
do so. In count II of the complaint, for invasion of privacy,
plaintiff alleged that Rush-Presbyterian wrongfully released his
medical records without his prior authorization or consultation. In
count III of the complaint, plaintiff sought damages for negligent
infliction of emotional distress. Count III is also based upon the
allegedly improper release of plaintiff’s medical records. Since
plaintiff authorized the release of the medical records, he can only
maintain an action based on the wrongful release of the records if
the authorization is invalid.

On its face, the authorization plaintiff gave Royal Insurance
is valid. Plaintiff signed the authorization so that Royal Insurance
would process plaintiff’s application for insurance and issue an
insurance policy to plaintiff. The authorization is rendered invalid
only if it fails to comply with the confidentiality provision of the
federal Act and regulations. The majority finds that the
authorization is valid. Implicit in this holding is that a plaintiff can
maintain a cause of action for breach of the physician-patient
relationship, invasion of privacy, or negligent infliction of
emotional distress based upon the release of the plaintiff’s medical
records if the plaintiff’s written consent fails to comply with the
federal Act and regulations.

It should be noted, however, that the federal courts have
determined that section 290dd-2 does not support a private
damages action. Chapa v. Adams, 168 F.3d 1036, 1038 (7th Cir.
1999); Ellison, 63 F.3d at 471. In Ellison the court explained,

“Congress felt that ‘the strictest adherence’ to the
confidentiality provision was needed, lest individuals in
need of drug abuse treatment be dissuaded from seeking
help. [Citation.] However, there is no indication that the
confidentiality provision was intended to be enforceable
by aggrieved private parties; the purpose of the provision
was not to create private rights as much as it was to create
public penalties in order to deter disclosure.” Ellison, 63
F.3d at 471.

See also Doe v. Broderick, 225 F.3d 440, 447 (4th Cir. 2000)
(“We hold that section 290dd-2 does not create ‘enforceable
rights, privileges, or immunities within the meaning of ?1983′ “).

The alleged invalidity of the authorization is based upon the
failure to comply with the confidentiality provision and the
regulations controlling the disclosure of alcohol- and drug-abuse
records. The majority fails to consider, however, whether it is
appropriate to base a private damages action upon a violation of
the federal Act and regulations. I agree with the federal decisions
cited above that a private damages action based upon a violation
of the federal Act and regulations is inappropriate. Accordingly,
I would affirm the circuit court’s order granting judgment on the
pleadings to Rush-Presbyterian.

CONCLUSION

I disagree with the majority’s conclusion that the
authorization for the release of plaintiff’s medical records is valid.
The authorization fails to comply with the regulations concerning
the release of medical records for the treatment of alcohol and
drug abuse. The authorization is overly broad. Moreover,
upholding an authorization of such breadth is contrary to the
purpose of any alcohol- or drug-abuse program. As recognized by
the legislature, the success of an alcohol- or drug-abuse program
is largely dependent upon maintaining the confidentiality of the
patient’s records. Because of the stigma associated with alcohol-
or drug-abuse, a patient may be deterred from seeking treatment if
the patient believes that his or her records will be disclosed to third
parties. Although I strongly disagree with the majority’s analysis,
however, I must join in the result the majority reaches. I am
persuaded that a patient may not maintain a private damages action
for the release of his medical records where the action is grounded
upon a violation of 42 U.S.C. ?290dd-2 and the federal
regulations concerning the disclosure of alcohol- or drug-abuse
treatment records. In my opinion, the trial court properly entered
judgment on the pleadings in favor of Rush-Presbyterian.
Accordingly, I concur in the result in this case.



JUSTICE KILBRIDE, dissenting:

I agree with Justice Freeman’s analysis of the regulation
requiring a “general designation of the program or person” and
reject the majority’s interpretation of this provision. See 42 C.F.R.
?2.31(a)(1) (2000). In addition, I note that the comments to the
amendments emphasize the flexibility for patients in defining the
scope of their consent. Under the amendments, patients may now
use a single form to consent to the disclosure of records from a
single named program or from only certain kinds of programs. 52
Fed. Reg. 21,796, 21,799 (June 9, 1987). “This change will permit
a patient to consent to disclosure from a category of facilities or
from a single specified program. For example, a patient who
chooses to authorize disclosure of all his or her records *** would
consent to disclosure from all programs in which the patient has
been enrolled as an alcohol or drug abuse patient ***
.”
(Emphasis added.) Slip op. at 7, quoting 52 Fed. Reg. 21,796,
21,799 (June 9, 1987). This example clarifies the proper
interpretation of the “general designation” requirement by
recognizing that patients may now identify either a “category of
facilities
” or “a single specified program” in their consent.
(Emphasis added.) 52 Fed. Reg. 21,796, 21,799 (June 9, 1987).
Thus, a consent could validly authorize the disclosure of records
from all programs falling within the category of “alcohol or drug
abuse programs” by explicitly identifying that type of program.

In the instant case, however, the consent did not designate any
specific program category. Instead, it broadly claimed to authorize
disclosure of all types of medical records. The excessive breadth
of this consent contradicts the language in the comments and
undermines the strong confidentiality protections secured by the
Public Health Services Act (federal Act) (42 U.S.C. ?201 et seq.
(1994)). See also Chapa v. Adams, 168 F.3d 1036, 1038 (7th Cir.
1999) (noting that the purpose of the federal regulations is to fight
the country’s drug problem, primarily by encouraging voluntary
treatment, and recognizing that addicts are more likely to seek
treatment if it is provided confidentially). Thus, I join the portion
of Justice Freeman’s special concurrence rejecting the majority’s
interpretation of the “general designation” language in the
regulations. I do not adopt the special concurrence in its entirety,
however, because I believe it is inappropriate at this time to decide
whether a private cause of action may be maintained here since
that issue was not briefed or argued by the parties.

Moreover, I disagree with the majority’s treatment of a second
issue. The majority summarily disregards the plaintiff’s argument
that the scope of his authorization did not include medical records
created after he signed the consent form. Rather than address this
issue on its merits, the majority perfunctorily concludes that the
plaintiff failed to provide sufficient supporting authority for his
argument. Slip op. at 12-13. Yet, an examination of the majority’s
own extensive recitation of the comments to the amendments
supports the plaintiff’s argument. See slip op. at 7-8.

The comments explain that the changes allow patients the
choice of authorizing, on a single form, disclosure of records
“from all programs in which the patient has been enrolled as an
alcohol or drug abuse patient.” (Emphasis added.) Slip op. at 7,
quoting 52 Fed. Reg. 21,796, 21,799 (June 9, 1987). The past
tense of this language clearly and explicitly directs it at patient
records created prior to the signing of the consent, not those
generated months later.

This interpretation is further supported by the comments’
statement that the amendments seek to maintain “the potential for
a patient’s making an informed consent to disclose patient
identifying information” since ” ‘the patient is in [a] position to be
informed of any programs in which he or she was previously
enrolled
.’ ” (Emphasis added.) Slip op. at 8, quoting 52 Fed. Reg.
21,796, 21,799 (June 9, 1987). Again, the language clearly limits
disclosure to existing records of past programs. Moreover, it is
well established that the alleged waiver of a right will not be
upheld unless the waiver was knowing and voluntary. Vaughn v.
Speaker
, 126 Ill. 2d 150, 161 (1988). Waiver is consensual and
consists of the intentional relinquishment of a known right.
Western Casualty & Surety Co. v. Brochu, 105 Ill. 2d 486, 499
(1985). It would defy logic to conclude that a patient may validly
waive the right of confidentiality in records that do not even exist
at the time, thereby giving informed consent to their disclosure.
See Vaughn, 126 Ill. 2d at 161; see also Schiff v. Prados, 92 Cal.
App. 4th 692, 706, 112 Cal. Rptr. 2d 171, 182 (2001)
(“meaningful choice is at the heart of the informed consent
doctrine”).

Thus, I believe that the comments to the amendments support
the plaintiff’s contention that a valid consent must be limited to
the disclosure of existing records and it excludes records
subsequently generated. Since the scope of the consent signed by
the plaintiff is impermissibly broad and violates the protective
purpose of the regulations and the federal Act, I dissent from the
majority opinion.